
<html lang="en"     class="pb-page"  data-request-id="1dc90131-637b-4dfe-a689-00fde632ff1a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2015.58.issue-17;article:article:10.1021/acs.jmedchem.5b00746;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inhibitors" /></meta><meta name="dc.Creator" content="Jure  Borišek" /></meta><meta name="dc.Creator" content="Matej  Vizovišek" /></meta><meta name="dc.Creator" content="Piotr  Sosnowski" /></meta><meta name="dc.Creator" content="Boris  Turk" /></meta><meta name="dc.Creator" content="Dušan  Turk" /></meta><meta name="dc.Creator" content="Barbara  Mohar" /></meta><meta name="dc.Creator" content="Marjana  Novič" /></meta><meta name="dc.Description" content="Cathepsin K is a major drug target for osteoporosis and related-bone disorders. Using a combination of virtual combinatorial chemistry, QSAR modeling, and molecular docking studies, a series of cat..." /></meta><meta name="Description" content="Cathepsin K is a major drug target for osteoporosis and related-bone disorders. Using a combination of virtual combinatorial chemistry, QSAR modeling, and molecular docking studies, a series of cat..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 26, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00746" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00746" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00746" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00746" /></link>
        
    
    

<title>Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00746" /></meta><meta property="og:title" content="Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0009.jpeg" /></meta><meta property="og:description" content="Cathepsin K is a major drug target for osteoporosis and related-bone disorders. Using a combination of virtual combinatorial chemistry, QSAR modeling, and molecular docking studies, a series of cathepsin K inhibitors based on N-(functionalized benzoyl)-homocycloleucyl-glycinonitrile scaffold was developed. In order to avoid previous problems of cathepsin K inhibitors associated with lysosomotropism of compounds with basic character that resulted in off-target effects, a weakly- to nonbasic moiety was incorporated into the P3 position. Compounds 5, 6, and 9 were highly selective for cathepsin K when compared with cathepsins L and S, with the Ki values in the 10–30 nM range. The kinetic studies revealed that the new compounds exhibited reversible tight binding to cathepsin K, while the X-ray structural studies showed covalent and noncovalent binding between the nitrile group and the catalytic cysteine (Cys25) site." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00746"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00746">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00746&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00746&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00746&amp;href=/doi/10.1021/acs.jmedchem.5b00746" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 6928-6937</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b00709" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b00801" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development of <i>N</i>-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jure++Bori%C5%A1ek">Jure Borišek</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matej++Vizovi%C5%A1ek">Matej Vizovišek</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Piotr++Sosnowski">Piotr Sosnowski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Boris++Turk">Boris Turk</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Du%C5%A1an++Turk">Dušan Turk</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barbara++Mohar">Barbara Mohar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marjana++Novi%C4%8D">Marjana Novič</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">National Institute of Chemistry, Hajdrihova 19, SI-1001 Ljubljana, Slovenia</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Biochemistry, Molecular and Structural Biology, Jozef Stefan Institute, Jamova cesta 39, SI-1000 Ljubljana, Slovenia</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins, Jamova cesta 39, SI-1000 Ljubljana, Slovenia</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Faculty of Chemistry and Chemical Technology, University of Ljubljana, Večna pot 113, SI-1000 Ljubljana, Slovenia</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#c9a4a8bba3a8a7a8e7a7a6bfa0aa89a2a0e7baa0"><span class="__cf_email__" data-cfemail="7b161a09111a151a5515140d12183b1012550812">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#b2d0ddc0dbc19cc6c7c0d9f2dbd8c19cc1db"><span class="__cf_email__" data-cfemail="2d4f425f445e0359585f466d44475e035e44">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#42263731232c6c36373029022b28316c312b"><span class="__cf_email__" data-cfemail="83e7f6f0e2edadf7f6f1e8c3eae9f0adf0ea">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00746&amp;href=/doi/10.1021%2Facs.jmedchem.5b00746" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 6928–6937</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 17, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 May 2015</li><li><span class="item_label"><b>Published</b> online</span>26 August 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 September 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00746" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00746</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6928%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJure%2BBori%25C5%25A1ek%252C%2BMatej%2BVizovi%25C5%25A1ek%252C%2BPiotr%2BSosnowski%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D17%26contentID%3Dacs.jmedchem.5b00746%26title%3DDevelopment%2Bof%2BN-%2528Functionalized%2Bbenzoyl%2529-homocycloleucyl-glycinonitriles%2Bas%2BPotent%2BCathepsin%2BK%2BInhibitors%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6937%26publicationDate%3DSeptember%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00746"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1895</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">16</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00746" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jure&quot;,&quot;last_name&quot;:&quot;Borišek&quot;},{&quot;first_name&quot;:&quot;Matej&quot;,&quot;last_name&quot;:&quot;Vizovišek&quot;},{&quot;first_name&quot;:&quot;Piotr&quot;,&quot;last_name&quot;:&quot;Sosnowski&quot;},{&quot;first_name&quot;:&quot;Boris&quot;,&quot;last_name&quot;:&quot;Turk&quot;},{&quot;first_name&quot;:&quot;Dušan&quot;,&quot;last_name&quot;:&quot;Turk&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;Mohar&quot;},{&quot;first_name&quot;:&quot;Marjana&quot;,&quot;last_name&quot;:&quot;Novič&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;26&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;6928-6937&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00746&quot;},&quot;abstract&quot;:&quot;Cathepsin K is a major drug target for osteoporosis and related-bone disorders. Using a combination of virtual combinatorial chemistry, QSAR modeling, and molecular docking studies, a series of cathepsin K inhibitors based on N-(functionalized benzoyl)-homocycloleucyl-glycinonitrile scaffold was developed. In order to avoid previous problems of cathepsin K inhibitors associated with lysosomotropism of compounds with basic character that resulted in off-target effects, a weakly- to nonbasic moiety was incorporated into the P3 position. Compounds 5, 6, and 9 were highly selective for cathepsin K when compared with cathepsins L and S, with the Ki values in the 10–30 nM range. The kinetic studies revealed that the new compounds exhibited reversible tight binding to cathepsin K, while the X-ray structural studies showed covalent and noncovalent binding between the nitrile group and the catalytic cysteine (Cys25) site.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00746&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00746" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00746&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00746" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00746&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00746" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00746&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00746&amp;href=/doi/10.1021/acs.jmedchem.5b00746" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00746" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00746" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00746%26sid%3Dliteratum%253Aachs%26pmid%3D26280490%26genre%3Darticle%26aulast%3DBori%25C5%25A1ek%26date%3D2015%26atitle%3DDevelopment%2Bof%2BN-%2528Functionalized%2Bbenzoyl%2529-homocycloleucyl-glycinonitriles%2Bas%2BPotent%2BCathepsin%2BK%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D17%26spage%3D6928%26epage%3D6937%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291983" title="Nitrogen compounds">Nitrogen compounds</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/jmcmar.2015.58.issue-17/20150910/jmcmar.2015.58.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/medium/jm-2015-007468_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00746&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Cathepsin K is a major drug target for osteoporosis and related-bone disorders. Using a combination of virtual combinatorial chemistry, QSAR modeling, and molecular docking studies, a series of cathepsin K inhibitors based on <i>N</i>-(functionalized benzoyl)-homocycloleucyl-glycinonitrile scaffold was developed. In order to avoid previous problems of cathepsin K inhibitors associated with lysosomotropism of compounds with basic character that resulted in off-target effects, a weakly- to nonbasic moiety was incorporated into the P3 position. Compounds <b>5</b>, <b>6</b>, and <b>9</b> were highly selective for cathepsin K when compared with cathepsins L and S, with the <i>K</i><sub><i>i</i></sub> values in the 10–30 nM range. The kinetic studies revealed that the new compounds exhibited reversible tight binding to cathepsin K, while the X-ray structural studies showed covalent and noncovalent binding between the nitrile group and the catalytic cysteine (Cys25) site.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36376" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36376" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cathepsin K (Cat K)<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6 ref7">(1-7)</a> is a lysosomal cysteine protease, which has a major role in osteoporosis and other bone-related pathologies, diabetes, obesity, cancer, and atherosclerosis,<a onclick="showRef(event, 'ref8 ref9 ref10 ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10 ref11 ref12 ref13 ref14">(8-14)</a> rendering it an attractive target for the development of new therapeutics. For the almost two past decades, pharmaceutical industry has been focusing on the development of reversible covalent Cat K inhibitors for osteoporosis treatment based on nitrile or carbonyl warheads.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> The most advanced drug candidates, such as ONO-5334 and Odanacatib, are currently in clinical trials with Odanacatib successfully concluding the first phase III in postmenopausal women with osteoporosis (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>a).<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25">(17-25)</a> In contrast, the phase II clinical trials with <i>N</i>-[4-(4-propyl-piperazino)benzoyl]-homocycloleucyl-glycinonitrile Balicatib were discontinued due to unexpected off-target effects.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The side effect of Balicatib causing morphea-like skin hardening was ascribed to its lysosomotrophism, a tendency of the drug with a basic character to accumulate in the acidic lysosomal environment.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In order to avoid such side effects, the design of less basic <i>N</i>-(functionalized benzoyl)-homocycloleucyl-glycinonitriles with high biological activity and selectivity is of great interest.</div><div class="NLM_p">Cat K binding pocket involves three main binding sites: the S1 site lies entirely in the L-domain. The P1 residue carbonyl group is placed into the oxyanion hole formed on the N-terminus of the central helix between the Cys25 amide proton and the Gln19 side chain amide, whereas its side chain points upward into the solvent regions. The binding site for the P1 side chain is formed between the Asn21, Cys22, and Gly23 loop, which continues down into the central helix on one side and a broad turn formed by the main-chain atoms of Cys63, Gly64, and Gly65 on the other side. Both chains are cross-linked at the top with the Cys22–Cys63 disulfide bond. Hence, a P1 residue side chain would point along the S1 site binding surface away from the bottom of the active site cleft toward the solvent. The hydrophobic S2 site with main chain amide and carbonyl groups of Gly66 as hydrogen donors and acceptors of the main chain P2 residue and hydrophobic moiety of the S2 site spanned between Tyr67, Ala134, and Leu209, and the S3 area, which is relatively shallow and solvent exposed (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>b).<a onclick="showRef(event, 'ref16 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref16 ref28 ref29">(16, 28, 29)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/medium/jm-2015-007468_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) Representative Cat K inhibitors. (b) Binding of <i>N</i>-(functionalized benzoyl)-homocycloleucyl-glycinonitriles within the Cat K active site indicated by S1–S3 subsites.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00746&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In order to develop <i>N</i>-(“low basic” functionalized benzoyl)-homocycloleucyl-glycinonitriles as Cat K inhibitors, we first combined several computer-assisted drug design (CADD) tools, including virtual combinatorial chemistry, quantitative structure–activity relationship (QSAR) modeling, and molecular docking, which were already described as a successful approach in drug lead discovery and optimization.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> The applied QSAR model is based on our published work related to the prediction of biological activity of a given organic compound.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Next, a selection of the most promising inhibitor candidates were prepared and evaluated for their selectivity against cysteine cathepsins K, S, and L.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10451" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10451" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Virtual Combinatorial Chemistry</h3><div class="NLM_p last">First, a virtual combinatorial library of <i>N</i>-(functionalized benzoyl)-homocycloleucyl-glycinonitriles was generated by amidification of homocycloleucyl-glycinonitrile (<b>3</b>) using a database of readily accessible functionalized benzoic acids. For this, a commercial “Enamine fragment database simple-fl”<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> was filtered by a rule-of-three<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> (molecular weight < 300 Da, calculated Log <i>P</i> < 3, number of H-bond donor < 3) and was applied in the virtual combinatorial synthesis generating a 270-membered set of compounds. Applying the Veber filter<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> for oral bioavailability resulted in a 254-membered virtual combinatorial chemistry series, referred to as the combinatorial data set (see the <a href="/doi/suppl/10.1021/acs.jmedchem.5b00746/suppl_file/jm5b00746_si_001.pdf" class="ext-link">Supporting Information, Table S1</a>).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> QSAR Modeling</h3><div class="NLM_p last">The QSAR model, Counter-Propagation- Artificial Neural Network (CP-ANN), which was developed by some of us,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> was used to predict the biological activity (<i>K</i><sub>i-pred</sub>) of the combinatorial data set within a nM range (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Molecular Docking</h3><div class="NLM_p">The experimentally determined structure of the Cat K-“0LB ligand” complex (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DMX">4DMX</a>, <a href="/doi/suppl/10.1021/acs.jmedchem.5b00746/suppl_file/jm5b00746_si_001.pdf" class="ext-link">Figure S1</a>)<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> was used to carry out covalent molecular docking with our 254-membered combinatorial data set. For validation of this method, a 52-membered series data set, referred to as the experimental data set, composed of known <i>N</i>-(aroyl)-homocycloleucyl-glycinonitriles<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> was exploited.</div><div class="NLM_p">Next, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DMX">4DMX</a> was used to visually assess the fitness and orientation of the docked compounds. Redocking ligand validation gave satisfactory results as GOLD calculation reproduced the binding pose of 0LB within Cat K binding site. The ChemScore scoring function (CSF) yielded the lowest root-mean-square deviation (rmsd) value of 0.19 Å for the redocking and it was chosen for the assessment of the binding affinities of the combinatorial (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) and experimental data sets.</div><div class="NLM_p">Postdocking analysis was carried out in two steps. In the first step, ligand (combinatorial and experimental data sets members) fitness and orientation were assessed and marked with either “T” (true) or “F” (false), depending on the experimentally determined poses of the functional groups of 0LB ligand reference. When both orientation and fitness were correct (T), then the ligand was analyzed in the second step. Thus, visual inspection yielded 113 compounds out of our 254-membered combinatorial data set, and 14 compounds out of the 52-membered experimental data set (see <a href="/doi/suppl/10.1021/acs.jmedchem.5b00746/suppl_file/jm5b00746_si_001.pdf" class="ext-link">Supporting Information, Table S2</a>).</div><div class="NLM_p">In the second step of postdocking analysis, the key distances (<i>d</i>) between the features of the combinatorial and experimental ligands (derived from the first analysis step) and the key amino acid residues in <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DMX">4DMX</a> were calculated. Relying on a published data in the field,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> three H-bond interactions between each ligand and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DMX">4DMX</a> were considered: (R<sup>1</sup>-N<b><u class="uu">H</u></b>-CH<sub>2</sub>-CN)-(Asn161-C<b><u class="uu">O</u></b>) [<i>d</i><sub>4DMX-1</sub> = 3.28 Å], (R<sup>2</sup>-C<b><u class="uu">O</u></b>-NH–CH<sub>2</sub>-CN)-(Gly66-N<b><u class="uu">H</u></b>) [<i>d</i><sub>4DMX-2</sub> = 3.22 Å], and (R<sup>3</sup>-Ph–CO-N<b><u class="uu">H</u></b>-R′)-(Gly66-C<b><u class="uu">O</u></b>) [<i>d</i><sub>4DMX-3</sub> = 2.9 Å]. Due to the dynamic nature of biological systems, a tolerance of ±1 Å was applied: (R<sup>1</sup>-N<b><u class="uu">H</u></b>-CH<sub>2</sub>-CN)-(Asn161-C<b><u class="uu">O</u></b>) [<i>d</i><sub>4DMX-1</sub> = 2.28–4.28 Å], (R<sup>2</sup>-C<b><u class="uu">O</u></b>-NH-CH<sub>2</sub>-CN)-(Gly66-N<b><u class="uu">H</u></b>) [<i>d</i><sub>4DMX-2</sub> = 2.22–4.22 Å], and (R<sup>3</sup>-Ph-CO-N<b><u class="uu">H</u></b>-R′)-(Gly66-C<b><u class="uu">O</u></b>) [<i>d</i><sub>4DMX-3</sub> = 1.9–3.9 Å] (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Interatomic distance calculations yielded 12 valid compounds (or ligands) out of the retained 113-membered combinatorial data set and 7 valid compounds out of the retained 14-membered experimental data set.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Most Suitable Virtual Combinatorial <i>N</i>-(Functionalized benzoyl)-homocycloleucyl-glycinonitrile Compounds after Combining QSAR Modeling and Molecular Docking</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/medium/jm-2015-007468_0007.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/medium/jm-2015-007468_0008.gif" alt="" id="fx2" /></img><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Consensus Results</h3><div class="NLM_p">The approach combining QSAR modeling and molecular docking analysis resulted in 4 finally valid compounds (out of our original 254-membered combinatorial data set), which were then synthesized and subjected to kinetic studies. In addition to their predicted biological activities (<i>K</i><sub>i-pred</sub>) within the nM range, these compounds presented a correct visual orientation and fitness, and appropriate key interatomic distances between their features and the key amino acid residues in <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DMX">4DMX</a> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/medium/jm-2015-007468_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Close view of the natively present and GOLD-calculated covalently bound combinatorial Cat K ligands within <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DMX">4DMX</a>. The 0LB ligand conformation is depicted in red, and the molecular docking-calculated binding poses for the 4 valid combinatorial compounds are colored as following: compound <b>4</b> in green, compound <b>5</b> in magenta, compound <b>6</b> in yellow, and compound <b>10</b> in cyan. The key attachment point is Cys25 and the amino acid residues Gly66 and Asn161 are important for the stabilization of the ligand through H-bonding.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00746&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In comparison with the basic piperazino-substituted P3 side chain of Balicatib, the final four selected compounds possess significantly weaker basic P3 side chain, which was expected to reduce the off-target effects of these compounds during their application.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Synthesis of the Selected <i>N</i>-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles</h3><div class="NLM_p">These compounds derive from homocycloleucyl-glycinonitrile (<b>3</b>; <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). This was prepared in 51% overall yield via the <i>N</i>-carboxylic acid cyclic anhydride <b>2</b><a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> derived from commercial homocycloleucine hydrochloride.</div><div class="NLM_p">Three strategies were applied for amidification of <b>3</b>, depending on the benzoyl unit. Thus, compound <b>4</b> was prepared by coupling <b>3</b> with 4-(2-ethyl-butyramido)-3-fluorobenzoyl chloride in 58% yield under standard conditions of amide bond formation. Resorting to the corresponding 4-halo-isatoic anhydrides proved to yield <b>5</b> and <b>6</b> in 26–28% yield after simple trituration. Similarly, compound <b>7</b> was obtained in 73% yield using 7-chloro-2-trifluoromethyl-4<i>H</i>-3,1-benzoxazin-4-one. The latter was prepared from 4-chloroanthranilic acid upon treatment with trifluoroacetic anhydride.</div><div class="NLM_p">However, the synthesis of the <i>N</i>-arylurea <b>10</b> necessitated a two-step conjugation as the preparation of <b>11</b> was unsuccessful. Thus, 3-fluoro-4-nitrobenzoyl chloride was coupled to <b>3</b> in 72% yield followed by Bechamp reduction of the nitro group into amino group which reacted in turn with 1-piperidinecarbonyl chloride to afford <b>10</b> (16% overall yield). Noteworthy, the reaction of 4-amino-3-fluorobenzoic acid with 1-piperidinecarbonyl chloride led to the piperidino aryl anhydride <b>12</b> or <i>N</i>-aroyl-piperidine <b>13</b>, depending on the choice of a neutral or acidic workup, respectively (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/medium/jm-2015-007468_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of <i>N</i>-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles <b>4</b>–<b>10</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00746&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/medium/jm-2015-007468_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Attempt to Prepare Functionalized Benzoic Acid <b>11</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00746&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Biochemical Evaluation</h3><div class="NLM_p">The <i>N</i>-(functionalized benzoyl)-homocycloleucyl-glycinonitriles <b>4</b>–<b>10</b> (compounds <b>4</b>, <b>5</b>, <b>6</b>, and <b>10</b> were designated by the consensus model, and compounds <b>7</b>, <b>8</b>, and <b>9</b> correspond to their synthetic precursors) were tested for their binding to human Cat K, Cat L, and Cat S (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Compounds <b>5</b>, <b>6</b>, and <b>9</b> exhibited high affinity for Cat K with <i>K<sub>i</sub></i> values between 10 and 30 nM, and were highly selective against Cat L and Cat S. These compounds then underwent a more thorough kinetic investigation. It is worth mentioning that compound <b>6</b> has at least 3-fold greater selectivity ratio over Cat L compared to Balicatib (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibition of Cats K, L, and S by <i>N</i>-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles <b>4</b>–<b>10</b> at pH 6.0 and 37 °C<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center"><i>K<sub>i</sub></i> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">Cat K</th><th class="colsep0 rowsep0" align="center">Cat L</th><th class="colsep0 rowsep0" align="center">Cat S</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">70</td><td class="colsep0 rowsep0" align="left">n.i.<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">4000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">16 ± 2</td><td class="colsep0 rowsep0" align="left">10000</td><td class="colsep0 rowsep0" align="left">n.i.<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">10 ± 3</td><td class="colsep0 rowsep0" align="left">11000</td><td class="colsep0 rowsep0" align="left">n.i.<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left"> >500</td><td class="colsep0 rowsep0" align="left">1200</td><td class="colsep0 rowsep0" align="left">n.i.<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">114</td><td class="colsep0 rowsep0" align="left">n.i.<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">n.i.<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">22 ± 1</td><td class="colsep0 rowsep0" align="left">720</td><td class="colsep0 rowsep0" align="left">5000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">55</td><td class="colsep0 rowsep0" align="left">n.i.<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Balicatib<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">503</td><td class="colsep0 rowsep0" align="left">65000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Experimental conditions were as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">No inhibition observed even at 100 μM.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">IC<sub>50</sub> (nM) values are listed for Balicatib.</p></div></div></div><div class="NLM_p last">As nitriles are known to be reversible inhibitors of cathepsins, we next checked the reversibility of Cat K inhibition by compounds <b>5</b>, <b>6</b>, and <b>9</b>, as described earlier for Cat K by rapid 100-fold dilution of the preformed enzyme–inhibitor complexes into the buffer solution containing the substrate.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The irreversible cysteine Cat inhibitor E-64<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> was used as a test control. As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.5b00746/suppl_file/jm5b00746_si_001.pdf" class="ext-link">Figure S2</a>, upward curvatures were observed for all three compounds, characteristic for reversible inhibitors, but not for E-64, in agreement with previous findings. Finally, we monitored kinetics of binding of compounds <b>5</b>, <b>6</b>, and <b>9</b> to Cat K. As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.5b00746/suppl_file/jm5b00746_si_001.pdf" class="ext-link">Figure S3</a>, all the curves exhibited a typical biphasic behavior slowly reaching the steady state, which is clearly seen at lower inhibitor concentrations (100–250 nM). Moreover, this also confirmed reversibility of the compounds. However, the rapid interaction between the inhibitors and Cat K precluded us from accurately determining the association (<i>k</i><sub>on</sub>) and dissociation (<i>k</i><sub>off</sub>) rate constants, as substantial parts of the initial portions of the curves were lost within the dead time of the method at inhibitor concentrations ≥250 nM. Therefore, only the curves obtained at 100 nM inhibitor concentration could have been used in the calculations, yielding estimates for the <i>k</i><sub>on</sub> value of ∼3 × 10<sup>4</sup> M<sup>–1</sup> s<sup>–1</sup> and for the <i>k</i><sub>off</sub> value of ∼1 × 10<sup>–4</sup> s<sup>–1</sup> for all three compounds. The slow binding kinetic of nitrile inhibitors to Cat K has already been observed previously for azadipeptide nitriles, although the <i>k</i><sub>on</sub> values for the latter were generally slightly higher (1 × 10<sup>5</sup> M<sup>–1</sup> s<sup>–1</sup> to 1 × 10<sup>6</sup> M<sup>–1</sup> s<sup>–1</sup>).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Ligand–Cat K Structures</h3><div class="NLM_p">The most promising compounds <b>5</b>, <b>6</b>, and <b>9</b> were then subjected to structural analysis using X-ray crystallography. The complex of Cat K with compound <b>5</b> crystallized in the monoclinic space group <i>P</i>2(1), whereas the complexes of Cat K with compounds <b>6</b> and <b>9</b> crystallized in the orthorhombic space group <i>P</i>2(1)2(1)2(1). All three complexes have one molecule of Cat K in the asymmetric unit. In all three structures the protein residues as well as the inhibitors are unambiguously defined by the electron density maps. The crystals of compound <b>9</b> complex diffracted to the atomic resolution of 1 Å. They bind into the active site of Cat K in the nonprimed region (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) occupying the S1, S2, and S3 binding sites.</div><div class="NLM_p">Despite all three compounds have the same structure at the P1 region, the nitrile group of the compound <b>5</b> formed a covalent bond with the reactive site S gamma atom of Cys25, whereas compound <b>6</b> did not. In this latter case, the nitrile group points away from the Cys25 reactive site. Interestingly, compound <b>9</b> exhibited a dual behavior. Most of the compound <b>9</b> (79%) formed a covalent bond with the reactive site SG atom, whereas the rest did not; its nitrile group is clearly chemically unaltered and is positioned similarly to that of compound <b>6</b>. Superimposition of determined Cat K complex structures revealed that the positions of the pair of reactive site Cys25 residues forming the covalent interaction (compound <b>5</b> and 79% of compound <b>9</b>) and the pair that does not form it (compound <b>6</b> and 21% of compound <b>9</b>) superimpose tightly and are distinct from each other (the catalytic sulfur atoms are positioned approximately 0.5 Å apart; <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). Due to the high resolution of the diffraction data we can conclude that these differences are real. Besides, according to the atomic distance (3.0 and 3.1 Å), the covalently bound nitrile groups form hydrogen bonds with the O atom of Gln19 of Cat K, indicating a flip of the Gln19 side chain and the change in the oxyanion hole electrostatic potential.</div><div class="NLM_p">The cyclohexyl groups of all three inhibitors bind in the S2 pocket in the same orientation, yet the covalently and noncovalently bound compounds exhibit the same positional shift as the glycinonitrile part. The carbonyl O atom of the homocycloleucyl residue is oriented toward the peptide bond N atom of Gly66 and the edge of the indole ring of Trp26.</div><div class="NLM_p">Each benzoyl group is positioned in the S3 pocket slightly differently. In the compound <b>5</b>, the interaction between the N atom at the meta position and Asp61 is mediated by a solvent molecule, while the F atom at the meta position in compound <b>9</b> is only 2.5 Å away from the carboxylic O atom of Asp61. The differences and similarities in the interaction patterns of compounds <b>5</b>, <b>6</b>, and <b>9</b> offer no explanation why Asp61 has been observed in two different conformations. It seems more likely that it is the change in the crystal lattice which leads to a different interaction pattern with the Asp61 side chain. Namely, the position of Asp61 is such that in the orthorhombic crystals it is tightly packed between two asymmetric molecules of Cat K, whereas in the monoclinic space group it is not.</div><div class="NLM_p">The binding of inhibitors is characterized by several H-bonds (<a class="ref internalNav" href="#fig3" aria-label="Figures 3">Figures 3</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.5b00746/suppl_file/jm5b00746_si_001.pdf" class="ext-link">S4</a>). They all form H-bonds with the main chain carbonyl of Asn161, the amide group of Gly66, and the edge of Trp26. The covalently bound inhibitors form an additional interaction with the O atom of amide side chain of Gln19, whereas the <i>ortho</i> N atoms of the benzoyl rings of the compounds <b>5</b> and <b>6</b> form H-bonds with the carbonyl of Gly64, and the F atom in the compound <b>9</b> is positioned 2.5 Å away from the Asp61 carboxylic group.</div><div class="NLM_p">The three crucial H-bonds between the inhibitor and Cat K Gly66 and Asn161 are consistent with the prediction made by GOLD molecular docking. The H-bond lengths between the inhibitor and the Cat K are listed in <a href="/doi/suppl/10.1021/acs.jmedchem.5b00746/suppl_file/jm5b00746_si_001.pdf" class="ext-link">Table S3</a>.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/medium/jm-2015-007468_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Human Cat K–inhibitor complexes. The blue electron density map is contoured: (a) around compound <b>5</b> at 2.0σ; (b) around compound <b>6</b> at 1.0σ; (c) around compound <b>9</b> at 1.5σ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00746&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/medium/jm-2015-007468_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Superimposition of crystal structures of compounds <b>5</b>, <b>6</b>, and <b>9</b> on 0LB (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DMX">4DMX</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00746&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18008" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18008" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Integrated CADD approaches encompassing virtual combinatorial chemistry, QSAR modeling, and molecular docking proved to be powerful for the design of compounds with targeted properties. As a matter of fact, a selected 4-membered series of <i>N</i>-(functionalized benzoyl)-homocycloleucyl-glycinonitriles (compounds <b>5</b>, <b>6</b>, <b>9</b>, and <b>10</b>) containing a weakly to nonbasic P3 moiety, showed high selectivity for Cat K when compared with cathepsins L and S with the <i>K<sub>i</sub></i> values in the 10–30 nM range. The kinetic studies revealed reversible and tight binding of these compounds to Cat K, whereas X-ray structural studies of their complexes showed covalent and noncovalent type binding between the nitrile group of the compound and the catalytic cysteine (Cys25) site. From the presented data, it could be hypothesized in this case that the establishment of a covalent bond is not essential for an inhibitor’s potency.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83653" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83653" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Virtual Combinatorial Chemistry Generation</h3><div class="NLM_p last">Pipeline Pilot’s reaction enumeration module (BIOVIA, U.S.A.) was employed for combinatorial generation of <i>N</i>-(functionalized benzoyl)-homocycloleucyl-glycinonitriles. All structures with PSA > 140 Å<sup>2</sup> and number of rotatable bonds (nRB) > 10 were removed.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Molecular Docking Calculations</h3><div class="NLM_p last">The covalent molecular docking studies were performed by GOLD Suite v5.1 docking package.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Binding site was defined around experimental coordinates of the 0LB<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> ligand in radius of 6 Å. In order to perform covalent docking, dummy sulfur linking atom was attached to each ligand. Subsequently, ligands were renumbered in a way that previously added sulfur atom number was set to 1. Cat K sulfur atom on Cys25 was then matched with dummy sulfur atom of ligand. Preparing ligands in this way was necessary for GOLD calculation to recognize and set the correct covalent bond between predefined ligands and Cat K linking atoms.<a onclick="showRef(event, 'ref41 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref41 ref44 ref45">(41, 44, 45)</a> Redocking procedure was performed by docking reference ligand 0LB into the binding site with early termination allowed if the top three solutions were within 1.5 Å of the rmsd value in order to define optimal parameters and scoring function.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Finally, each ligand was docked into the binding site by the selected scoring function and applying the following parameters of the GOLD genetic algorithm: population size = 100, selection pressure = 1.1, No. of operations = 100 000, No. of islands = 5, niche size = 2, migrate = 10, mutate = 95, crossover = 95.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Synthetic Procedures</h3><div class="NLM_p last">Reactions were conducted under an inert atmosphere using anhydrous solvents when required. Analytical (TLC) and preparative (PLC) layer chromatographies were performed on Silica Gel 60F<sub>254</sub> plates. TLC <i>R</i><sub><i>f</i></sub> values are reported and visualization was accomplished with an UV lamp (254 nm) and staining with KMnO<sub>4</sub> solution. Filtration over a bed of silica gel was performed using Silica Gel 60 (40–63 μm). Melting points were determined on a Kofler apparatus and are uncorrected. <sup>1</sup>H (300 MHz, internal Me<sub>4</sub>Si), <sup>13</sup>C (75 MHz, internal CDCl<sub>3</sub>), and <sup>19</sup>F NMR (282 MHz, internal CFCl<sub>3</sub>) were recorded as solutions in either CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub>. IR spectra were recorded using ATR cell equipped with a diamond crystal. HRMS measurements were obtained on a Waters Micromass Q-TOF Premier instrument equipped with an orthogonal Z-spray ESI interface. The chemical purity of all compounds <b>4</b>–<b>10</b> for biochemical evaluation was confirmed to be >95% based on elemental analysis which matched within ±0.4% of the calculated values.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Materials</h3><div class="NLM_p">Homocycloleucine hydrochloride, glycinonitrile sulfate, 4-amino-3-fluorobenzoic acid, 3-fluoro-4-nitrobenzoic acid, 4-chloroanthranilic acid, and 4-bromoanthranilic acid are commercially available.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <i>N</i>-Ethoxycarbonyl-homocycloleucine (<b>1</b>)</h4><div class="NLM_p last">To a cold (0 °C) mixture of homocycloleucine hydrochloride (5.00 g, 27.8 mmol) and Et<sub>3</sub>N (13.5 mL, 96.9 mmol) in DMF (10 mL)/CH<sub>2</sub>Cl<sub>2</sub> (90 mL) was added dropwise ethyl chloroformate (4.0 mL, 41.8 mmol). After stirring overnight, the mixture was concentrated, diluted with water (100 mL), acidified to pH 2 using 1 M HCl (ca. 8 mL), and extracted with EtOAc (2 × 100 mL). Filtration through a bed of silica gel/Na<sub>2</sub>SO<sub>4</sub> and concentration (at 15 mbar followed by 0.1 mbar) afforded colorless syrup which was triturated with <i>i</i>Pr<sub>2</sub>O and the solidified product filtered, yielding a white powder (4.70 g, 78.5%). Mp 90–92 °C; <sup>1</sup>H NMR spectroscopy revealed two conformational isomers in 65:35 ratio. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 12.19 (s, 1H), 7.23 (s, 1H), 3.99 (m, 2H), 1.93 (m, 2H), 1.84–1.59 (m, 2H), 1.59–1.38 (m, 5H), 1.19 (m, 4H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 176.5, 169.7, 155.8, 60.3, 59.79, 59.72, 32.2, 31.8, 25.4, 25.1, 21.4, 21.1, 15.0. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>10</sub>H<sub>17</sub>NO<sub>4</sub> + H<sup>+</sup> [M + H<sup>+</sup>], 216.1236; found, 216.1238.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Homocycloleucine <i>N</i>-Carboxylic Acid Anhydride (<b>2</b>)</h4><div class="NLM_p last">To a cold solution (0 °C) of <i>N</i>-EtOCO-homocycloleucine (<b>1</b>; 4.00 g, 18.6 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (60 mL) containing DMF (1 mL) was added dropwise oxalyl chloride (2.4 mL, 28.4 mmol). After stirring at rt for 2 h, the mixture was concentrated, dissolved in a small amount of CH<sub>2</sub>Cl<sub>2</sub>, and filtered through silica gel eluting with hexane/EtOAc (1:1). The residue was triturated with hexane, yielding white crystals (2.33 g, 74.2%). <sup>1</sup>H NMR: δ 7.62 (s, 1H), 2.05–1.60 (m, 8H), 1.60–1.34 (m, 2H). <sup>1</sup>H NMR data were consistent with those reported in the literature.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a></div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Homocycloleucyl-glycinonitrile (<b>3</b>)</h4><div class="NLM_p last">To a solution of the anhydride <b>2</b> (4.00 g, 23.6 mmol) and <i>i</i>Pr<sub>2</sub>NEt (29 mL, 0.165 mol) in dry CH<sub>2</sub>Cl<sub>2</sub> (100 mL) was added glycinonitrile sulfate (3.32 g, 15.8 mmol). After heating at reflux for 4 h, the mixture was concentrated and partitioned between EtOAc (100 mL)/water (100 mL). The water layer was re-extracted with EtOAc (2 × 100 mL) and the combined EtOAc phases were washed with satd aq NaHCO<sub>3</sub> (30 mL) and brine (100 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The oily residue was redissolved in a small amount of CH<sub>2</sub>Cl<sub>2</sub> and filtered through silica gel eluting with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (95:5) to afford a yellowish viscous syrup (3.73 g, 87.0%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.37 (br s, 1H), 4.17 (d, <i>J</i> = 6.0 Hz, 2H), 2.02–1.92 (m, 2H), 1.83–1.57 (m, 3H), 1.57–1.10 (m, 7H). <sup>1</sup>H NMR data were consistent with those reported in the literature.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 4-Chloroisatoic Anhydride</h4><div class="NLM_p last">To a solution of 4-chloroanthranilic acid (0.500 g, 2.91 mmol) in THF (10 mL) was added triphosgene (0.294 g, 0.99 mmol) under nitrogen. After stirring at rt overnight, the solid was filtered and washed with Et<sub>2</sub>O (2 × 10 mL), affording white crystals (0.543 g, 94.4%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.83 (s, 1H), 7.92 (d, <i>J</i> = 8.5 Hz, 1H), 7.29 (dd, <i>J</i> = 8.5 and 2.0 Hz, 1H), 7.14 (d, <i>J</i> = 1.9 Hz, 1H). <sup>1</sup>H NMR data were consistent with those reported in the literature.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 4-Bromoisatoic Anhydride</h4><div class="NLM_p last">Prepared from 4-bromoanthranilic acid (0.629 g, 2.91 mmol) following a similar procedure as for 4-chloroisatoic anhydride, affording white fluffy crystals (0.574 g, 81.4%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.81 (s, 1H), 7.83 (d, <i>J</i> = 8.4 Hz, 1H), 7.43 (dd, <i>J</i> = 8.4 and 1.8 Hz, 1H), 7.30 (d, <i>J</i> = 1.8 Hz, 1H). <sup>1</sup>H NMR data were consistent with those reported in the literature.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 7-Chloro-2-trifluoromethyl-4<i>H</i>-3,1-benzoxazin-4-one</h4><div class="NLM_p last">To trifluoroacetic anhydride (5 mL) was added in portions 4-chloroanthranilic acid (0.343 g, 2.00 mmol). After stirring at rt for 3 h, the mixture was concentrated, dissolved in dry Et<sub>2</sub>O (ca. 10 mL), and filtered under nitrogen to remove the insoluble yellow material. Concentration afforded the title compound as an off-white solid (0.505 g, 94.4%) in 95+% purity, as determined by <sup>19</sup>F NMR. Mp 53–54 °C (lit.:<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> 54.2–54.8 °C (<i>n</i>-hexane)). <sup>1</sup>H NMR: δ 8.22 (d, <i>J</i> = 8.5 Hz, 1H), 7.79 (d, <i>J</i> = 1.9 Hz, 1H), 7.67 (dd, <i>J</i> = 8.5 and 2.0 Hz, 1H). <sup>19</sup>F NMR: δ −65.3 (s).</div></div><div id="sec4_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>N</i>-Trifluoroacetyl-4-chloroanthranilic Acid</h4><div class="NLM_p last">A mixture of 7-chloro-2-trifluoromethyl-4<i>H</i>-3,1-benzoxazin-4-one (50 mg, 0.20 mmol) in water (5 mL) was heated at 60 °C for 20 min. Upon cooling to rt, the formed precipitate was filtered and recrystallized from water/MeOH, affording white needles (0.490 g, 91.6%). Mp 165–166 °C (lit.:<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> 177.5–178.5 °C (benzene)). <sup>1</sup>H NMR: δ 12.05 (s, 1H), 8.77 (d, <i>J</i> = 2.0 Hz, 1H), 8.14 (d, <i>J</i> = 8.6 Hz, 1H), 7.28 (dd, <i>J</i> = 8.6 and 2.1 Hz, 1H). <sup>13</sup>C NMR: δ 171.1, 155.3 (q, <i>J</i> = 38 Hz), 142.6, 140.2, 133.1, 125.3, 120.9, 115.3 (q, <i>J</i> = 310 Hz), 113.6. <sup>19</sup>F NMR: δ −69.0 (d, <i>J</i> = 0.9 Hz). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>9</sub>H<sub>5</sub>ClF<sub>3</sub>NO<sub>3</sub> – H<sup>–</sup> [M – H<sup>–</sup>], 265.9832; found, 265.9840.</div></div><div id="sec4_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 4-(2-Ethyl-butyramido)-3-fluorobenzoic Acid</h4><div class="NLM_p last">To a cold (0 °C) solution of 4-amino-3-fluorobenzoic acid (0.50 g, 3.22 mmol) in dry pyridine (2.5 mL) was added dropwise 2-ethylbutyryl chloride (0.60 mL, 4.31 mmol). After stirring at rt overnight, water (5 mL) was added then acidified to pH 2 using <i>c</i>. HCl. The precipitate was filtered and recrystallized from MeCN affording an off-white powder (0.47 g, 57.6%). <i>R</i><sub>f</sub> 0.61 (EtOAc); mp 205–206 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 13.08 (br s, 1H), 9.90 (s, 1H), 8.10 (t, <i>J</i> = 8.1 Hz, 1H), 7.76–7.67 (m, 2H), 1.70–1.31 (m, 4H), 0.97–0.75 (m, 6H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 174.8, 166.0, 152.6 (d, <i>J</i> = 242 Hz), 130.5 (d, <i>J</i> = 12 Hz), 127.0 (d, <i>J</i> = 7 Hz), 125.7 (d, <i>J</i> = 3 Hz), 123.3, 116.0 (d, <i>J</i> = 21 Hz), 48.9, 25.2, 11.7. <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>): δ −116.7 (m). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>16</sub>FNO<sub>3</sub> – H<sup>–</sup> [M – H<sup>–</sup>], 252.1036; found, 252.1032.</div></div><div id="sec4_4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>-[4-(2-Ethyl-butyramido)-3-fluorobenzoyl]homocycloleucyl-glycinonitrile (<b>4</b>)</h4><div class="NLM_p last">To a cold (0 °C) solution of 4-(2-ethyl-butyramido)-3-fluorobenzoic acid (0.385 g, 1.52 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) containing DMF (1 mL) was added dropwise oxalyl chloride (0.17 mL, 2.01 mmol). After stirring at rt for 1 h, it was partially concentrated and added dropwise to a cold solution (0 °C) of homocycloleucyl-glycinonitrile (<b>3</b>; 0.286 g, 1.579 mmol), DMAP (a crystal), and <i>i</i>Pr<sub>2</sub>NEt (0.55 mL, 3.1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL). The mixture was stirred at rt overnight and concentrated to dryness. The residue was partitioned between EtOAc (20 mL) containing few drops of MeOH and satd. aq. NaHCO<sub>3</sub> (15 mL). The organic phase was washed with brine (10 mL), filtered through a bed of silica gel/MgSO<sub>4</sub>, and concentrated. The residue was recrystallized from EtOAc, affording an off-white powder (0.365 g, 57.7%). <i>R</i><sub><i>f</i></sub> 0.78 (EtOAc); mp 220–221 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.83 (s, 1H), 8.21 (t, <i>J</i> = 5.7 Hz, 1H), 8.15–7.91 (m, 2H), 7.80 (m, 1H), 7.70 (m, 1H), 4.04 (d, <i>J</i> = 5.6 Hz, 2H), 2.13–2.09 (m, <i>J</i> = 12.8 Hz, 2H), 1.75–1.72 (m, <i>J</i> = 8.5 Hz, 2H), 1.66–1.37 (m, 9H), 1.29–1.25 (m, 1H), 0.87 (t, <i>J</i> = 7.4 Hz, 6H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 174.8, 174.6, 164.7, 152.9 (d, <i>J</i> = 242 Hz), 131.2 (d, <i>J</i> = 6 Hz), 128.8 (d, <i>J</i> = 12 Hz), 124.0 (d, <i>J</i> = 3 Hz), 123.4, 117.8, 115.0 (d, <i>J</i> = 21 Hz), 59.4, 49.0, 31.7, 27.6, 25.2, 25.0, 21.2, 11.8. <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>): δ −117.1 (m). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>29</sub>FN<sub>4</sub>O<sub>3</sub> + H<sup>+</sup> [M + H<sup>+</sup>], 417.2302; found, 417.2300. Elem anal. Calcd for C<sub>22</sub>H<sub>29</sub>FN<sub>4</sub>O<sub>3</sub> (%): C, 63.44; H, 7.02; N, 13.45. Found: C, 63.18; H, 6.78; N, 13.43.</div></div><div id="sec4_4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>N</i>-(2-Amino-4-chlorobenzoyl)homocycloleucyl-glycinonitrile (<b>5</b>)</h4><div class="NLM_p last">To a solution of homocycloleucyl-glycinonitrile (<b>3</b>; 0.181 g, 1.00 mmol) in DMF (1 mL) was added DMAP (37 mg, 0.30 mmol) and 4-chloroisatoic anhydride (0.198 g, 1.00 mmol). After stirring at 60 °C for 16 h, the mixture was concentrated, dissolved in MeCN (1 mL), and added dropwise onto 5% aq NaHCO<sub>3</sub> (5 mL). The precipitated product was filtered, rinsed successively with water, Et<sub>2</sub>O, and hexane, and then dried at 60 °C for 5 h, affording an off-white powder (0.095 g, 28.4%). Mp 219–220 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.17 (t, <i>J</i> = 5.6 Hz, 1H), 7.83 (s, 1H), 7.56 (d, <i>J</i> = 8.4 Hz, 1H), 6.90 (d, <i>J</i> = 1.9 Hz, 1H), 6.68 (dd, <i>J</i> = 8.4 and 1.9 Hz, 1H), 6.47 (s, 2H), 4.05 (d, <i>J</i> = 5.6 Hz, 2H), 2.07–2.03 (m, 2H), 1.73–1.70 (m, 2H), 1.51 (m, 5H), 1.28–1.25 (m, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 175.1, 168.0, 150.9, 136.2, 131.1, 117.8, 114.8, 114.0, 113.8, 59.0, 31.8, 27.6, 25.1, 21.3. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>19</sub><sup>35</sup>ClN<sub>4</sub>O<sub>2</sub> + H<sup>+</sup> [M + H<sup>+</sup>], 335.1275; found, 335.1269. Elem anal. Calcd for C<sub>16</sub>H<sub>19</sub>ClN<sub>4</sub>O<sub>2</sub> (%): C, 57.40; H, 5.72; N, 16.73. Found: C, 57.07; H, 5.38; N, 16.49.</div></div><div id="sec4_4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>-(2-Amino-4-bromobenzoyl)homocycloleucyl-glycinonitrile (<b>6</b>)</h4><div class="NLM_p last">Prepared from homocycloleucyl-glycinonitrile (<b>3</b>; 0.181 g, 1.00 mmol) and 4-bromoisatoic anhydride (0.242 g, 1.00 mmol) following a similar procedure as for <b>5</b>, affording off-white powder (0.100 g, 26.4%). Mp 216–217 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.16 (t, <i>J</i> = 5.7 Hz, 1H), 7.83 (s, 1H), 7.56 (d, <i>J</i> = 8.4 Hz, 1H), 6.89 (d, <i>J</i> = 2.0 Hz, 1H), 6.68 (dd, <i>J</i> = 8.4 and 2.0 Hz, 1H), 6.47 (s, 2H), 4.05 (d, <i>J</i> = 5.6 Hz, 2H), 2.07–2.03 (m, 2H), 1.73–1.70 (m, 2H), 1.51 (s, 5H), 1.28–1.25 (m, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 175.1, 168.1, 150.9, 131.2, 125.1, 117.79, 117.76, 116.8, 114.2, 59.0, 31.7, 27.6, 25.1, 21.3. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>19</sub><sup>79</sup>BrN<sub>4</sub>O<sub>2</sub> + H<sup>+</sup> [M + H<sup>+</sup>], 379.0770; found, 379.0766. Elem anal. Calcd for C<sub>16</sub>H<sub>19</sub>BrN<sub>4</sub>O<sub>2</sub> (%): C, 50.67; H, 5.05; N, 14.77. Found: C, 50.35; H, 4.65; N, 14.68.</div></div><div id="sec4_4_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i>-(2-Trifluoroacetamido-4-chlorobenzoyl)homocycloleucyl-glycinonitrile (<b>7</b>)</h4><div class="NLM_p last">To a solution of homocycloleucyl-glycinonitrile (<b>3</b>; 0.180 g, 1.00 mmol) in DMF (1 mL) was added 7-chloro-2-trifluoromethyl-4<i>H</i>-3,1-benzoxazin-4-one (0.194 g, 0.78 mmol) and pyridine (0.100 mL, 1.24 mmol). After stirring at 50 °C for 8 h, the mixture was concentrated, suspended in EtOAc (10 mL), washed successively with satd aq NH<sub>4</sub>Cl (2 × 10 mL), satd aq NaHCO<sub>3</sub> (10 mL), and brine (10 mL), and filtered through a bed of silica gel/Na<sub>2</sub>SO<sub>4</sub>. The residue was triturated with Et<sub>2</sub>O and filtered, affording a white powder (0.245 g, 73.0%). Mp 191–192 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 12.29 (s, 1H), 8.67 (s, 1H), 8.28 (t, <i>J</i> = 5.5 Hz, 1H), 8.20 (d, <i>J</i> = 1.8 Hz, 1H), 7.98 (d, <i>J</i> = 8.5 Hz, 1H), 7.50 (dd, <i>J</i> = 8.4 and 1.9 Hz, 1H), 4.02 (d, <i>J</i> = 5.6 Hz, 2H), 2.10–2.05 (m, 2H), 1.77–1.74 (m, 2H), 1.55 (m, 5H), 1.30–1.27 (m, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 174.3, 167.3, 154.56 (q, <i>J</i> = 37 Hz), 136.9, 136.3, 131.3, 125.0, 122.7, 121.3, 117.4, 115.5 (q, <i>J</i> = 292 Hz), 60.1, 31.5, 27.6, 25.0, 21.2. <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>): δ −68.0 (s). ν<sub>max</sub>: 3344, 2935, 2870, 1729, 1662, 1584, 1518, 1452, 1412 cm<sup>–1</sup>. HRMS-ESI (<i>m</i>/<i>z</i>): calcd for C<sub>18</sub>H<sub>18</sub>ClF<sub>3</sub>N<sub>4</sub>O<sub>3</sub> + H<sup>+</sup> [M + H<sup>+</sup>], 431.1098; found, 431.1091. Elem anal. Calcd for C<sub>18</sub>H<sub>18</sub>ClF<sub>3</sub>N<sub>4</sub>O<sub>3</sub> (%): C, 50.18; H, 4.21; N, 13.01. Found: C, 50.43; H, 3.81; N, 12.99.</div></div><div id="sec4_4_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>N</i>-(3-Fluoro-4-nitrobenzoyl)homocycloleucyl-glycinonitrile (<b>8</b>)</h4><div class="NLM_p last">To a cold (0 °C) solution of 3-fluoro-4-nitrobenzoic acid (0.500 g, 2.70 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) containing DMF (0.2 mL) was added dropwise oxalyl chloride (0.34 mL, 4.05 mmol). After stirring at rt overnight, it was concentrated to about 1/5 of its volume, diluted with CH<sub>2</sub>Cl<sub>2</sub> (5 mL), and added dropwise onto a cold (0 °C) solution of homocycloleucyl-glycinonitrile (<b>3</b>; 0.510 g, 2.81 mmol) in pyridine (2 mL). The mixture was stirred at rt for 3 h and poured onto water (30 mL). The precipitate was filtered, washed with water, dissolved in hot MeCN (30 mL), and filtered to remove the brown insoluble matter. Water (40 mL) was added, and the precipitate filtered and triturated with hexane/EtOAc (1:1), affording an off-white powder (0.675 g, 71.8%). <i>R</i><sub><i>f</i></sub> 0.71 (EtOAc); mp 216–217 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.41 (s, 1H), 8.31 (t, <i>J</i> = 5.5 Hz, 1H), 8.25 (t, <i>J</i> = 8.1 Hz, 1H), 8.06 (dd, <i>J</i> = 12.1 and 1.3 Hz, 1H), 7.88 (d, <i>J</i> = 8.5 Hz, 1H), 4.06 (d, <i>J</i> = 5.5 Hz, 2H), 2.13–2.08 (m, 2H), 1.77–1.74 (m, 2H), 1.53 (m, 5H), 1.29–1.26 (m, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 174.4, 163.7, 154.1 (d, <i>J</i> = 257 Hz), 141.6 (d, <i>J</i> = 7 Hz), 138.2 (d, <i>J</i> = 8 Hz), 126.2 (d, <i>J</i> = 3 Hz), 124.6 (d, <i>J</i> = 4 Hz), 118.0, 117.7, 59.9, 31.6, 27.6, 25.0, 21.2. <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>): δ −111.8 (dd, <i>J</i> = 12.0 and 7.7 Hz). HRMS (ESI): <i>m</i>/<i>z</i> calcd for for C<sub>16</sub>H<sub>17</sub>FN<sub>4</sub>O<sub>4</sub> + H<sup>+</sup> [M + H<sup>+</sup>], 349.1312; found, 349.1304. Elem anal. Calcd for C<sub>16</sub>H<sub>17</sub>FN<sub>4</sub>O<sub>4</sub> (%): C, 55.17; H, 4.92; N, 16.08. Found: C, 55.48; H, 4.64; N, 16.10.</div></div><div id="sec4_4_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>N</i>-(3-Fluoro-4-aminobenzoyl)homocycloleucyl-glycinonitrile (<b>9</b>)</h4><div class="NLM_p last">To compound <b>8</b> (0.385 g, 1.105 mmol) in EtOH (4 mL), AcOH (4 mL), and water (2 mL) was added iron powder (0.370 g, 6.63 mmol), and the mixture was heated at 30–40 °C under ultrasound for 1 h. The red-brown mixture was poured onto satd aq NaHCO<sub>3</sub> (12 mL) and extracted with EtOAc (10 mL) containing MeOH (2 mL). The organic layer was filtered through a bed of silica gel/Na<sub>2</sub>SO<sub>4</sub> and concentrated, affording off-white crystals (0.295 g, 83.8%). <i>R</i><sub><i>f</i></sub> 0.76 (EtOAc); mp 218–219 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.13 (t, <i>J</i> = 5.6 Hz, 1H), 7.75–7.56 (m, 2H), 7.49 (dd, <i>J</i> = 8.3 and 1.9 Hz, 1H), 6.75 (t, <i>J</i> = 8.7 Hz, 1H), 5.70 (s, 2H), 4.03 (d, <i>J</i> = 5.6 Hz, 2H), 2.11–2.07 (m, 2H), 1.75–1.69 (m, 2H), 1.51 (m, 5H), 1.27–1.24 (m, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 175.2, 165.2, 149.3 (d, <i>J</i> = 232 Hz), 139.7 (d, <i>J</i> = 13 Hz), 125.0, 121.6 (d, <i>J</i> = 5 Hz), 117.8, 114.6 (d, <i>J</i> = 19 Hz), 114.4, 59.0, 31.7, 27.6, 25.1, 21.2. <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>): δ −128.9 (m). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>19</sub>FN<sub>4</sub>O<sub>2</sub> + H<sup>+</sup> [M + H<sup>+</sup>], 319.1570; found, 319.1566. Elem anal. Calcd for C<sub>16</sub>H<sub>19</sub>FN<sub>4</sub>O<sub>2</sub> (%): C, 60.37; H, 6.02; N, 17.60. Found: C, 60.39; H, 5.65; N, 17.47.</div></div><div id="sec4_4_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>-[3-Fluoro-4-(piperidinocarboxamido)benzoyl]homocycloleucyl-glycinonitrile (<b>10</b>)</h4><div class="NLM_p last">To a solution of compound <b>9</b> (50 mg, 0.157 mmol) and DMAP (37 mg, 0.30 mmol) in pyridine (1 mL) was added dropwise 1-piperidinecarbonyl chloride (0.10 mL, 0.80 mmol). After stirring at 35 °C for 1 day, the mixture was concentrated and partitioned between EtOAc (10 mL) containing a few drops of MeOH and 1 mM HCl (10 mL). The organic phase was washed with brine (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The residue was purified on a PLC plate eluting with EtOAc. The product was washed from silica gel using EtOAc/MeOH (10:1) and triturated with Et<sub>2</sub>O, affording an off-white powder (18 mg, 26.8%). <i>R</i><sub><i>f</i></sub> 0.73 (EtOAc); mp 195–196 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.39 (s, 1H), 8.20 (t, <i>J</i> = 5.4 Hz, 1H), 7.95 (s, 1H), 7.82–7.47 (m, 3H), 4.04 (d, <i>J</i> = 5.5 Hz, 2H), 3.41 (m, 4H), 2.13–2.08 (m, 2H), 1.74–1.72 (m, 2H), 1.72–1.30 (m, 11H), 1.29–1.26 (m, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 174.9, 164.8 (d, <i>J</i> = 2.0 Hz), 154.4, 153.7 (d, <i>J</i> = 241 Hz), 131.0 (d, <i>J</i> = 11 Hz), 130.1 (d, <i>J</i> = 6 Hz), 123.9 (d, <i>J</i> = 1 Hz), 123.7 (d, <i>J</i> = 2 Hz), 117.8, 114.9 (d, <i>J</i> = 21 Hz), 59.4, 44.8, 31.7, 27.6, 25.5, 25.1, 24.0, 21.2. <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>): δ −116.6 (dd, <i>J</i> = 11.5 and 7.8 Hz). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>28</sub>FN<sub>5</sub>O<sub>3</sub> + H<sup>+</sup> [M + H<sup>+</sup>], 430.225; found, 430.224. Elem anal. Calcd for C<sub>22</sub>H<sub>28</sub>FN<sub>5</sub>O<sub>3</sub> (%): C, 61.52; H, 6.57; N, 16.31. Found: C, 61.18; H, 6.31; N, 16.22.</div></div><div id="sec4_4_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>N</i>-(4-Amino-3-fluorobenzoyloxycarbonyl)piperidine (<b>12</b>)</h4><div class="NLM_p last">To a cold (0 °C) solution of 4-amino-3-fluorobenzoic acid (0.50 g, 3.22 mmol) in dry pyridine (2.5 mL) was added dropwise 1-piperidinecarbonyl chloride (0.55 mL, 4.32 mmol). After stirring at rt overnight, the mixture was concentrated and partitioned between EtOAc (10 mL) containing a few drops of MeOH and 0.01 M HCl (5 mL). The EtOAc phase was dried over MgSO<sub>4</sub> and concentrated, affording an amber colored syrup that solidified upon standing overnight (0.768 g, 91.2%). <i>R</i><sub><i>f</i></sub> 0.78 (EtOAc). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.77–7.61 (m, 2H), 6.76 (t, <i>J</i> = 8.6 Hz, 1H), 4.30 (s, 2H), 3.59 (m, 2H), 3.51–3.35 (m, 2H), 1.63 (m, 6H). Upon heating <b>12</b> in MeCN in the presence of DMAP (cat), <i>N</i>-(4-amino-3-fluorobenzoyl)piperidine (<b>13</b>) was formed quantitatively.</div></div><div id="sec4_4_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i>-(4-Amino-3-fluorobenzoyl)piperidine (<b>13</b>)</h4><div class="NLM_p last">To a cold (0 °C) solution of 4-amino-3-fluorobenzoic acid (0.50 g, 3.22 mmol) in dry pyridine (2.5 mL) was added dropwise 1-piperidinecarbonyl chloride (0.55 mL, 4.32 mmol). After stirring at rt overnight, water (5 mL) was added, and then the solution was acidified to pH 2 using concd HCl. The oily precipitate was extracted with Et<sub>2</sub>O (2 × 10 mL), filtered through a bed of silica gel/Na<sub>2</sub>SO<sub>4</sub>, and concentrated, affording an orange colored oil that solidified upon standing overnight (0.755 g, 88.0%). <i>R</i><sub><i>f</i></sub> 0.64 (EtOAc); mp 265–268 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.18–6.96 (m, 2H), 6.74 (t, <i>J</i> = 9 Hz, 1H), 3.92 (br s, 2H), 3.53 (m, 4H), 1.70–1.50 (m, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 169.7, 150.7 (d, <i>J</i> = 240 Hz), 136.4 (d, <i>J</i> = 13 Hz), 126.0 (d, <i>J</i> = 6 Hz), 124.1 (d, <i>J</i> = 3 Hz), 116.1 (d, <i>J</i> = 4 Hz), 114.9 (d, <i>J</i> = 20 Hz), 26.2, 24.7.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> In Vitro Inhibition Assay</h3><div class="NLM_p last">Human Cat K, L, and S were expressed in <i>Pichia pastoris</i>, as described elsewhere.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50, 51)</a> Active enzyme concentration was determined by titration with E-64 (Peptide Institute, Japan). Cat activities were monitored using synthetic fluorogenic peptide substrates Z-Gly-Pro-Arg-AMC (Cat K), Z-Phe-Arg-AMC (Cat L), and Z-Phe-Val-Arg-AMC (Cat S; Bachem, Switzerland) at an excitation wavelength of 370 nm and an emission wavelength of 460 nm, as previously described.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> All reactions were performed in 100 mM sodium phosphate buffer pH 6.0 in the presence of 1 mM DTT. For the inhibition assays, 96-well black flat bottom microplates were used (Greiner, Germany); all measurements were performed using a Tecan M1000 plate reader (Tecan, Switzerland). Different concentrations of inhibitor (10 nM to 10 μM) were mixed with Cat K, L, or S (5–50 nM) and incubated for 30 min at 37 °C to allow the formation of enzyme–inhibitor complex in a total volume of 100 μL. After the incubation, substrate was added in a negligible volume to a final concentration of 50 μM (10 μM for Cat L) and fluorescence was continuously monitored over 10 min. The initial velocities in the presence (<i>v</i><sub>i</sub>) and absence of the inhibitor (<i>v</i><sub>o</sub>) were then calculated from the initial linear portion of the curves by linear regression analysis. The determination of <i>K</i><sub>i</sub> values was then performed, as previously described.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Briefly, by plotting <i>v</i><sub>o</sub>/<i>v</i><sub>i</sub> – 1 = [<i>I</i>]/<i>K</i><sub>i,app</sub>, the <i>K</i><sub>i,app</sub> values were obtained,<a onclick="showRef(event, 'ref37 ref41 ref52'); return false;" href="javascript:void(0);" class="ref ref37 ref41 ref52">(37, 41, 52)</a> and <i>K</i><sub>i</sub> values were then calculated from the <i>K</i><sub>i,app</sub> values using the equation <i>K</i><sub>i</sub> = <i>K</i><sub>i,app</sub>/(1 + [<i>S</i><sub>0</sub>]/<i>K</i><sub>M</sub>), where the following <i>K</i><sub>M</sub> values were used to correct for substrate competition: 48 μM<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> for Cat K and Z-Gly-Pro-Arg-AMC as the substrate, 2 μM for Cat L and Z-Phe-Arg-AMC as the substrate, and 8 μM for Cat S and Z-Phe-Val-Arg-AMC as the substrate.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Kinetics of Cat K Inhibition by Compounds <b>5</b>, <b>6</b>, and <b>9</b></h3><div class="NLM_p last">Initially, reversibility of binding of compounds <b>5</b>, <b>6</b>, and <b>9</b> to Cat K was first evaluated as described elsewhere.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Briefly, the compounds (5 μM) and Cat K (1 μM) were incubated for 30 min, which is sufficient for completion of the reaction, before rapidly diluted 100-fold in the reaction buffer containing the substrate. Progress of the reaction was then monitored continuously as described above. Next, kinetics of binding of the three compounds to Cat K was studied to better understand the mechanistic aspects of the inhibition. All measurements were performed under the same conditions as for the inhibition assay. A total of 10 nM preactivated Cat K was added to a reaction buffer containing the substrate and varying concentrations of inhibitor (100 nM to 10 μM). The inhibitor concentration was always at least 10-fold higher as the enzyme concentration to ensure the pseudo-first-order reaction conditions. The progress curves were continuously recorded for 1.5 h and could be best fitted to the following equation by nonlinear regression analysis and the GraphPad Prism software (GraphPad Software, U.S.A.):<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/jm-2015-007468_m001.gif" alt="" /></img></span>where [<i>P</i>] is the product concentration, <i>v</i><sub>oi</sub> and <i>v</i><sub>s</sub> are the initial and steady-state reaction velocities, respectively, whereas <i>k</i> stands for the observed pseudo-first order rate constant describing the presteady state of the reaction.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> On this basis it is possible to calculate association and dissociation rate constants, <i>k</i><sub>on</sub> and <i>k</i><sub>off</sub>, using the following relationships: <i>k</i> = <i>k</i><sub>on</sub>[<i>I</i><sub>0</sub>]/(1 + [<i>S</i><sub>0</sub>]/<i>K</i><sub>M</sub>) + <i>k</i><sub>off</sub> that enables <i>k</i><sub>on</sub> and <i>k</i><sub>off</sub> using linear regression analysis. However, due to unfavorable reaction condition, estimates of <i>k</i><sub>off</sub> and <i>k</i><sub>on</sub> values were calculated using the following relationships:<span class="NLM_disp-formula" id="ueq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/jm-2015-007468_m002.gif" alt="" /></img></span>The equations were adapted from standard protocols published previously.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56, 57)</a></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> X-ray Diffraction</h3><div class="NLM_p">The cDNA of human procathepsin K was obtained from Deutsches Ressourcenzentrum für Genomforschung. Expression of human Cat K: cDNA for human procathepsin K was amplified by PCR. PCR products were cloned into vector pPIC9 (Invitrogen). Recombinant plasmids were electroporated in <i>P. pastoris</i> strain GS115 (Invitrogen). Recombinant clones were selected according to Pichia Expression kit manual (Invitrogen). The clone with the highest protein expression was chosen and expressed according to the Invitrogen protocol.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Afterward, the expression crude medium was dialyzed to buffer_1 (50 mM sodium acetate, pH 5.5, 2.5 mM EDTA, 2.5 mM DTT). Dialyzed medium containing Cat K was concentrated to 350 mL. Procathepsin K was activated by adding pepsin to final concentration of 0.03 mg/mL and reducing buffer pH to 4.0. The activation took 4 h at 37 °C. Afterward, the protein was dialyzed to buffer_2 (50 mM sodium acetate, pH 5.5) and blocked reversibly with 10-fold molar excess of <i>S</i>-methylmethanethiosulfonate. The prepared protein solution was applied to 25 mL of conditioned SP sepharose. Cat K was eluted using NaCl gradient from 0 to 2 M NaCl in buffer_2. Fractions containing pure Cat K were collected and dialyzed again against buffer_2. Afterward, pure cat K was concentrated to a final concentration of 36 mg/mL.</div><div class="NLM_p last">Protein crystallization and crystal harvesting: For crystallization trials, the protein was activated by adding DTT to the 2 mM final concentration and incubated for 10 min. Afterward, the inhibitor was added to 2 mM final concentration and incubated for 30 min at room temperature. Final complexes were concentrated to 10–15 mg/mL and centrifuged at 20000g for 30 min. Sitting drops of 0.1 μL protein solution and 0.1 μL reservoir solution against 70 μL of reservoir solution were set at 22 °C using commercial screens from QIAGEN and Hampton Research. Crystals grew in 1 week. Crystals of Cat K with compound <b>5</b> grew in 0.2 M KCl, 0.05 M HEPES (pH 7.5), 35% pentaerythritol propoxylate (5/4 PO/OH) solution. Crystals of Cat K with compound <b>6</b> grew in 0.2 M Li<sub>2</sub>SO<sub>4</sub>, 0.1 M NaOAc (pH 4.5), 30% PEG 8000 solution. Crystals of Cat K with compound <b>9</b> grew in 2.4 M (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>/0.1 M NaOAc (pH 5.0) medium. All crystals were transferred for 5 s into cryobuffer, reservoir solution supplemented with 20% glycerol, and flash-cooled in liquid nitrogen.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Data Processing</h3><div class="NLM_p">Crystals of Cat K with compounds <b>5</b> and <b>6</b> were diffracting to 1.6 Å at home source using Bruker Microstar rotation anode, whereas the crystals of Cat K with compound <b>9</b> diffracted to 1.0 Å at BESSY BEAMLINE 14.1 in Berlin on PILATUS 6 M detector using 1.0 wavelength.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Data sets of the first two crystals were processed with PROTEUM (Proteum Software Pty Ltd.), whereas the third one was processed with XDSAPP.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div><div class="NLM_p last">The diffraction pattern of all crystals revealed the presence of a single crystal lattice. Data sets were scaled in P21 for Cat K with compound <b>5</b>, in P212121 for Cat K with compound <b>6</b>, and Cat K with compound <b>9</b>. Data statistics are presented in <a href="/doi/suppl/10.1021/acs.jmedchem.5b00746/suppl_file/jm5b00746_si_001.pdf" class="ext-link">Table S4</a>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Molecular Replacement</h3><div class="NLM_p last">Matthews coefficient analysis ambiguously defined one molecule in the asymmetric unit for all three Cat K structures. The structures were solved using <i>PHASER</i><a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> with the PDB model <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DMX">4DMX</a>.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Refinement was performed using <i>REFMAC5</i><a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> and <i>MAIN</i>.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Model building was done using <i>Coot</i><a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> and <i>MAIN</i>.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Complete chain of Cat K from 1st to 215th in all three crystals is well resolved by electron density maps. Several residues were built with alternative conformations. Additionally, one potassium and one chloride ion was built in the compound <b>5</b> complex, five SO<sub>4</sub><sup>2–</sup> anions in the crystal complex of Cat K with compound <b>6</b> and six SO<sub>4</sub><sup>2–</sup>, two NH<sub>4</sub><sup>+</sup>, and one AcO<sup>–</sup> anions in the compound <b>9</b> complex. Determined coordinates of Cat K with compounds <b>5</b>, <b>6</b>, and <b>9</b> were deposited in PDB as <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X6J">4X6J</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X6I">4X6I</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X6H">4X6H</a>, respectively.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00746">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66130" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66130" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b00746" class="ext-link">10.1021/acs.jmedchem.5b00746</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Additional details of combinatorial data set and consensus modeling, tables of crystallographic data, schematic representation of virtual synthetic pathways, reversibility test, NMR spectra (<a href="/doi/suppl/10.1021/acs.jmedchem.5b00746/suppl_file/jm5b00746_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">CSV file containing molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.5b00746/suppl_file/jm5b00746_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Additional experimental and combinatorial data and consensus results (<a href="/doi/suppl/10.1021/acs.jmedchem.5b00746/suppl_file/jm5b00746_si_003.xlsx" class="ext-link">XLSX</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00746/suppl_file/jm5b00746_si_001.pdf">jm5b00746_si_001.pdf (4.07 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00746/suppl_file/jm5b00746_si_002.csv">jm5b00746_si_002.csv (0.88 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00746/suppl_file/jm5b00746_si_003.xlsx">jm5b00746_si_003.xlsx (161.63 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB ID codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X6J">4X6J</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X6I">4X6I</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X6H">4X6H</a>.</p><div class="testing" data-doi="10.1021/acs.jmedchem.5b00746" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36582" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36582" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Boris Turk</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, Molecular and Structural Biology, Jozef Stefan Institute, Jamova cesta 39, SI-1000 Ljubljana, Slovenia</span>; 
    <span class="hlFld-Affiliation affiliation">Centre of Excellence
for Integrated Approaches in Chemistry and Biology of Proteins, Jamova cesta 39, SI-1000 Ljubljana, Slovenia</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3c5e534e554f1248494e577c55564f124f55"><span class="__cf_email__" data-cfemail="f0929f829983de8485829bb0999a83de8399">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dušan Turk</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, Molecular and Structural Biology, Jozef Stefan Institute, Jamova cesta 39, SI-1000 Ljubljana, Slovenia</span>; 
    <span class="hlFld-Affiliation affiliation">Centre of Excellence
for Integrated Approaches in Chemistry and Biology of Proteins, Jamova cesta 39, SI-1000 Ljubljana, Slovenia</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Chemistry and Chemical Technology, University
of Ljubljana, Večna
pot 113, SI-1000 Ljubljana, Slovenia</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bcd8c9cfddd292c8c9ced7fcd5d6cf92cfd5"><span class="__cf_email__" data-cfemail="b4d0c1c7d5da9ac0c1c6dff4dddec79ac7dd">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marjana Novič</span> - <span class="hlFld-Affiliation affiliation">National Institute
of Chemistry, Hajdrihova 19, SI-1001 Ljubljana, Slovenia</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#caa7abb8a0aba4abe4a4a5bca3a98aa1a3e4b9a3"><span class="__cf_email__" data-cfemail="600d01120a010e014e0e0f160903200b094e1309">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jure Borišek</span> - <span class="hlFld-Affiliation affiliation">National Institute
of Chemistry, Hajdrihova 19, SI-1001 Ljubljana, Slovenia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matej Vizovišek</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, Molecular and Structural Biology, Jozef Stefan Institute, Jamova cesta 39, SI-1000 Ljubljana, Slovenia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Piotr Sosnowski</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, Molecular and Structural Biology, Jozef Stefan Institute, Jamova cesta 39, SI-1000 Ljubljana, Slovenia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara Mohar</span> - <span class="hlFld-Affiliation affiliation">National Institute
of Chemistry, Hajdrihova 19, SI-1001 Ljubljana, Slovenia</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d5566e3264-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77545" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77545" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the Slovene Research Agency (Grants No. P1-0017, P1-0140 and P1-0048).</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34577" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34577" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 64 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Fonovic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, B.</span><span> </span><span class="NLM_article-title">Cysteine cathepsins and extracellular matrix degradation</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Gen. Subj.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1840</span><span class="NLM_x">, </span> <span class="NLM_fpage">2560</span><span class="NLM_x">–</span> <span class="NLM_lpage">2570</span><span class="refDoi"> DOI: 10.1016/j.bbagen.2014.03.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1016%2Fj.bbagen.2014.03.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1840&publication_year=2014&pages=2560-2570&author=M.+Fonovicauthor=B.+Turk&title=Cysteine+cathepsins+and+extracellular+matrix+degradation&doi=10.1016%2Fj.bbagen.2014.03.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2014.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2014.03.017%26sid%3Dliteratum%253Aachs%26aulast%3DFonovic%26aufirst%3DM.%26aulast%3DTurk%26aufirst%3DB.%26atitle%3DCysteine%2520cathepsins%2520and%2520extracellular%2520matrix%2520degradation%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2014%26volume%3D1840%26spage%3D2560%26epage%3D2570%26doi%3D10.1016%2Fj.bbagen.2014.03.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Novinec, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenarcic, B.</span><span> </span><span class="NLM_article-title">Cathepsin K: a unique collagenolytic cysteine peptidase</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">394</span><span class="NLM_x">, </span> <span class="NLM_fpage">1163</span><span class="NLM_x">–</span> <span class="NLM_lpage">1179</span><span class="refDoi"> DOI: 10.1515/hsz-2013-0134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1515%2Fhsz-2013-0134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=23629523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvFylsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=394&publication_year=2013&pages=1163-1179&author=M.+Novinecauthor=B.+Lenarcic&title=Cathepsin+K%3A+a+unique+collagenolytic+cysteine+peptidase&doi=10.1515%2Fhsz-2013-0134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin K: a unique collagenolytic cysteine peptidase</span></div><div class="casAuthors">Novinec, Marko; Lenarcic, Brigita</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">394</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1163-1179</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">A review.  Cathepsin K has emerged as a promising target for the treatment of osteoporosis in recent years.  Initially identified as a papain-like cysteine peptidase expressed in high levels in osteoclasts, the important role of this enzyme in bone metab. was highlighted by the finding that mutations in the CTSK gene cause the rare recessive disorder pycnodysostosis, which is characterized by severe bone anomalies.  At the mol. level, the physiol. role of cathepsin K is reflected by its unique cleavage pattern of type I collagen mols., which is fundamentally different from that of other endogenous collagenases.  Several cathepsin K inhibitors have been developed to reduce the excessive bone matrix degrdn. assocd. with osteoporosis, with the frontrunner odanacatib about to successfully conclude Phase 3 clin. trials.  Apart from osteoclasts, cathepsin K is expressed in different cell types throughout the body and is involved in processes of adipogenesis, thyroxine liberation and peptide hormone regulation.  Elevated activity of cathepsin K has been assocd. with arthritis, atherosclerosis, obesity, schizophrenia, and tumor metastasis.  Accordingly, its activity is tightly regulated via multiple mechanisms, including competitive inhibition by endogenous macromol. inhibitors and allosteric regulation by glycosaminoglycans.  This review provides a state-of-the-art description of the activity of cathepsin K at the mol. level, its biol. functions and the mechanisms involved in its regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnGDT8B0IwW7Vg90H21EOLACvtfcHk0lhT3uSuin7Tag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvFylsL4%253D&md5=7608c0877f60fdd9265b797f3f423835</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2013-0134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2013-0134%26sid%3Dliteratum%253Aachs%26aulast%3DNovinec%26aufirst%3DM.%26aulast%3DLenarcic%26aufirst%3DB.%26atitle%3DCathepsin%2520K%253A%2520a%2520unique%2520collagenolytic%2520cysteine%2520peptidase%26jtitle%3DBiol.%2520Chem.%26date%3D2013%26volume%3D394%26spage%3D1163%26epage%3D1179%26doi%3D10.1515%2Fhsz-2013-0134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Deaton, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span> </span><span class="NLM_article-title">6. Cathepsin K inhibitors: their potential as anti-osteoporosis agents</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span><span class="refDoi"> DOI: 10.1016/S0079-6468(04)42006-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1016%2FS0079-6468%2804%2942006-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=15003723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksF2qs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2004&pages=245-375&author=D.+M.+Deatonauthor=S.+Kumar&title=6.+Cathepsin+K+inhibitors%3A+their+potential+as+anti-osteoporosis+agents&doi=10.1016%2FS0079-6468%2804%2942006-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin K inhibitors: their potential as anti-osteoporosis agents</span></div><div class="casAuthors">Deaton, David N.; Kumar, Sanjay</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">245-375</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5lac51vejU7Vg90H21EOLACvtfcHk0lhG-U4jcVvmlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksF2qs7g%253D&md5=c1b2a00cf0aa73abbb2491012b3e78cd</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2804%2942006-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252804%252942006-2%26sid%3Dliteratum%253Aachs%26aulast%3DDeaton%26aufirst%3DD.%2BM.%26aulast%3DKumar%26aufirst%3DS.%26atitle%3D6.%2520Cathepsin%2520K%2520inhibitors%253A%2520their%2520potential%2520as%2520anti-osteoporosis%2520agents%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D42%26spage%3D245%26epage%3D375%26doi%3D10.1016%2FS0079-6468%2804%2942006-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Katunuma, N.</span><span> </span><span class="NLM_article-title">Structure-based development of specific inhibitors for individual cathepsins and their medical applications</span> <span class="citation_source-journal">Proc. Jpn. Acad., Ser. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.2183/pjab.87.29</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.2183%2Fpjab.87.29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt1alsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2011&pages=29-39&author=N.+Katunuma&title=Structure-based+development+of+specific+inhibitors+for+individual+cathepsins+and+their+medical+applications&doi=10.2183%2Fpjab.87.29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based development of specific inhibitors for individual cathepsins and their medical applications</span></div><div class="casAuthors">Katunuma, Nobuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Japan Academy, Series B: Physical and Biological Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">29-39</span>CODEN:
                <span class="NLM_cas:coden">PJABDW</span>;
        ISSN:<span class="NLM_cas:issn">0386-2208</span>.
    
            (<span class="NLM_cas:orgname">Nippon Gakushiin</span>)
        </div><div class="casAbstract">A review.  Specific inhibitors for individual cathepsins have been developed based on their tertiary structures of X-ray crystallog.  Cathepsin B-specific inhibitors, CA-074 and CA-030, and cathepsin L specific inhibitors, CLIK-148 and CLIK-195, were designed as the epoxysuccinate derivs.  Cathepsin S inhibitor, CLIK-060, and cathepsin K inhibitor, CLIK-166, were synthesized.  These inhibitors can use in vitro and also in vivo, and show no toxicity for exptl. animals by the amts. used as the cathepsin inhibitor.  Various cathepsins are used in the processing of antigenic proteins.  The CLIK-060 treatment to the autoimmune disease, Sjogren model mice, led to strongly suppress the expression of the pathol. symptoms.  Cathepsins L or K participates to the degrdn. of bone collagen.  The CLIK-148 protects osteoporosis in animals and also protects the bone metastasis of cancer cells.  Cathepsin L also enhances insulin-induced glucose uptake into 3T3-L1 adipocytes, suggesting cathepsin L plays the roles in adipogenesis and glucose tolerance in type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl9gYdvAtAJ7Vg90H21EOLACvtfcHk0lhG-U4jcVvmlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt1alsL8%253D&md5=75d9e6e6b75de8093775dd148b808d44</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2183%2Fpjab.87.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2183%252Fpjab.87.29%26sid%3Dliteratum%253Aachs%26aulast%3DKatunuma%26aufirst%3DN.%26atitle%3DStructure-based%2520development%2520of%2520specific%2520inhibitors%2520for%2520individual%2520cathepsins%2520and%2520their%2520medical%2520applications%26jtitle%3DProc.%2520Jpn.%2520Acad.%252C%2520Ser.%2520B%26date%3D2011%26volume%3D87%26spage%3D29%26epage%3D39%26doi%3D10.2183%2Fpjab.87.29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Nomura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katunuma, N.</span><span> </span><span class="NLM_article-title">Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells</span> <span class="citation_source-journal">J. Med. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.2152/jmi.52.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.2152%2Fjmi.52.1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=1-9&author=T.+Nomuraauthor=N.+Katunuma&title=Involvement+of+cathepsins+in+the+invasion%2C+metastasis+and+proliferation+of+cancer+cells&doi=10.2152%2Fjmi.52.1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2152%2Fjmi.52.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2152%252Fjmi.52.1%26sid%3Dliteratum%253Aachs%26aulast%3DNomura%26aufirst%3DT.%26aulast%3DKatunuma%26aufirst%3DN.%26atitle%3DInvolvement%2520of%2520cathepsins%2520in%2520the%2520invasion%252C%2520metastasis%2520and%2520proliferation%2520of%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Invest.%26date%3D2005%26volume%3D52%26spage%3D1%26epage%3D9%26doi%3D10.2152%2Fjmi.52.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Turk, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, D.</span><span> </span><span class="NLM_article-title">Lysosomal cysteine proteases: facts and opportunities</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4629</span><span class="NLM_x">–</span> <span class="NLM_lpage">4633</span><span class="refDoi"> DOI: 10.1093/emboj/20.17.4629</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1093%2Femboj%2F20.17.4629" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=11532926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnt1CmtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=4629-4633&author=V.+Turkauthor=B.+Turkauthor=D.+Turk&title=Lysosomal+cysteine+proteases%3A+facts+and+opportunities&doi=10.1093%2Femboj%2F20.17.4629"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomal cysteine proteases: facts and opportunities</span></div><div class="casAuthors">Turk, Vito; Turk, Boris; Turk, Dusan</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4629-4633</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with 45 refs.  From their discovery in the 1st half of the 20th century, lysosomal cysteine proteases have come a long way: from being the enzymes nonselectively degrading proteins in lysosomes to being those responsible for a no. of important cellular processes.  Some of the features and roles of their structures, specificity, regulation and physiol. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0zs_42JgTMLVg90H21EOLACvtfcHk0lhG-U4jcVvmlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnt1CmtrY%253D&md5=c9d0d915891974839ecf3862698cd093</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F20.17.4629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F20.17.4629%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DV.%26aulast%3DTurk%26aufirst%3DB.%26aulast%3DTurk%26aufirst%3DD.%26atitle%3DLysosomal%2520cysteine%2520proteases%253A%2520facts%2520and%2520opportunities%26jtitle%3DEMBO%2520J.%26date%3D2001%26volume%3D20%26spage%3D4629%26epage%3D4633%26doi%3D10.1093%2Femboj%2F20.17.4629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Turk, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoka, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasiljeva, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, D.</span><span> </span><span class="NLM_article-title">Cysteine cathepsins: from structure, function and regulation to new frontiers</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Proteins Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1824</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span><span class="refDoi"> DOI: 10.1016/j.bbapap.2011.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1016%2Fj.bbapap.2011.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=22024571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFOns7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1824&publication_year=2012&pages=68-88&author=V.+Turkauthor=V.+Stokaauthor=O.+Vasiljevaauthor=M.+Renkoauthor=T.+Sunauthor=B.+Turkauthor=D.+Turk&title=Cysteine+cathepsins%3A+from+structure%2C+function+and+regulation+to+new+frontiers&doi=10.1016%2Fj.bbapap.2011.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cysteine cathepsins: From structure, function and regulation to new frontiers</span></div><div class="casAuthors">Turk, Vito; Stoka, Veronika; Vasiljeva, Olga; Renko, Miha; Sun, Tao; Turk, Boris; Turk, Dusan</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1824</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">68-88</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  It is more than 50 years since the lysosome was discovered.  Since then its hydrolytic machinery, including proteases and other hydrolases, has been fairly well identified and characterized.  Among these are the cysteine cathepsins, members of the family of papain-like cysteine proteases.  They have unique reactive-site properties and an uneven tissue-specific expression pattern.  In living organisms, their activity is a delicate balance of expression, targeting, zymogen activation, inhibition by protein inhibitors and degrdn.  The specificity of their substrate binding sites, small-mol. inhibitor repertoire and crystal structures are providing new tools for research and development.  Their unique reactive-site properties have made it possible to confine the targets simply by the use of appropriate reactive groups.  The epoxysuccinyls still dominate the field, but now nitriles seem to be the most appropriate "warhead".  The view of cysteine cathepsins as lysosomal proteases is changing as there is now clear evidence of their localization in other cellular compartments.  Besides being involved in protein turnover, they build an important part of endosomal antigen presentation.  Together with the growing no. of non-endosomal roles of cysteine cathepsins is growing also the knowledge of their involvement in diseases such as cancer and rheumatoid arthritis, among others.  Finally, cysteine cathepsins are important regulators and signaling mols. of an unimaginable no. of biol. processes.  The current challenge is to identify their endogenous substrates, in order to gain an insight into the mechanisms of substrate degrdn. and processing.  In this review, some of the remarkable advances that have taken place in the past decade are presented.  This article is part of a Special Issue entitled: Proteolysis 50 years after the discovery of lysosome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUEZ0u2P21D7Vg90H21EOLACvtfcHk0lgSnPVnNAtIag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFOns7rI&md5=8615c1f0205d66b0fad932d6ff874390</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2011.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2011.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DV.%26aulast%3DStoka%26aufirst%3DV.%26aulast%3DVasiljeva%26aufirst%3DO.%26aulast%3DRenko%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DT.%26aulast%3DTurk%26aufirst%3DB.%26aulast%3DTurk%26aufirst%3DD.%26atitle%3DCysteine%2520cathepsins%253A%2520from%2520structure%252C%2520function%2520and%2520regulation%2520to%2520new%2520frontiers%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2012%26volume%3D1824%26spage%3D68%26epage%3D88%26doi%3D10.1016%2Fj.bbapap.2011.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Aguda, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panwar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brayer, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brömme, D.</span><span> </span><span class="NLM_article-title">Structural basis of collagen fiber degradation by cathepsin K</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">17474</span><span class="NLM_x">–</span> <span class="NLM_lpage">17479</span><span class="refDoi"> DOI: 10.1073/pnas.1414126111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1073%2Fpnas.1414126111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=25422423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKmu7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=17474-17479&author=A.+H.+Agudaauthor=P.+Panwarauthor=X.+Duauthor=N.+T.+Nguyenauthor=G.+D.+Brayerauthor=D.+Br%C3%B6mme&title=Structural+basis+of+collagen+fiber+degradation+by+cathepsin+K&doi=10.1073%2Fpnas.1414126111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of collagen fiber degradation by cathepsin K</span></div><div class="casAuthors">Aguda, Adeleke H.; Panwar, Preety; Du, Xin; Nguyen, Nham T.; Brayer, Gary D.; Bromme, Dieter</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">17474-17479</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Cathepsin K (I) is the major collagenolytic protease in bone that facilitates physiol. as well as pathol. bone degrdn.  Despite its key role in bone remodeling and for being a highly sought-after drug target for the treatment of osteoporosis, the mechanism of collagen fiber degrdn. by I remained elusive.  Here, the authors report the structure of a collagenolytically active I protein dimer.  I is organized into elongated C-shaped protease dimers that reveal a putative collagen-binding interface aided by glycosaminoglycans.  Mol. modeling of collagen binding to the dimer indicated the participation of non-active site residues, Gln-21 and Gln-92, in collagen unfolding.  Mutations at these sites as well as perturbation of the dimer protein-protein interface completely inhibited I-mediated fiber degrdn. without affecting the hydrolysis of gelatin or synthetic peptides.  Using SEM, the authors demonstrated the specific binding of I at the edge of the fibrillar gap region of collagen fibers, which suggested initial cleavage events at the N- and C-terminal ends of tropocollagen mols.  Edman degrdn. anal. of collagen fiber degrdn. products revealed those initial cleavage sites.  The authors propose that one I mol. binds to collagen-bound glycosaminoglycans at the gap region and recruits a 2nd protease mol. that provides an unfolding and cleavage mechanism for triple helical collagen.  Removal of collagen-assocd. glycosaminoglycans prevents I binding and subsequently fiber hydrolysis.  I dimer and glycosaminoglycan binding sites represent novel targeting sites for the development of non-active site-directed 2nd-generation inhibitors of this important drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrq5uozwCNg7Vg90H21EOLACvtfcHk0lgSnPVnNAtIag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKmu7rM&md5=25e4c1be01bc9b16fa126134659a7441</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1414126111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1414126111%26sid%3Dliteratum%253Aachs%26aulast%3DAguda%26aufirst%3DA.%2BH.%26aulast%3DPanwar%26aufirst%3DP.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DNguyen%26aufirst%3DN.%2BT.%26aulast%3DBrayer%26aufirst%3DG.%2BD.%26aulast%3DBr%25C3%25B6mme%26aufirst%3DD.%26atitle%3DStructural%2520basis%2520of%2520collagen%2520fiber%2520degradation%2520by%2520cathepsin%2520K%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D17474%26epage%3D17479%26doi%3D10.1073%2Fpnas.1414126111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Hua, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, S.</span><span> </span><span class="NLM_article-title">Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Basis Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">1852</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span><span class="refDoi"> DOI: 10.1016/j.bbadis.2014.04.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1016%2Fj.bbadis.2014.04.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=24815358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotlOqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1852&publication_year=2015&pages=195-208&author=Y.+Huaauthor=S.+Nair&title=Proteases+in+cardiometabolic+diseases%3A+Pathophysiology%2C+molecular+mechanisms+and+clinical+applications&doi=10.1016%2Fj.bbadis.2014.04.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications</span></div><div class="casAuthors">Hua, Yinan; Nair, Sreejayan</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1852</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-208</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Cardiovascular disease is the leading cause of death in the U.S. and other developed countries.  Metabolic syndrome, including obesity, diabetes/insulin resistance, hypertension and dyslipidemia is a major threat for public health in the modern society.  It is well established that metabolic syndrome contributes to the development of cardiovascular disease collective called as cardiometabolic disease.  Despite documented studies in the research field of cardiometabolic disease, the underlying mechanisms are far from clear.  Proteases are enzymes that break down proteins, many of which have been implicated in various diseases including cardiac disease.  Matrix metalloproteinase (MMP), calpain, cathepsin and caspase are among the major proteases involved in cardiac remodeling.  Recent studies have also implicated proteases in the pathogenesis of cardiometabolic disease.  Elevated expression and activities of proteases in atherosclerosis, coronary heart disease, obesity/insulin-assocd. heart disease as well as hypertensive heart disease have been documented.  Furthermore, transgenic animals that are deficient in or over-express proteases allow scientists to understand the causal relationship between proteases and cardiometabolic disease.  Mechanistically, MMPs and cathepsins exert their effect on cardiometabolic diseases mainly through modifying the extracellular matrix.  However, MMP and cathepsin are also reported to affect intracellular proteins, by which they contribute to the development of cardiometabolic diseases.  On the other hand, activation of calpain and caspases has been shown to influence intracellular signaling cascade including the NF-κB and apoptosis pathways.  Clin., proteases are reported to function as biomarkers of cardiometabolic diseases.  More importantly, the inhibitors of proteases are credited with beneficial cardiometabolic profile, although the exact mol. mechanisms underlying these salutary effects are still under investigation.  A better understanding of the role of MMPs, cathepsins, calpains and caspases in cardiometabolic diseases process may yield novel therapeutic targets for treating or controlling these diseases.  This article is part of a Special Issue entitled: Autophagy and protein quality control in cardiometabolic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWm9CSuGAt77Vg90H21EOLACvtfcHk0lgSnPVnNAtIag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotlOqt7s%253D&md5=e23b20735ac3c18cb1332cb64af81eef</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2014.04.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2014.04.032%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DY.%26aulast%3DNair%26aufirst%3DS.%26atitle%3DProteases%2520in%2520cardiometabolic%2520diseases%253A%2520Pathophysiology%252C%2520molecular%2520mechanisms%2520and%2520clinical%2520applications%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2015%26volume%3D1852%26spage%3D195%26epage%3D208%26doi%3D10.1016%2Fj.bbadis.2014.04.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Nagase, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manako, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, S.</span><span> </span><span class="NLM_article-title">Bone turnover markers and pharmacokinetics of a new sustained-release formulation of the cathepsin K inhibitor, ONO-5334, in healthy post-menopausal women</span> <span class="citation_source-journal">J. Bone Miner. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span><span class="refDoi"> DOI: 10.1007/s00774-013-0558-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1007%2Fs00774-013-0558-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2015&pages=93-100&author=S.+Nagaseauthor=M.+Ohyamaauthor=Y.+Hashimotoauthor=M.+Smallauthor=J.+Sharpeauthor=J.+Manakoauthor=T.+Kuwayamaauthor=S.+Deacon&title=Bone+turnover+markers+and+pharmacokinetics+of+a+new+sustained-release+formulation+of+the+cathepsin+K+inhibitor%2C+ONO-5334%2C+in+healthy+post-menopausal+women&doi=10.1007%2Fs00774-013-0558-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs00774-013-0558-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00774-013-0558-2%26sid%3Dliteratum%253Aachs%26aulast%3DNagase%26aufirst%3DS.%26aulast%3DOhyama%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DSmall%26aufirst%3DM.%26aulast%3DSharpe%26aufirst%3DJ.%26aulast%3DManako%26aufirst%3DJ.%26aulast%3DKuwayama%26aufirst%3DT.%26aulast%3DDeacon%26aufirst%3DS.%26atitle%3DBone%2520turnover%2520markers%2520and%2520pharmacokinetics%2520of%2520a%2520new%2520sustained-release%2520formulation%2520of%2520the%2520cathepsin%2520K%2520inhibitor%252C%2520ONO-5334%252C%2520in%2520healthy%2520post-menopausal%2520women%26jtitle%3DJ.%2520Bone%2520Miner.%2520Metab.%26date%3D2015%26volume%3D33%26spage%3D93%26epage%3D100%26doi%3D10.1007%2Fs00774-013-0558-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Cheng, X. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuzuya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murohara, T.</span><span> </span><span class="NLM_article-title">Role for cysteine protease cathepsins in heart disease: focus on biology and mechanisms with clinical implication</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">1551</span><span class="NLM_x">–</span> <span class="NLM_lpage">1562</span><span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.111.066712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1161%2FCIRCULATIONAHA.111.066712" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2012&pages=1551-1562&author=X.+W.+Chengauthor=G.+P.+Shiauthor=M.+Kuzuyaauthor=T.+Sasakiauthor=K.+Okumuraauthor=T.+Murohara&title=Role+for+cysteine+protease+cathepsins+in+heart+disease%3A+focus+on+biology+and+mechanisms+with+clinical+implication&doi=10.1161%2FCIRCULATIONAHA.111.066712"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.111.066712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.111.066712%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DX.%2BW.%26aulast%3DShi%26aufirst%3DG.%2BP.%26aulast%3DKuzuya%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DOkumura%26aufirst%3DK.%26aulast%3DMurohara%26aufirst%3DT.%26atitle%3DRole%2520for%2520cysteine%2520protease%2520cathepsins%2520in%2520heart%2520disease%253A%2520focus%2520on%2520biology%2520and%2520mechanisms%2520with%2520clinical%2520implication%26jtitle%3DCirculation%26date%3D2012%26volume%3D125%26spage%3D1551%26epage%3D1562%26doi%3D10.1161%2FCIRCULATIONAHA.111.066712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Brömme, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecaille, F.</span><span> </span><span class="NLM_article-title">Cathepsin K inhibitors for osteoporosis and potential off-target effects</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">585</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span><span class="refDoi"> DOI: 10.1517/13543780902832661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1517%2F13543780902832661" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=585-600&author=D.+Br%C3%B6mmeauthor=F.+Lecaille&title=Cathepsin+K+inhibitors+for+osteoporosis+and+potential+off-target+effects&doi=10.1517%2F13543780902832661"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1517%2F13543780902832661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543780902832661%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25B6mme%26aufirst%3DD.%26aulast%3DLecaille%26aufirst%3DF.%26atitle%3DCathepsin%2520K%2520inhibitors%2520for%2520osteoporosis%2520and%2520potential%2520off-target%2520effects%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D18%26spage%3D585%26epage%3D600%26doi%3D10.1517%2F13543780902832661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Vassalle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iervasi, G.</span><span> </span><span class="NLM_article-title">Cathepsin K - A classical bone biomarker in cardiovascular disease: The heart is not alone anymore</span> <span class="citation_source-journal">Atherosclerosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">228</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span><span class="refDoi"> DOI: 10.1016/j.atherosclerosis.2013.01.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1016%2Fj.atherosclerosis.2013.01.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2013&pages=36-37&author=C.+Vassalleauthor=G.+Iervasi&title=Cathepsin+K+-+A+classical+bone+biomarker+in+cardiovascular+disease%3A+The+heart+is+not+alone+anymore&doi=10.1016%2Fj.atherosclerosis.2013.01.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.atherosclerosis.2013.01.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.atherosclerosis.2013.01.042%26sid%3Dliteratum%253Aachs%26aulast%3DVassalle%26aufirst%3DC.%26aulast%3DIervasi%26aufirst%3DG.%26atitle%3DCathepsin%2520K%2520-%2520A%2520classical%2520bone%2520biomarker%2520in%2520cardiovascular%2520disease%253A%2520The%2520heart%2520is%2520not%2520alone%2520anymore%26jtitle%3DAtherosclerosis%26date%3D2013%26volume%3D228%26spage%3D36%26epage%3D37%26doi%3D10.1016%2Fj.atherosclerosis.2013.01.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Hua, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolence, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, S.</span><span> </span><span class="NLM_article-title">Cathepsin K knockout mitigates high-fat diet-induced cardiac hypertrophy and contractile dysfunction</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span><span class="refDoi"> DOI: 10.2337/db12-0350</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.2337%2Fdb12-0350" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=498-509&author=Y.+Huaauthor=Y.+Zhangauthor=J.+Dolenceauthor=G.+P.+Shiauthor=J.+Renauthor=S.+Nair&title=Cathepsin+K+knockout+mitigates+high-fat+diet-induced+cardiac+hypertrophy+and+contractile+dysfunction&doi=10.2337%2Fdb12-0350"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2337%2Fdb12-0350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb12-0350%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDolence%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DG.%2BP.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DNair%26aufirst%3DS.%26atitle%3DCathepsin%2520K%2520knockout%2520mitigates%2520high-fat%2520diet-induced%2520cardiac%2520hypertrophy%2520and%2520contractile%2520dysfunction%26jtitle%3DDiabetes%26date%3D2013%26volume%3D62%26spage%3D498%26epage%3D509%26doi%3D10.2337%2Fdb12-0350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Frizler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirnberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisay, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gütschow, M.</span><span> </span><span class="NLM_article-title">Development of Nitrile-Based Peptidic Inhibitors of Cysteine Cathepsins</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span><span class="refDoi"> DOI: 10.2174/156802610790725452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.2174%2F156802610790725452" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=20166952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1entL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=294-322&author=M.+Frizlerauthor=M.+Stirnbergauthor=M.+T.+Sisayauthor=M.+G%C3%BCtschow&title=Development+of+Nitrile-Based+Peptidic+Inhibitors+of+Cysteine+Cathepsins&doi=10.2174%2F156802610790725452"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Development of nitrile-based peptidic inhibitors of cysteine cathepsins</span></div><div class="casAuthors">Frizler, Maxim; Stirnberg, Marit; Sisay, Mihiret Tekeste; Guetschow, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">294-322</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  It is now becoming clear that several papain-like cysteine cathepsins are involved in the pathophysiol. of diseases such as osteoporosis, autoimmune disorders, and cancer.  Therefore, the development of potent and selective cathepsin inhibitors is an attractive subject for medicinal chemists.  New advances have been made for nitrile-based inhibitors, leading to the identification of the cathepsin K inhibitor odanacatib and other candidates with potential for therapeutic use.  This review summarizes the development of peptidic and peptidomimetic compds. with an electrophilic nitrile 'warhead' as inhibitors of the cysteine cathepsins B, S, L, C, and K.  Peptide nitriles have been shown to reversibly react with the active site cysteine under formation of a covalent thioimidate adduct.  The structural optimization with respect to the positions P3, P2, P1, P1', and P2' resulted in the identification of potent and selective inhibitors of the corresponding cathepsins.  The underlying structure-activity relationships are discussed herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxV5N3L7sVS7Vg90H21EOLACvtfcHk0lh7FVgwsUixxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1entL8%253D&md5=8b0004f6aca64540b7f206ecc8527ff4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F156802610790725452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610790725452%26sid%3Dliteratum%253Aachs%26aulast%3DFrizler%26aufirst%3DM.%26aulast%3DStirnberg%26aufirst%3DM.%26aulast%3DSisay%26aufirst%3DM.%2BT.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520Nitrile-Based%2520Peptidic%2520Inhibitors%2520of%2520Cysteine%2520Cathepsins%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D294%26epage%3D322%26doi%3D10.2174%2F156802610790725452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Wijkmans, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gossen, J.</span><span> </span><span class="NLM_article-title">Inhibitors of cathepsin K: a patent review (2004 - 2010)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1611</span><span class="NLM_x">–</span> <span class="NLM_lpage">1629</span><span class="refDoi"> DOI: 10.1517/13543776.2011.616283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1517%2F13543776.2011.616283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=21923554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2jsLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1611-1629&author=J.+Wijkmansauthor=J.+Gossen&title=Inhibitors+of+cathepsin+K%3A+a+patent+review+%282004+-+2010%29&doi=10.1517%2F13543776.2011.616283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of cathepsin K: a patent review (2004 - 2010)</span></div><div class="casAuthors">Wijkmans, Jac; Gossen, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1611-1629</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction:Cathepsin K is a lysosomal cysteine protease involved in osteoclast-mediated bone resorption.  Inhibition of cathepsin K represents a potentially attractive therapeutic approach for treating diseases characterized by excessive bone resorption, such as osteoporosis.  Areas covered:The present review provides an overview of low mol. wt. cathepsin K inhibitors published in the patent literature from July 2004 to 2010.  Different chemotypes are surveyed and listed according to electrophilic warhead type.  Relevant information from original research articles in peer-reviewed journals and clin. investigations is also described.  Expert opinion:Between 2004 and 2010, more than 50 patent applications have appeared, underlining the continued interest in small mol. cathepsin K inhibition for therapeutic intervention.  Most compds. claimed are peptide-derived inhibitors displaying a reversible binding nitrile or ketone warhead.  The success of these compds. in the clinic will be detd. by the selectivity that can be achieved against other off-target cathepsin.  In this respect, eliminating lysosomotropic characteristics may prove to be crucial in the design of selective cathepsin K inhibitors.  During the review period, ONO-5334 and odanacatib have progressed to Phase II and Phase III clin. trials, resp.  The results of these studies are eagerly awaited and may det. the future of these agents as disease-modifying therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpewEY2N2yCN7Vg90H21EOLACvtfcHk0lh7FVgwsUixxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2jsLnN&md5=7d46cbea0f4fcbf6bb5565272dd5a3a9</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.616283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.616283%26sid%3Dliteratum%253Aachs%26aulast%3DWijkmans%26aufirst%3DJ.%26aulast%3DGossen%26aufirst%3DJ.%26atitle%3DInhibitors%2520of%2520cathepsin%2520K%253A%2520a%2520patent%2520review%2520%25282004%2520-%25202010%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D1611%26epage%3D1629%26doi%3D10.1517%2F13543776.2011.616283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Chapurlat, R. D.</span><span> </span><span class="NLM_article-title">Treatment of postmenopausal osteoporosis with odanacatib</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1517/14656566.2014.881470</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1517%2F14656566.2014.881470" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=24456412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFamtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=559-564&author=R.+D.+Chapurlat&title=Treatment+of+postmenopausal+osteoporosis+with+odanacatib&doi=10.1517%2F14656566.2014.881470"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of postmenopausal osteoporosis with odanacatib</span></div><div class="casAuthors">Chapurlat, Roland D.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">559-564</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The market of antiosteoporosis drugs has been declining in recent years, possibly in part due to the publicity around adverse events obsd. with bisphosphonates.  Also, the proportion of patients with clin. fracture who receive adequate treatment remains low.  So there are still unmet needs in this field. is a cathepsin K inhibitor currently being developed for the treatment of postmenopausal osteoporosis that could be an advance in this context.  Areas covered: Odanacatib is a bone resorption inhibitor, but it preserves some degree of bone formation, which differentiates this new family of drugs from existing therapies.  Odanacatib increases bone mineral d. at the spine and hip, improves estd. bone strength using finite element anal. at the spine and hip as well as at the distal tibia and radius.  The safety profile has been satisfactory so far.  A robust antifracture efficacy has been announced when the Phase III pivotal trial was terminated after interim anal., but we do not yet have access to the complete results.  Expert opinion: Odanacatib may have an important role in future guidelines if it provides a substantial advantage compared to the effective and inexpensive current generic drugs, in terms of antifracture efficacy or safety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopvs10g2jS8bVg90H21EOLACvtfcHk0lh7FVgwsUixxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFamtrY%253D&md5=c102af0fc54035b87cb7051060a83c06</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F14656566.2014.881470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2014.881470%26sid%3Dliteratum%253Aachs%26aulast%3DChapurlat%26aufirst%3DR.%2BD.%26atitle%3DTreatment%2520of%2520postmenopausal%2520osteoporosis%2520with%2520odanacatib%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2014%26volume%3D15%26spage%3D559%26epage%3D564%26doi%3D10.1517%2F14656566.2014.881470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Engelke, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagase, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuerst, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genant, H. K.</span><span> </span><span class="NLM_article-title">The Effect of the Cathepsin K Inhibitor ONO-5334 on Trabecular and Cortical Bone in Postmenopausal Osteoporosis: The OCEAN Study</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">629</span><span class="NLM_x">–</span> <span class="NLM_lpage">638</span><span class="refDoi"> DOI: 10.1002/jbmr.2080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1002%2Fjbmr.2080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=24038152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjt1Sgsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2014&pages=629-638&author=K.+Engelkeauthor=S.+Nagaseauthor=T.+Fuerstauthor=M.+Smallauthor=T.+Kuwayamaauthor=S.+Deaconauthor=R.+Eastellauthor=H.+K.+Genant&title=The+Effect+of+the+Cathepsin+K+Inhibitor+ONO-5334+on+Trabecular+and+Cortical+Bone+in+Postmenopausal+Osteoporosis%3A+The+OCEAN+Study&doi=10.1002%2Fjbmr.2080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The Effect of the Cathepsin K Inhibitor ONO-5334 on Trabecular and Cortical Bone in Postmenopausal Osteoporosis: The OCEAN Study</span></div><div class="casAuthors">Engelke, Klaus; Nagase, Shinichi; Fuerst, Thomas; Small, Maria; Kuwayama, Tomohiro; Deacon, Stephen; Eastell, Richard; Genant, Harry K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">629-638</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">ONO-5334 (Ono Pharmaceutical Co., Ltd., Osaka, Japan) inhibits cathepsin K and has been shown to increase areal bone mineral d. (BMD) at the hip and spine in postmenopausal osteoporosis.  Quant. computed tomog. (QCT) allows the study of the cortical and trabecular bone sep. and provides structural information such as cortical thickness.  We investigated the impact of 2 years of cathepsin K inhibition on these different bone compartments with ONO-5334.  The clin. study was a randomized, double-blind, placebo, and active controlled parallel group study conducted in 13 centers in six European countries.  The original study period of 12 mo was extended by another 12 mo.  A total of 147 subjects (age 55-75 years) of the QCT substudy who participated in the extension period were included.  Subjects had been randomized into one of five treatment arms: placebo; ONO-5334 50 mg twice per day (BID); ONO-5334 100 mg once daily (QD); ONO-5334 300 mg QD; or alendronate 70 mg once weekly (QW).  QCT was obtained to evaluate bone structure at the lumbar spine and proximal femur.  After 24 mo ONO-5334 showed statistically significant increases vs. placebo for integral, trabecular, and cortical BMD at the spine and the hip (for ONO-5334 300 mg QD, BMD increases were 10.5%, 7.1%, and 13.4% for integral, cortical, and trabecular BMD at the spine, resp., and 6.2%, 3.4%, and 14.6% for integral, cortical, and trabecular total femur BMD, resp.).  Changes in cortical and trabecular BMD in the spine and hip were similar for alendronate as for ONO-5334.  Integral vol. did not demonstrate statistically significant changes under ONO-5334 treatment, thus there was no evidence of periosteal apposition, neither at the spine nor at the femur.  Cortical thickness changes were not statistically significant for ONO-5334 in the spine and hip, with exception of a 2.1% increase after month 24 in the intertrochanter for ONO-5334 300 mg QD.  Over 2 years ONO-5334 showed a statistically significant and persistent increase of trabecular and integral BMD at the spine and the hip.  Cortical BMD also progressively increased but at a lower rate.  Changes in bone size and of periosteal apposition were not obsd. 2014 American Society for Bone and Mineral Research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx-HiYdqkuWrVg90H21EOLACvtfcHk0lg5cvrOPTdWJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjt1Sgsbc%253D&md5=91d8549ae224522b701668e864f00a34</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fjbmr.2080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjbmr.2080%26sid%3Dliteratum%253Aachs%26aulast%3DEngelke%26aufirst%3DK.%26aulast%3DNagase%26aufirst%3DS.%26aulast%3DFuerst%26aufirst%3DT.%26aulast%3DSmall%26aufirst%3DM.%26aulast%3DKuwayama%26aufirst%3DT.%26aulast%3DDeacon%26aufirst%3DS.%26aulast%3DEastell%26aufirst%3DR.%26aulast%3DGenant%26aufirst%3DH.%2BK.%26atitle%3DThe%2520Effect%2520of%2520the%2520Cathepsin%2520K%2520Inhibitor%2520ONO-5334%2520on%2520Trabecular%2520and%2520Cortical%2520Bone%2520in%2520Postmenopausal%2520Osteoporosis%253A%2520The%2520OCEAN%2520Study%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2014%26volume%3D29%26spage%3D629%26epage%3D638%26doi%3D10.1002%2Fjbmr.2080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Duong, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickarski, M.</span><span> </span><span class="NLM_article-title">Efficacy of a Cathepsin K Inhibitor in a Preclinical Model for Prevention and Treatment of Breast Cancer Bone Metastasis</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2898</span><span class="NLM_x">–</span> <span class="NLM_lpage">2909</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-14-0253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1158%2F1535-7163.MCT-14-0253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=25249554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVCju7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=2898-2909&author=L.+T.+Duongauthor=G.+A.+Wesolowskiauthor=P.+Leungauthor=R.+Oballaauthor=M.+Pickarski&title=Efficacy+of+a+Cathepsin+K+Inhibitor+in+a+Preclinical+Model+for+Prevention+and+Treatment+of+Breast+Cancer+Bone+Metastasis&doi=10.1158%2F1535-7163.MCT-14-0253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of a Cathepsin K Inhibitor in a Preclinical Model for Prevention and Treatment of Breast Cancer Bone Metastasis</span></div><div class="casAuthors">Duong, Le T.; Wesolowski, Gregg A.; Leung, Patrick; Oballa, Renata; Pickarski, Maureen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2898-2909</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cathepsin K (CatK) is essential for osteoclast-mediated bone resorption.  CatK expression is also detected in breast cancer cells that metastasize to bone.  Here, the CatK inhibitor L-235 dosed in prevention (10, 30, and 100 mg/kg, p.o., b.i.d.) or treatment regimen (30 mg/kg) was compared with the bisphosphonate zoledronic acid (ZOL, 7.5 μg/kg/wk, s.c.) in the intratibial injection model of MDA-MB-231 breast carcinoma in nude rats.  Progression of osteolysis, skeletal tumor burden, and local metastasis was evaluated by radiog. through 42 days and ex vivo μCT and histol.  IHC and RT-PCR confirmed the increases in CatK protein and mRNA levels in human breast cancer primary and metastatic tumors.  In the exptl. model of breast cancer bone metastasis, L-235 dosed in preventive mode resulted in a dose-related redn. of osteolysis of 72%, 75%, and 87% resp., compared with ZOL by 86% vs. intact.  Similarly, L-235 significantly reduced intratibial tumor vol. by 29%, 40%, and 63%, resp., compared with 56% by ZOL vs. vehicle.  Efficacy of L-235 and ZOL on redn. of osteolytic lesions and tumor burden was comparable in treatment vs. preventive regimens.  All L-235 doses inhibited cortical disruption and extraskeletal tumor growth to a level comparable with ZOL.  Assessment of local metastasis demonstrated that treatment with the CatK inhibitor was more effective than ZOL in reducing breast cancer invasion.  These data support the role of CatK in breast cancer skeletal growth and metastasis and CatK inhibitors may represent a novel oral therapy for treatment of metastatic breast cancer.  Mol Cancer Ther; 13(12); 2898-909. 2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhrElug3rOBrVg90H21EOLACvtfcHk0lg5cvrOPTdWJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVCju7vE&md5=42c6bca739efd821458aea99c403fd8e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-14-0253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-14-0253%26sid%3Dliteratum%253Aachs%26aulast%3DDuong%26aufirst%3DL.%2BT.%26aulast%3DWesolowski%26aufirst%3DG.%2BA.%26aulast%3DLeung%26aufirst%3DP.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DPickarski%26aufirst%3DM.%26atitle%3DEfficacy%2520of%2520a%2520Cathepsin%2520K%2520Inhibitor%2520in%2520a%2520Preclinical%2520Model%2520for%2520Prevention%2520and%2520Treatment%2520of%2520Breast%2520Cancer%2520Bone%2520Metastasis%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2014%26volume%3D13%26spage%3D2898%26epage%3D2909%26doi%3D10.1158%2F1535-7163.MCT-14-0253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukunaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomomitsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santora, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagomi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsubouchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchida, S.</span><span> </span><span class="NLM_article-title">Effect of the cathepsin K inhibitor odanacatib administered once weekly on bone mineral density in Japanese patients with osteoporosis-a double-blind, randomized, dose-finding study</span> <span class="citation_source-journal">Osteoporosis Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">376</span><span class="refDoi"> DOI: 10.1007/s00198-013-2398-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1007%2Fs00198-013-2398-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=23716037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlCksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2014&pages=367-376&author=T.+Nakamuraauthor=M.+Shirakiauthor=M.+Fukunagaauthor=T.+Tomomitsuauthor=A.+C.+Santoraauthor=R.+Tsaiauthor=G.+Fujimotoauthor=M.+Nakagomiauthor=H.+Tsubouchiauthor=E.+Rosenbergauthor=S.+Uchida&title=Effect+of+the+cathepsin+K+inhibitor+odanacatib+administered+once+weekly+on+bone+mineral+density+in+Japanese+patients+with+osteoporosis-a+double-blind%2C+randomized%2C+dose-finding+study&doi=10.1007%2Fs00198-013-2398-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the cathepsin K inhibitor odanacatib administered once weekly on bone mineral density in Japanese patients with osteoporosis-a double-blind, randomized, dose-finding study</span></div><div class="casAuthors">Nakamura, T.; Shiraki, M.; Fukunaga, M.; Tomomitsu, T.; Santora, A. C.; Tsai, R.; Fujimoto, G.; Nakagomi, M.; Tsubouchi, H.; Rosenberg, E.; Uchida, S.</div><div class="citationInfo"><span class="NLM_cas:title">Osteoporosis International</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">367-376</span>CODEN:
                <span class="NLM_cas:coden">OSINEP</span>;
        ISSN:<span class="NLM_cas:issn">0937-941X</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag London Ltd.</span>)
        </div><div class="casAbstract">Summary: The efficacy and safety of oral placebo or odanacatib 10, 25, or 50 mg once weekly for 52 wk were evaluated in a double-blind, randomized, multi-center study in Japanese female and male patients with osteoporosis.  Introduction: Odanacatib is a selective and reversible cathepsin K inhibitor that decreases bone resorption and increases bone mineral d. (BMD).  Methods: The primary efficacy endpoint was percent change from baseline to week 52 in lumbar spine BMD.  Secondary endpoints included percent change in total hip, femoral neck, and trochanter BMD and in bone biomarkers after treatment for 52 wk.  Results: In this study, 286 patients [94 % female, mean age (SD) 68.2 (7.1) years] were included in the anal.  The least-squares mean percent changes from baseline to week 52 in the groups receiving placebo, 10, 25 and 50 mg of odanacatib for lumbar spine (L1∼L4) BMD were 0.5, 4.1, 5.7, and 5.9 % and for total hip BMD were -0.4, 1.3, 1.8, and 2.7 %, resp.  The changes in femoral neck and trochanter BMD were similar to those at the total hip.  Bone turnover markers were reduced in a dose-dependent manner.  However, the effects of odanacatib on bone formation markers were less compared with the effects on bone resorption markers.  Tolerability and safety profiles were similar among all treatment groups with no dose-related trends in any adverse events.  Conclusions: Weekly odanacatib treatment for 52 wk increased BMD at the lumbar spine and at all hip sites in a dose-dependent manner and was well tolerated in Japanese patients with osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoemcWV-4GgxrVg90H21EOLACvtfcHk0lg5cvrOPTdWJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlCksQ%253D%253D&md5=4240c5cdad454936bffede88656ba191</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs00198-013-2398-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00198-013-2398-2%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DShiraki%26aufirst%3DM.%26aulast%3DFukunaga%26aufirst%3DM.%26aulast%3DTomomitsu%26aufirst%3DT.%26aulast%3DSantora%26aufirst%3DA.%2BC.%26aulast%3DTsai%26aufirst%3DR.%26aulast%3DFujimoto%26aufirst%3DG.%26aulast%3DNakagomi%26aufirst%3DM.%26aulast%3DTsubouchi%26aufirst%3DH.%26aulast%3DRosenberg%26aufirst%3DE.%26aulast%3DUchida%26aufirst%3DS.%26atitle%3DEffect%2520of%2520the%2520cathepsin%2520K%2520inhibitor%2520odanacatib%2520administered%2520once%2520weekly%2520on%2520bone%2520mineral%2520density%2520in%2520Japanese%2520patients%2520with%2520osteoporosis-a%2520double-blind%252C%2520randomized%252C%2520dose-finding%2520study%26jtitle%3DOsteoporosis%2520Int.%26date%3D2014%26volume%3D25%26spage%3D367%26epage%3D376%26doi%3D10.1007%2Fs00198-013-2398-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Brixen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapurlat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keaveny, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuerst, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelke, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dardzinski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbruggen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ather, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Papp, A. E.</span><span> </span><span class="NLM_article-title">Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trial</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span><span class="refDoi"> DOI: 10.1210/jc.2012-2972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1210%2Fjc.2012-2972" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=23337728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlOks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2013&pages=571-580&author=K.+Brixenauthor=R.+Chapurlatauthor=A.+M.+Cheungauthor=T.+M.+Keavenyauthor=T.+Fuerstauthor=K.+Engelkeauthor=R.+Reckerauthor=B.+Dardzinskiauthor=N.+Verbruggenauthor=S.+Atherauthor=E.+Rosenbergauthor=A.+E.+de+Papp&title=Bone+density%2C+turnover%2C+and+estimated+strength+in+postmenopausal+women+treated+with+odanacatib%3A+a+randomized+trial&doi=10.1210%2Fjc.2012-2972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trial</span></div><div class="casAuthors">Brixen, Kim; Chapurlat, Roland; Cheung, Angela M.; Keaveny, Tony M.; Fuers, Thomas; Engelke, Klaus; Recker, Robert; Dardzinski, Bernard; Verbruggen, Nadia; Ather, Shabana; Rosenberg, Elizabeth; de Papp, Anne E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">571-580</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Context: Odanacatib, a cathepsin K inhibitor, increases spine and hip areal bone mineral d. (BMD) in postmenopausal women with low BMD and cortical thickness in ovariectomized monkeys.  Objective: The objective of the study was to examine the impact of odanacatib on the trabecular and cortical bone compartments and estd. strength at the hip and spine.  Design: This was a randomized, double-blind, 2-yr trial.  Setting: The study was conducted at a private or institutional practice.  Participants: Participants included 214 postmenopausal women with low areal BMD.  Intervention: The intervention included odanacatib 50 mg or placebo weekly.  Main Outcome Measures: Changes in areal BMD by dual-energy x-ray absorptiometry (primary end point, 1 yr areal BMD change at lumbar spine), bone turnover markers, volumetric BMD by quant. computed tomog. (QCT), and bone strength estd. by finite element anal. were measured.  Results: Year 1 lumbar spine areal BMD percent change from baseline was 3.5% greater with odanacatib than placebo (P < .001).  Bone-resorption marker C-telopeptide of type 1 collagen was significantly lower with odanacatib vs placebo at 6 mo and 2 years (P < .001).  Bone-formation marker procollagen I N-terminal peptide initially decreased with odanacatib but by 2 years did not differ from placebo.  After 6 mo, odanacatib-treated women had greater increases in trabecular volumetric BMD and estd. compressive strength at the spine and integral and trabecular volumetric BMD and estd. strength at the hip (P < .001).  At the cortical envelope of the femoral neck, bone mineral content, thickness, vol., and cross-sectional area also increased from baseline with odanacatib vs placebo (P < .001 at 24 mo).  Adverse experiences were similar between groups.  Conclusions: Over 2 years, odanacatib decreased bone resorption, maintained bone formation, increased areal and volumetric BMD, and increased estd. bone strength at both the hip and spine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5IgjyjsYm47Vg90H21EOLACvtfcHk0lgMu_bNYXtK7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlOks74%253D&md5=2dc289cb3ccc6576fb66711b6f69be8d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1210%2Fjc.2012-2972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2012-2972%26sid%3Dliteratum%253Aachs%26aulast%3DBrixen%26aufirst%3DK.%26aulast%3DChapurlat%26aufirst%3DR.%26aulast%3DCheung%26aufirst%3DA.%2BM.%26aulast%3DKeaveny%26aufirst%3DT.%2BM.%26aulast%3DFuerst%26aufirst%3DT.%26aulast%3DEngelke%26aufirst%3DK.%26aulast%3DRecker%26aufirst%3DR.%26aulast%3DDardzinski%26aufirst%3DB.%26aulast%3DVerbruggen%26aufirst%3DN.%26aulast%3DAther%26aufirst%3DS.%26aulast%3DRosenberg%26aufirst%3DE.%26aulast%3Dde%2BPapp%26aufirst%3DA.%2BE.%26atitle%3DBone%2520density%252C%2520turnover%252C%2520and%2520estimated%2520strength%2520in%2520postmenopausal%2520women%2520treated%2520with%2520odanacatib%253A%2520a%2520randomized%2520trial%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2013%26volume%3D98%26spage%3D571%26epage%3D580%26doi%3D10.1210%2Fjc.2012-2972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Stoch, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Bortel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lasseter, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pramanik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cilissen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panebianco, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesdiener, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J. A.</span><span> </span><span class="NLM_article-title">Odanacatib, a Selective Cathepsin K inhibitor to Treat Osteoporosis: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics - Results from Single Oral Dose Studies in Healthy Volunteers</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">1240</span><span class="NLM_x">–</span> <span class="NLM_lpage">1254</span><span class="refDoi"> DOI: 10.1111/j.1365-2125.2012.04471.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1111%2Fj.1365-2125.2012.04471.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=23013236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC3sXps1CqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2013&pages=1240-1254&author=S.+A.+Stochauthor=S.+Zajicauthor=J.+A.+Stoneauthor=D.+L.+Millerauthor=L.+van+Bortelauthor=K.+C.+Lasseterauthor=B.+Pramanikauthor=C.+Cilissenauthor=Q.+Liuauthor=L.+Liuauthor=B.+B.+Scottauthor=D.+Panebiancoauthor=Y.+Dingauthor=K.+Gottesdienerauthor=J.+A.+Wagner&title=Odanacatib%2C+a+Selective+Cathepsin+K+inhibitor+to+Treat+Osteoporosis%3A+Safety%2C+Tolerability%2C+Pharmacokinetics+and+Pharmacodynamics+-+Results+from+Single+Oral+Dose+Studies+in+Healthy+Volunteers&doi=10.1111%2Fj.1365-2125.2012.04471.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics - results from single oral dose studies in healthy volunteers</span></div><div class="casAuthors">Stoch, S. Aubrey; Zajic, Stefan; Stone, Julie A.; Miller, Deborah L.; van Bortel, Lucas; Lasseter, Kenneth C.; Pramanik, Barnali; Cilissen, Caroline; Liu, Qi; Liu, Lida; Scott, Boyd B.; Panebianco, Deborah; Ding, Yu; Gottesdiener, Keith; Wagner, John A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1240-1254</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">1365-2125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">AIMS: To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of odanacatib (ODN), a cathepsin K inhibitor, in humans.  METHODS: Two double-blind, randomized, placebo-controlled, single oral dose studies were performed with ODN (2-600 mg) in 44 healthy volunteers (36 men and eight postmenopausal women).  RESULTS: Adverse experiences (AEs) with single doses of ODN were transient and mild to moderate, with the exception of one severe AE of gastroenteritis.  Headache was the most frequent AE.  After absorption of ODN (initial peak concns. 4-6 h postdose), plasma concns. exhibited a monophasic decline, with an apparent terminal half-life of -40-80 h.  The area under the curve0-24 h (AUC0-24 h), concn. at 24 h (C24 h) and max. concn. (Cmax,overall) increased in a less than dose-proportional manner from 2 to 600 mg.  Administration of ODN with a high-fat meal led to -100% increases in AUC0-24 h, Cmax,day1, Cmax,overall and C24 h relative to the fasted state, while administration with a low-fat meal led to a -30% increase in those parameters.  Redn. of biomarkers of bone resorption, the C- and N-telopeptides of cross-links of type I collagen, (CTx and NTx, resp.), was noted at 24 h for doses ≥5 mg and at 168 h postdose for ≥ 10 mg.  In postmenopausal women administered 50 mg ODN, redns. in serum CTx of -66% and urine NTx/creatinine (uNTx/Cr) of -51% relative to placebo were obsd. at 24 h.  At 168 h, redns. in serum CTx (-70%) and uNTx/Cr (-78%) were obsd. relative to baseline.  Pharmacokinetic/pharmacodynamic modeling characterized the ODN concn./uNTx/Cr relation, with a modeled EC50 value of 43.8 nM and -80% maximal redn.  CONCLUSIONS: Odanacatib was well tolerated and has a pharmacokinetic and pharmacodynamic profile suitable for once weekly dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxIvJw_wnUo7Vg90H21EOLACvtfcHk0lgMu_bNYXtK7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXps1CqsLs%253D&md5=ebaccd5e624479a5cd237386e5fc58e5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2012.04471.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2012.04471.x%26sid%3Dliteratum%253Aachs%26aulast%3DStoch%26aufirst%3DS.%2BA.%26aulast%3DZajic%26aufirst%3DS.%26aulast%3DStone%26aufirst%3DJ.%2BA.%26aulast%3DMiller%26aufirst%3DD.%2BL.%26aulast%3Dvan%2BBortel%26aufirst%3DL.%26aulast%3DLasseter%26aufirst%3DK.%2BC.%26aulast%3DPramanik%26aufirst%3DB.%26aulast%3DCilissen%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DScott%26aufirst%3DB.%2BB.%26aulast%3DPanebianco%26aufirst%3DD.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DGottesdiener%26aufirst%3DK.%26aulast%3DWagner%26aufirst%3DJ.%2BA.%26atitle%3DOdanacatib%252C%2520a%2520Selective%2520Cathepsin%2520K%2520inhibitor%2520to%2520Treat%2520Osteoporosis%253A%2520Safety%252C%2520Tolerability%252C%2520Pharmacokinetics%2520and%2520Pharmacodynamics%2520-%2520Results%2520from%2520Single%2520Oral%2520Dose%2520Studies%2520in%2520Healthy%2520Volunteers%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2013%26volume%3D75%26spage%3D1240%26epage%3D1254%26doi%3D10.1111%2Fj.1365-2125.2012.04471.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Nagase, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, S.</span><span> </span><span class="NLM_article-title">Serum and urine bone resorption markers and pharmacokinetics of the cathepsin K inhibitor ONO-5334 after ascending single doses in post menopausal women</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">959</span><span class="NLM_x">–</span> <span class="NLM_lpage">970</span><span class="refDoi"> DOI: 10.1111/j.1365-2125.2012.04307.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1111%2Fj.1365-2125.2012.04307.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=22533981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqtr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2012&pages=959-970&author=S.+Nagaseauthor=Y.+Hashimotoauthor=M.+Smallauthor=M.+Ohyamaauthor=T.+Kuwayamaauthor=S.+Deacon&title=Serum+and+urine+bone+resorption+markers+and+pharmacokinetics+of+the+cathepsin+K+inhibitor+ONO-5334+after+ascending+single+doses+in+post+menopausal+women&doi=10.1111%2Fj.1365-2125.2012.04307.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Serum and urine bone resorption markers and pharmacokinetics of the cathepsin K inhibitor ONO-5334 after ascending single doses in post menopausal women</span></div><div class="casAuthors">Nagase, Shinichi; Hashimoto, Yoshitaka; Small, Maria; Ohyama, Michiyo; Kuwayama, Tomohiro; Deacon, Steve</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">959-970</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">AIMS : To investigate the safety, pharmacokinetics and pharmacodynamics of the new cathepsin K inhibitor, ONO-5334.  METHODS : A double-blind, placebo-controlled, randomized study was carried out in 52 healthy post menopausal females.  Single ascending doses of ONO-5334 (3-600 mg) were evaluated in six cohorts.  The effect of food was studied at ONO-5334 100 mg.  RESULTS : Across the doses tested, mean ONO-5334 Cmax occurred 0.5-1.0 h after dosing and the the t1/2 ranged from 9.1 to 22 h.  Linear increases in Cmax and AUC(0,∞) were obsd. in the 3-300 mg and 3-600 mg dose range, resp.  After food, the geometric mean ratio (95% CI) Cmax and AUC(0,∞) for ONO-5334 were 0.78 (0.31, 1.94) and 0.95 (0.67, 1.35)-fold greater than fasted, resp.  ONO-5334 significantly reduced serum bone resorption markers within 4 h vs. placebo.  Statistical significance was achieved for ONO-5334 doses ≥30 mg for C-terminal telopeptide of type 1 collagen (CTX) and ≥300 mg for N-terminal telopeptide of type 1 collagen (NTX).  Statistical significance was still evident at 24 h for ONO-5334 100 mg with serum CTX and 600 mg with serum NTX.  The max. suppression in serum CTX occurred at 4 h post dose with difference compared with placebo of -32%, -59%, -60% and -66% for 30, 100, 300 and 600 mg ONO-5334, resp.  Second morning urine void 24 h post dose showed statistically significant suppression of urinary CTX and NTX at 100 mg and above vs. placebo.  ONO-5334 600 mg showed statistically significant suppression up to 72 h for serum CTX, urinary CTX and urinary NTX and 48 h for serum NTX vs. placebo.  Adverse events were transient with no evidence of dose relationship.  CONCLUSIONS : ONO-5334 displayed linear plasma pharmacokinetics over the (predicted therapeutic) dose range, 3-300 mg, with clear suppression of urinary bone resorption markers at doses ≥100 mg for serum markers at 24 h.  ONO-5334 was well tolerated up to 600 mg day-1 when administered to healthy post menopausal women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG1J-vZCPMobVg90H21EOLACvtfcHk0lit3HNjGuJz-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqtr%252FF&md5=ebf7f40d9859b67aa11355d4667eef90</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2012.04307.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2012.04307.x%26sid%3Dliteratum%253Aachs%26aulast%3DNagase%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DSmall%26aufirst%3DM.%26aulast%3DOhyama%26aufirst%3DM.%26aulast%3DKuwayama%26aufirst%3DT.%26aulast%3DDeacon%26aufirst%3DS.%26atitle%3DSerum%2520and%2520urine%2520bone%2520resorption%2520markers%2520and%2520pharmacokinetics%2520of%2520the%2520cathepsin%2520K%2520inhibitor%2520ONO-5334%2520after%2520ascending%2520single%2520doses%2520in%2520post%2520menopausal%2520women%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2012%26volume%3D74%26spage%3D959%26epage%3D970%26doi%3D10.1111%2Fj.1365-2125.2012.04307.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Ng, K. W.</span><span> </span><span class="NLM_article-title">Potential role of odanacatib in the treatment of osteoporosis</span> <span class="citation_source-journal">Clin. Interventions Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">247</span><span class="refDoi"> DOI: 10.2147/CIA.S26729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.2147%2FCIA.S26729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=22866001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVyis77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=235-247&author=K.+W.+Ng&title=Potential+role+of+odanacatib+in+the+treatment+of+osteoporosis&doi=10.2147%2FCIA.S26729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Potential role of odanacatib in the treatment of osteoporosis</span></div><div class="casAuthors">Ng, Kong Wah</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Interventions in Aging</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">235-247</span>CODEN:
                <span class="NLM_cas:coden">CIALBC</span>;
        ISSN:<span class="NLM_cas:issn">1178-1998</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Cathepsin K is a key enzyme involved in the degrdn. of org. bone matrix by osteoclasts.  Inhibition of bone resorption obsd. in human and animal models deficient for cathepsin K has identified this enzyme as a suitable target for intervention by small mols. with the potential to be used as therapeutic agents in the treatment of osteoporosis.  Odanacatib (ODN) is a nonbasic selective cathepsin K inhibitor with good pharmacokinetic parameters such as minimal in vitro metab., long half-life, and oral bioavailability.  In preclin. studies, ovariectomized monkeys and rabbits treated with ODN showed substantial inhibition of bone resorption markers along with increases in bone mineral d. (BMD).  Significant differences were obsd. in the effects of ODN treatment compared with those of other antiresorptive agents such as bisphosphonates and denosumab.  ODN displayed compartment-specific effects on trabecular vs. cortical bone formation, with treatment resulting in marked increases in periosteal bone formation and cortical thickness in ovariectomized monkeys whereas trabecular bone formation was reduced.  Furthermore, osteoclasts remained viable.  Phase I and II studies conducted in postmenopausal women showed ODN to be safe and well tolerated.  After 5 years, women who received ODN 50 mg weekly continuously from year 1 (n = 13), showed BMD increases from baseline of 11.9% at the lumbar spine, 9.8% at the femoral neck, 10.9% at the hip trochanter, and 8.5% at the total hip.  Addnl., these subjects maintained a low level of the urine bone resorption marker N-terminal telopeptide/creatinine (-67.4% from baseline) through 5 years of treatment, while levels of serum bone-specific alk. phosphatase remained only slightly reduced relative to baseline (-15.3%).  In women who were switched from ODN to placebo after 2 years, bone turnover markers were transiently increased and BMD gains reversed after 12 mo off medication.  Adverse experiences in the ODN-treated group were not significantly different from the placebo group.  In conclusion, available data suggests that cathepsin K inhibition could be a promising intervention with which to treat osteoporosis.  Ongoing studies are expected to provide information on the long-term efficacy in fracture redn. and safety of prolonged treatment with ODN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyDx4-oCZx97Vg90H21EOLACvtfcHk0lit3HNjGuJz-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVyis77N&md5=12c276abdb01d5a5d9a6b96f630cf8bd</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2147%2FCIA.S26729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FCIA.S26729%26sid%3Dliteratum%253Aachs%26aulast%3DNg%26aufirst%3DK.%2BW.%26atitle%3DPotential%2520role%2520of%2520odanacatib%2520in%2520the%2520treatment%2520of%2520osteoporosis%26jtitle%3DClin.%2520Interventions%2520Aging%26date%3D2012%26volume%3D7%26spage%3D235%26epage%3D247%26doi%3D10.2147%2FCIA.S26729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Ochi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayasuga, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunishige, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugitani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabata, K.</span><span> </span><span class="NLM_article-title">Effects of ONO-5334, a novel orally-active inhibitor of cathepsin K, on bone metabolism</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1351</span><span class="NLM_x">–</span> <span class="NLM_lpage">1356</span><span class="refDoi"> DOI: 10.1016/j.bone.2011.09.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1016%2Fj.bone.2011.09.041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2011&pages=1351-1356&author=Y.+Ochiauthor=H.+Yamadaauthor=H.+Moriauthor=Y.+Nakanishiauthor=S.+Nishikawaauthor=R.+Kayasugaauthor=N.+Kawadaauthor=A.+Kunishigeauthor=Y.+Hashimotoauthor=M.+Tanakaauthor=M.+Sugitaniauthor=K.+Kawabata&title=Effects+of+ONO-5334%2C+a+novel+orally-active+inhibitor+of+cathepsin+K%2C+on+bone+metabolism&doi=10.1016%2Fj.bone.2011.09.041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bone.2011.09.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bone.2011.09.041%26sid%3Dliteratum%253Aachs%26aulast%3DOchi%26aufirst%3DY.%26aulast%3DYamada%26aufirst%3DH.%26aulast%3DMori%26aufirst%3DH.%26aulast%3DNakanishi%26aufirst%3DY.%26aulast%3DNishikawa%26aufirst%3DS.%26aulast%3DKayasuga%26aufirst%3DR.%26aulast%3DKawada%26aufirst%3DN.%26aulast%3DKunishige%26aufirst%3DA.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DSugitani%26aufirst%3DM.%26aulast%3DKawabata%26aufirst%3DK.%26atitle%3DEffects%2520of%2520ONO-5334%252C%2520a%2520novel%2520orally-active%2520inhibitor%2520of%2520cathepsin%2520K%252C%2520on%2520bone%2520metabolism%26jtitle%3DBone%26date%3D2011%26volume%3D49%26spage%3D1351%26epage%3D1356%26doi%3D10.1016%2Fj.bone.2011.09.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Rünger, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamou, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czerwiński, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrerons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendler, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mindeholm, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Realdi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, V.</span><span> </span><span class="NLM_article-title">Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatib</span> <span class="citation_source-journal">J. Am. Acad. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">e89</span><span class="NLM_x">–</span> <span class="NLM_lpage">e96</span><span class="refDoi"> DOI: 10.1016/j.jaad.2010.11.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1016%2Fj.jaad.2010.11.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2012&pages=e89-e96&author=T.+M.+R%C3%BCngerauthor=S.+Adamiauthor=C.+L.+Benhamouauthor=E.+Czerwi%C5%84skiauthor=J.+Farreronsauthor=D.+L.+Kendlerauthor=L.+Mindeholmauthor=G.+Realdiauthor=C.+Rouxauthor=V.+Smith&title=Morphea-like+skin+reactions+in+patients+treated+with+the+cathepsin+K+inhibitor+balicatib&doi=10.1016%2Fj.jaad.2010.11.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.jaad.2010.11.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaad.2010.11.033%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25BCnger%26aufirst%3DT.%2BM.%26aulast%3DAdami%26aufirst%3DS.%26aulast%3DBenhamou%26aufirst%3DC.%2BL.%26aulast%3DCzerwi%25C5%2584ski%26aufirst%3DE.%26aulast%3DFarrerons%26aufirst%3DJ.%26aulast%3DKendler%26aufirst%3DD.%2BL.%26aulast%3DMindeholm%26aufirst%3DL.%26aulast%3DRealdi%26aufirst%3DG.%26aulast%3DRoux%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DV.%26atitle%3DMorphea-like%2520skin%2520reactions%2520in%2520patients%2520treated%2520with%2520the%2520cathepsin%2520K%2520inhibitor%2520balicatib%26jtitle%3DJ.%2520Am.%2520Acad.%2520Dermatol.%26date%3D2012%26volume%3D66%26spage%3De89%26epage%3De96%26doi%3D10.1016%2Fj.jaad.2010.11.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Falgueyret, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khougaz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toulmond, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span> </span><span class="NLM_article-title">Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7535</span><span class="NLM_x">–</span> <span class="NLM_lpage">7543</span><span class="refDoi"> DOI: 10.1021/jm0504961</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0504961" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKgsLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7535-7543&author=J.+P.+Falgueyretauthor=S.+Desmaraisauthor=R.+Oballaauthor=W.+C.+Blackauthor=W.+Cromlishauthor=K.+Khougazauthor=S.+Lamontagneauthor=F.+Mass%C3%A9author=D.+Riendeauauthor=S.+Toulmondauthor=M.+D.+Percival&title=Lysosomotropism+of+basic+cathepsin+K+inhibitors+contributes+to+increased+cellular+potencies+against+off-target+cathepsins+and+reduced+functional+selectivity&doi=10.1021%2Fjm0504961"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomotropism of Basic Cathepsin K Inhibitors Contributes to Increased Cellular Potencies against Off-Target Cathepsins and Reduced Functional Selectivity</span></div><div class="casAuthors">Falgueyret, Jean-Pierre; Desmarais, Sylvie; Oballa, Renata; Black, W. Cameron; Cromlish, Wanda; Khougaz, Karine; Lamontagne, Sonia; Masse, Frederic; Riendeau, Denis; Toulmond, Sylvie; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7535-7543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The lysosomal cysteine protease cathepsin K is a target for osteoporosis therapy.  The aryl-piperazine-contg. cathepsin K inhibitor CRA-013783/L-006235 (1) displays greater than 4000-fold selectivity against the lysosomal/endosomal antitargets cathepsin B, L, and S.  However, 1 and other aryl-piperazine-contg. analogs, including balicatib (10), are ∼10-100-fold more potent in cell-based enzyme occupancy assays than against each purified enzyme.  This phenomenon arises from their basic, lipophilic nature, which results in lysosomal trapping.  Consistent with its lysosomotropic nature, 1 accumulates in cells and in rat tissues of high lysosome content.  In contrast, nonbasic aryl-morpholino-contg. analogs do not exhibit lysosomotropic properties.  Increased off-target activities of basic cathepsin K inhibitors were obsd. in a cell-based cathepsin S antigen presentation assay.  No potency increases of basic inhibitors in a functional cathepsin K bone resorption whole cell assay were detected.  Therefore, basic cathepsin K inhibitors, such as 1, suffer from reduced functional selectivities compared to those predicted using purified enzyme assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1NUHyZtwrwLVg90H21EOLACvtfcHk0lhM9wQgMdrjUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKgsLbE&md5=9522026bb34984bc66b462b2e95fcbb0</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm0504961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0504961%26sid%3Dliteratum%253Aachs%26aulast%3DFalgueyret%26aufirst%3DJ.%2BP.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DKhougaz%26aufirst%3DK.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DMass%25C3%25A9%26aufirst%3DF.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DToulmond%26aufirst%3DS.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DLysosomotropism%2520of%2520basic%2520cathepsin%2520K%2520inhibitors%2520contributes%2520to%2520increased%2520cellular%2520potencies%2520against%2520off-target%2520cathepsins%2520and%2520reduced%2520functional%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7535%26epage%3D7543%26doi%3D10.1021%2Fjm0504961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">McGrath, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brömme, D.</span><span> </span><span class="NLM_article-title">Crystal structure of human cathepsin K complexed with a potent inhibitor</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span><span class="refDoi"> DOI: 10.1038/nsb0297-105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1038%2Fnsb0297-105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1997&pages=105-109&author=M.+E.+McGrathauthor=J.+L.+Klausauthor=M.+G.+Barnesauthor=D.+Br%C3%B6mme&title=Crystal+structure+of+human+cathepsin+K+complexed+with+a+potent+inhibitor&doi=10.1038%2Fnsb0297-105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnsb0297-105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb0297-105%26sid%3Dliteratum%253Aachs%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DKlaus%26aufirst%3DJ.%2BL.%26aulast%3DBarnes%26aufirst%3DM.%2BG.%26aulast%3DBr%25C3%25B6mme%26aufirst%3DD.%26atitle%3DCrystal%2520structure%2520of%2520human%2520cathepsin%2520K%2520complexed%2520with%2520a%2520potent%2520inhibitor%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D1997%26volume%3D4%26spage%3D105%26epage%3D109%26doi%3D10.1038%2Fnsb0297-105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Turk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guncar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podobnik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, B.</span><span> </span><span class="NLM_article-title">Revised definition of substrate binding sites of papain-like cysteine proteases</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">379</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span><span class="refDoi"> DOI: 10.1515/bchm.1998.379.2.137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1515%2Fbchm.1998.379.2.137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=9524065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADyaK1cXhtF2mtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=1998&pages=137-147&author=D.+Turkauthor=G.+Guncarauthor=M.+Podobnikauthor=B.+Turk&title=Revised+definition+of+substrate+binding+sites+of+papain-like+cysteine+proteases&doi=10.1515%2Fbchm.1998.379.2.137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Revised definition of substrate binding sites of papain-like cysteine proteases</span></div><div class="casAuthors">Turk, Dusan; Guncar, Gregor; Podobnik, Marjetka; Turk, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-147</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter & Co.</span>)
        </div><div class="casAbstract">Data of kinetics and structure of papain-like Cys proteases were reviewed and the authors reconsider the definition of substrate binding sites in papain-like Cys proteases.  Only 3 substrate binding sites, S2, S1 and S1', involve main as well as side chain contacts between substrate and enzyme residues.  Interactions between the enzymes and the substrate P3 and P2' residues are based on side chains (an exception is cathepsin B which is a carboxydipeptidase), so their interaction surface spreads over a relatively wide area.  The location and definition of substrate binding sites beyond S3 and S2' is even more questionable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcF-RPqg1WzLVg90H21EOLACvtfcHk0lhM9wQgMdrjUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtF2mtLg%253D&md5=7967ae6285405cab9a5ba1857a26f18e</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1515%2Fbchm.1998.379.2.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fbchm.1998.379.2.137%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DD.%26aulast%3DGuncar%26aufirst%3DG.%26aulast%3DPodobnik%26aufirst%3DM.%26aulast%3DTurk%26aufirst%3DB.%26atitle%3DRevised%2520definition%2520of%2520substrate%2520binding%2520sites%2520of%2520papain-like%2520cysteine%2520proteases%26jtitle%3DBiol.%2520Chem.%26date%3D1998%26volume%3D379%26spage%3D137%26epage%3D147%26doi%3D10.1515%2Fbchm.1998.379.2.137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Minovski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perdih, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solmajer, T.</span><span> </span><span class="NLM_article-title">Combinatorially-generated library of 6-fluoroquinolone analogs as potential novel antitubercular agents: a chemometric and molecular modeling assessment</span> <span class="citation_source-journal">J. Mol. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1735</span><span class="NLM_x">–</span> <span class="NLM_lpage">1753</span><span class="refDoi"> DOI: 10.1007/s00894-011-1179-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1007%2Fs00894-011-1179-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=21833830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVais78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=1735-1753&author=N.+Minovskiauthor=A.+Perdihauthor=T.+Solmajer&title=Combinatorially-generated+library+of+6-fluoroquinolone+analogs+as+potential+novel+antitubercular+agents%3A+a+chemometric+and+molecular+modeling+assessment&doi=10.1007%2Fs00894-011-1179-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Combinatorially-generated library of 6-fluoroquinolone analogs as potential novel antitubercular agents: a chemometric and molecular modeling assessment</span></div><div class="casAuthors">Minovski, Nikola; Perdih, Andrej; Solmajer, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1735-1753</span>CODEN:
                <span class="NLM_cas:coden">JMMOFK</span>;
        ISSN:<span class="NLM_cas:issn">0948-5023</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The virtual combinatorial chem. approach as a methodol. for generating chem. libraries of structurally-similar analogs in a virtual environment was employed for building a general mixed virtual combinatorial library with a total of 53.871 6-FQ structural analogs, introducing the real synthetic pathways of three well known 6-FQ inhibitors.  The druggability properties of the generated combinatorial 6-FQs were assessed using an inhouse developed drug-likeness filter integrating the Lipinski/Veber rule-sets.  The compds. recognized as drug-like were used as an external set for prediction of the biol. activity values using a neural-networks (NN) model based on an exptl.-detd. set of active 6-FQs.  Furthermore, a subset of compds. was extd. from the pool of drug-like 6-FQs, with predicted biol. activity, and subsequently used in virtual screening (VS) campaign combining pharmacophore modeling and mol. docking studies.  This complex scheme, a powerful combination of chemometric and mol. modeling approaches provided novel QSAR guidelines that could aid in the further lead development of 6-FQs agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuyWBPCN5PdLVg90H21EOLACvtfcHk0liUYeItuoKOZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVais78%253D&md5=3fa3a38f493232c74ea8a271f7a908f7</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2Fs00894-011-1179-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00894-011-1179-0%26sid%3Dliteratum%253Aachs%26aulast%3DMinovski%26aufirst%3DN.%26aulast%3DPerdih%26aufirst%3DA.%26aulast%3DSolmajer%26aufirst%3DT.%26atitle%3DCombinatorially-generated%2520library%2520of%25206-fluoroquinolone%2520analogs%2520as%2520potential%2520novel%2520antitubercular%2520agents%253A%2520a%2520chemometric%2520and%2520molecular%2520modeling%2520assessment%26jtitle%3DJ.%2520Mol.%2520Model.%26date%3D2012%26volume%3D18%26spage%3D1735%26epage%3D1753%26doi%3D10.1007%2Fs00894-011-1179-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Minovski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perdih, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solmajer, T.</span><span> </span><span class="NLM_article-title">Cluster-based molecular docking study for in silico identification of novel 6-fluoroquinolones as potential inhibitors against mycobacterium tuberculosis</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">790</span><span class="NLM_x">–</span> <span class="NLM_lpage">801</span><span class="refDoi"> DOI: 10.1002/jcc.23205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1002%2Fjcc.23205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=23280926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVyiu7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=790-801&author=N.+Minovskiauthor=A.+Perdihauthor=M.+Novicauthor=T.+Solmajer&title=Cluster-based+molecular+docking+study+for+in+silico+identification+of+novel+6-fluoroquinolones+as+potential+inhibitors+against+mycobacterium+tuberculosis&doi=10.1002%2Fjcc.23205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Cluster-based molecular docking study for in silico identification of novel 6-fluoroquinolones as potential inhibitors against Mycobacterium tuberculosis</span></div><div class="casAuthors">Minovski, Nikola; Perdih, Andrej; Novic, Marjana; Solmajer, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">790-801</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A classical protein sequence alignment and homol. modeling strategy were used for building three Mycobacterium tuberculosis-DNA gyrase protein models using the available topoII-DNA-6FQ crystal structure complexes originating from different organisms.  The recently detd. M. tuberculosis-DNA gyrase apoprotein structures and topoII-DNA-6FQ complexes were used for defining the 6-fluoroquinolones (6-FQs) binding pockets.  The quality of the generated models was initially validated by docking of the cocrystd. ligands into their binding site, and subsequently by quant. evaluation of their discriminatory performances (identification of active/inactive 6-FQs) for a set of 145 6-FQs with known biol. activity values.  The M. tuberculosis-DNA gyrase model with the highest estd. discriminatory power was selected and used afterwards in an addnl. mol. docking expt. on a mixed combinatorial set of 427 drug-like 6-FQ analogs for which the biol. activity values were predicted using a prebuilt counter-propagation artificial neural network model.  A novel three-level Boolean-based [T/F (true/false)] clustering algorithm was used to assess the generated binding poses: Level 1 (geometry properties assessment), Level 2 (score-based clustering and selection of the (T)-signed highly scored Level 1 poses), and Level 3 (activity-based clustering and selection of the most "active" (T)-signed Level 2 hits).  The frequency anal. of occurrence of the fragments attached at R1 and R7 position of the (T)-signed 6-FQs selected in Level 3 revealed several novel attractive fragments and confirmed some previous findings.  We believe that this methodol. could be successfully used in establishing novel possible structure-activity relationship recommendations in the 6-FQs optimization, which could be of great importance in the current antimycobacterial hit-to-lead processes. © 2012 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOpvcTVL2K37Vg90H21EOLACvtfcHk0liUYeItuoKOZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVyiu7nM&md5=6d46127b35a889f04646a892655beb81</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fjcc.23205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.23205%26sid%3Dliteratum%253Aachs%26aulast%3DMinovski%26aufirst%3DN.%26aulast%3DPerdih%26aufirst%3DA.%26aulast%3DNovic%26aufirst%3DM.%26aulast%3DSolmajer%26aufirst%3DT.%26atitle%3DCluster-based%2520molecular%2520docking%2520study%2520for%2520in%2520silico%2520identification%2520of%2520novel%25206-fluoroquinolones%2520as%2520potential%2520inhibitors%2520against%2520mycobacterium%2520tuberculosis%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2013%26volume%3D34%26spage%3D790%26epage%3D801%26doi%3D10.1002%2Fjcc.23205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Borišek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drgan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minovski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novič, M.</span><span> </span><span class="NLM_article-title">Mechanistic interpretation of artificial neural network-based QSAR model for prediction of cathepsin K inhibition potency</span> <span class="citation_source-journal">J. Chemom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">272</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span><span class="refDoi"> DOI: 10.1002/cem.2617</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1002%2Fcem.2617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFKrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=272-281&author=J.+Bori%C5%A1ekauthor=V.+Drganauthor=N.+Minovskiauthor=M.+Novi%C4%8D&title=Mechanistic+interpretation+of+artificial+neural+network-based+QSAR+model+for+prediction+of+cathepsin+K+inhibition+potency&doi=10.1002%2Fcem.2617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic interpretation of artificial neural network-based QSAR model for prediction of cathepsin K inhibition potency</span></div><div class="casAuthors">Borisek, Jure; Drgan, Viktor; Minovski, Nikola; Novic, Marjana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemometrics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">272-281</span>CODEN:
                <span class="NLM_cas:coden">JOCHEU</span>;
        ISSN:<span class="NLM_cas:issn">0886-9383</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Cathepsin K (Cat K) is a lysosomal cysteine protease that plays an important role in many bone diseases including osteoporosis, which makes Cat K an interesting drug target.  Several compds., including balicatib, were tested in clin. trials for their potency as Cat K inhibitors.  Balicatib was found as a potent inhibitor; however, the side effects caused by the lysosomotropic drug candidate behavior as a consequence of its basic nature prevented further drug development.  Here, we present a counter-propagation artificial neural network (CP-ANN) quant. structure-activity relationship model of benzamide-contg. aminonitriles with good predictive ability.  The quality of all models developed was evaluated internally by leave-one-out cross-validation (LOOCV) on the training set and externally by an independent validation set.  The best model performed with the LOOCV and external validation squared correlation coeff. of 0.81 and 0.84, resp.  In order to interpret the selection of variables and consequently discuss the mechanism of inhibition, the layer of the CP-ANN model representing the distribution of individual mol. descriptors was compared with the output layer representing the response surface.  The measures indicating the overlap/similarity of the response surface with selected levels in the input layer were introduced.  The results signify not only the importance of the covalent bonding parameters, which are responsible for the S1 binding pocket of the enzyme, but also the impact of 3D shapes of the mols. on the inhibitor-enzyme interactions implying the stabilization of the inhibitors poses within the S2 and S3 binding sites.  Copyright © 2014 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEJCMH0esjI7Vg90H21EOLACvtfcHk0liUYeItuoKOZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFKrs70%253D&md5=26ed295244b7e23b54213f131dd29930</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fcem.2617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcem.2617%26sid%3Dliteratum%253Aachs%26aulast%3DBori%25C5%25A1ek%26aufirst%3DJ.%26aulast%3DDrgan%26aufirst%3DV.%26aulast%3DMinovski%26aufirst%3DN.%26aulast%3DNovi%25C4%258D%26aufirst%3DM.%26atitle%3DMechanistic%2520interpretation%2520of%2520artificial%2520neural%2520network-based%2520QSAR%2520model%2520for%2520prediction%2520of%2520cathepsin%2520K%2520inhibition%2520potency%26jtitle%3DJ.%2520Chemom.%26date%3D2014%26volume%3D28%26spage%3D272%26epage%3D281%26doi%3D10.1002%2Fcem.2617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span>Enamine fragment database. URL: <a href="http://www.enamine.net/index.php?option=com_content&amp;task=view&amp;id=117" class="extLink">http://www.enamine.net/index.php?option=com_content&task=view&id=117</a> (accessed Feb., 15,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Enamine+fragment+database.+URL%3A+http%3A%2F%2Fwww.enamine.net%2Findex.php%3Foption%3Dcom_content%26task%3Dview%26id%3D117+%28accessed+Feb.%2C+15%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhoti, H.</span><span> </span><span class="NLM_article-title">A rule of three for fragment-based lead discovery?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">876</span><span class="NLM_x">–</span> <span class="NLM_lpage">877</span><span class="refDoi"> DOI: 10.1016/S1359-6446(03)02831-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1016%2FS1359-6446%2803%2902831-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=14554012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A280%3ADC%252BD3svns1Cnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=876-877&author=M.+Congreveauthor=R.+Carrauthor=C.+Murrayauthor=H.+Jhoti&title=A+rule+of+three+for+fragment-based+lead+discovery%3F&doi=10.1016%2FS1359-6446%2803%2902831-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A 'rule of three' for fragment-based lead discovery?</span></div><div class="casAuthors">Congreve Miles; Carr Robin; Murray Chris; Jhoti Harren</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">876-7</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfFswFSn5vb43yKPtYViAGfW6udTcc2easI5Fqmnbv67ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svns1Cnsw%253D%253D&md5=137886dbb2062f7a3ad39277dd888df3</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2803%2902831-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252803%252902831-9%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DCarr%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DC.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DA%2520rule%2520of%2520three%2520for%2520fragment-based%2520lead%2520discovery%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2003%26volume%3D8%26spage%3D876%26epage%3D877%26doi%3D10.1016%2FS1359-6446%2803%2902831-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopple, K. D.</span><span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2615</span><span class="NLM_x">–</span> <span class="NLM_lpage">2623</span><span class="refDoi"> DOI: 10.1021/jm020017n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.+Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates&doi=10.1021%2Fjm020017n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0lhyHfjbzmc3TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.%2BY.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623%26doi%3D10.1021%2Fjm020017n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Dossetter, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beeley, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finlayson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heron, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Highton, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jestel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacFaul, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morley, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawney, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbacher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickers, M.</span><span> </span><span class="NLM_article-title">(1R,2R)-N-(1-cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b]indole −2-carbonyl)cyclohexanecarboxamide (AZD4996): a potent and highly selective cathepsin K inhibitor for the treatment of osteoarthritis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6363</span><span class="NLM_x">–</span> <span class="NLM_lpage">6374</span><span class="refDoi"> DOI: 10.1021/jm3007257</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3007257" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6363-6374&author=A.+G.+Dossetterauthor=H.+Beeleyauthor=J.+Bowyerauthor=C.+R.+Cookauthor=J.+J.+Crawfordauthor=J.+E.+Finlaysonauthor=N.+M.+Heronauthor=C.+Heyesauthor=A.+J.+Hightonauthor=J.+A.+Hudsonauthor=A.+Jestelauthor=P.+W.+Kennyauthor=S.+Krappauthor=S.+Martinauthor=P.+A.+MacFaulauthor=T.+M.+McGuireauthor=P.+M.+Gutierrezauthor=A.+D.+Morleyauthor=J.+J.+Morrisauthor=K.+M.+Pageauthor=L.+R.+Ribeiroauthor=H.+Sawneyauthor=S.+Steinbacherauthor=C.+Smithauthor=M.+Vickers&title=%281R%2C2R%29-N-%281-cyanocyclopropyl%29-2-%286-methoxy-1%2C3%2C4%2C5-tetrahydropyrido%5B4%2C3-b%5Dindole+%E2%88%922-carbonyl%29cyclohexanecarboxamide+%28AZD4996%29%3A+a+potent+and+highly+selective+cathepsin+K+inhibitor+for+the+treatment+of+osteoarthritis&doi=10.1021%2Fjm3007257"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm3007257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3007257%26sid%3Dliteratum%253Aachs%26aulast%3DDossetter%26aufirst%3DA.%2BG.%26aulast%3DBeeley%26aufirst%3DH.%26aulast%3DBowyer%26aufirst%3DJ.%26aulast%3DCook%26aufirst%3DC.%2BR.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26aulast%3DFinlayson%26aufirst%3DJ.%2BE.%26aulast%3DHeron%26aufirst%3DN.%2BM.%26aulast%3DHeyes%26aufirst%3DC.%26aulast%3DHighton%26aufirst%3DA.%2BJ.%26aulast%3DHudson%26aufirst%3DJ.%2BA.%26aulast%3DJestel%26aufirst%3DA.%26aulast%3DKenny%26aufirst%3DP.%2BW.%26aulast%3DKrapp%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DMacFaul%26aufirst%3DP.%2BA.%26aulast%3DMcGuire%26aufirst%3DT.%2BM.%26aulast%3DGutierrez%26aufirst%3DP.%2BM.%26aulast%3DMorley%26aufirst%3DA.%2BD.%26aulast%3DMorris%26aufirst%3DJ.%2BJ.%26aulast%3DPage%26aufirst%3DK.%2BM.%26aulast%3DRibeiro%26aufirst%3DL.%2BR.%26aulast%3DSawney%26aufirst%3DH.%26aulast%3DSteinbacher%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DVickers%26aufirst%3DM.%26atitle%3D%25281R%252C2R%2529-N-%25281-cyanocyclopropyl%2529-2-%25286-methoxy-1%252C3%252C4%252C5-tetrahydropyrido%255B4%252C3-b%255Dindole%2520%25E2%2588%25922-carbonyl%2529cyclohexanecarboxamide%2520%2528AZD4996%2529%253A%2520a%2520potent%2520and%2520highly%2520selective%2520cathepsin%2520K%2520inhibitor%2520for%2520the%2520treatment%2520of%2520osteoarthritis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6363%26epage%3D6374%26doi%3D10.1021%2Fjm3007257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setti, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rydzewski, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Z. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrill, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janc, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somoza, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enriquez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickley, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venuti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G.</span><span> </span><span class="NLM_article-title">Design and synthesis of tri-ring P3 benzamide-containing aminonitriles as potent, selective, orally effective inhibitors of cathepsin K</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7520</span><span class="NLM_x">–</span> <span class="NLM_lpage">7534</span><span class="refDoi"> DOI: 10.1021/jm058198r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm058198r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7520-7534&author=J.+T.+Palmerauthor=C.+Bryantauthor=D.+X.+Wangauthor=D.+E.+Davisauthor=E.+L.+Settiauthor=R.+M.+Rydzewskiauthor=S.+Venkatramanauthor=Z.+Q.+Tianauthor=L.+C.+Burrillauthor=R.+V.+Mendoncaauthor=E.+Springmanauthor=J.+McCarterauthor=T.+Chungauthor=H.+Cheungauthor=J.+W.+Jancauthor=M.+McGrathauthor=J.+R.+Somozaauthor=P.+Enriquezauthor=Z.+W.+Yuauthor=R.+M.+Strickleyauthor=L.+Liuauthor=M.+C.+Venutiauthor=M.+D.+Percivalauthor=J.+P.+Falgueyretauthor=P.+Prasitauthor=R.+Oballaauthor=D.+Riendeauauthor=R.+N.+Youngauthor=G.+Wesolowskiauthor=S.+B.+Rodanauthor=C.+Johnsonauthor=D.+B.+Kimmelauthor=G.+Rodan&title=Design+and+synthesis+of+tri-ring+P3+benzamide-containing+aminonitriles+as+potent%2C+selective%2C+orally+effective+inhibitors+of+cathepsin+K&doi=10.1021%2Fjm058198r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm058198r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058198r%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DBryant%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DD.%2BX.%26aulast%3DDavis%26aufirst%3DD.%2BE.%26aulast%3DSetti%26aufirst%3DE.%2BL.%26aulast%3DRydzewski%26aufirst%3DR.%2BM.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DZ.%2BQ.%26aulast%3DBurrill%26aufirst%3DL.%2BC.%26aulast%3DMendonca%26aufirst%3DR.%2BV.%26aulast%3DSpringman%26aufirst%3DE.%26aulast%3DMcCarter%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DT.%26aulast%3DCheung%26aufirst%3DH.%26aulast%3DJanc%26aufirst%3DJ.%2BW.%26aulast%3DMcGrath%26aufirst%3DM.%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DEnriquez%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DZ.%2BW.%26aulast%3DStrickley%26aufirst%3DR.%2BM.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DVenuti%26aufirst%3DM.%2BC.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DFalgueyret%26aufirst%3DJ.%2BP.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DJohnson%26aufirst%3DC.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DRodan%26aufirst%3DG.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520tri-ring%2520P3%2520benzamide-containing%2520aminonitriles%2520as%2520potent%252C%2520selective%252C%2520orally%2520effective%2520inhibitors%2520of%2520cathepsin%2520K%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7520%26epage%3D7534%26doi%3D10.1021%2Fjm058198r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Frizler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohr, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furtmann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kläs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gütschow, M.</span><span> </span><span class="NLM_article-title">Structural Optimization of Azadipeptide Nitriles Strongly Increases Association Rates and Allows the Development of Selective Cathepsin Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">396</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span><span class="refDoi"> DOI: 10.1021/jm101272p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101272p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=396-400&author=M.+Frizlerauthor=F.+Lohrauthor=N.+Furtmannauthor=J.+Kl%C3%A4sauthor=M.+G%C3%BCtschow&title=Structural+Optimization+of+Azadipeptide+Nitriles+Strongly+Increases+Association+Rates+and+Allows+the+Development+of+Selective+Cathepsin+Inhibitors&doi=10.1021%2Fjm101272p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm101272p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101272p%26sid%3Dliteratum%253Aachs%26aulast%3DFrizler%26aufirst%3DM.%26aulast%3DLohr%26aufirst%3DF.%26aulast%3DFurtmann%26aufirst%3DN.%26aulast%3DKl%25C3%25A4s%26aufirst%3DJ.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26atitle%3DStructural%2520Optimization%2520of%2520Azadipeptide%2520Nitriles%2520Strongly%2520Increases%2520Association%2520Rates%2520and%2520Allows%2520the%2520Development%2520of%2520Selective%2520Cathepsin%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D396%26epage%3D400%26doi%3D10.1021%2Fjm101272p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Frizler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohr, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lülsdorff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gütschow, M.</span><span> </span><span class="NLM_article-title">Facing the gem-Dialkyl Effect in Enzyme Inhibitor Design: Preparation of Homocycloleucine-Based Azadipeptide Nitriles</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">11419</span><span class="NLM_x">–</span> <span class="NLM_lpage">11423</span><span class="refDoi"> DOI: 10.1002/chem.201101350</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1002%2Fchem.201101350" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=21898616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFers73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=11419-11423&author=M.+Frizlerauthor=F.+Lohrauthor=M.+L%C3%BClsdorffauthor=M.+G%C3%BCtschow&title=Facing+the+gem-Dialkyl+Effect+in+Enzyme+Inhibitor+Design%3A+Preparation+of+Homocycloleucine-Based+Azadipeptide+Nitriles&doi=10.1002%2Fchem.201101350"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Facing the gem-Dialkyl Effect in Enzyme Inhibitor Design: Preparation of Homocycloleucine-Based Azadipeptide Nitriles</span></div><div class="casAuthors">Frizler, Maxim; Lohr, Friederike; Luelsdorff, Michael; Guetschow, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">11419-11423, S11419/1-S11419/41</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors confirmed that homocycloleucine is a particularly suitable building block for the design of cathepsin K inhibitors.  The incorporation of this amino acid into the azadipeptide nitrile scaffold afforded remarkable selectivity, and when combined with the triaryl motif at the P3 position, excellent inhibitory potency of cathepsin enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGisGXRel3DrVg90H21EOLACvtfcHk0lharpT3L6RpEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFers73O&md5=e58d21cd363f7548920e34ce33fa5879</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fchem.201101350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201101350%26sid%3Dliteratum%253Aachs%26aulast%3DFrizler%26aufirst%3DM.%26aulast%3DLohr%26aufirst%3DF.%26aulast%3DL%25C3%25BClsdorff%26aufirst%3DM.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26atitle%3DFacing%2520the%2520gem-Dialkyl%2520Effect%2520in%2520Enzyme%2520Inhibitor%2520Design%253A%2520Preparation%2520of%2520Homocycloleucine-Based%2520Azadipeptide%2520Nitriles%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2011%26volume%3D17%26spage%3D11419%26epage%3D11423%26doi%3D10.1002%2Fchem.201101350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Falgueyret, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khougaz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toulmond, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span> </span><span class="NLM_article-title">Lysosomotropism of Basic Cathepsin K Inhibitors Contributes to Increased Cellular Potencies against Off-Target Cathepsins and Reduced Functional Selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7535</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span><span class="refDoi"> DOI: 10.1021/jm0504961</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0504961" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKgsLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7535-43&author=J.+P.+Falgueyretauthor=S.+Desmaraisauthor=R.+Oballaauthor=W.+C.+Blackauthor=W.+Cromlishauthor=K.+Khougazauthor=S.+Lamontagneauthor=F.+Mass%C3%A9author=D.+Riendeauauthor=S.+Toulmondauthor=M.+D.+Percival&title=Lysosomotropism+of+Basic+Cathepsin+K+Inhibitors+Contributes+to+Increased+Cellular+Potencies+against+Off-Target+Cathepsins+and+Reduced+Functional+Selectivity&doi=10.1021%2Fjm0504961"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomotropism of Basic Cathepsin K Inhibitors Contributes to Increased Cellular Potencies against Off-Target Cathepsins and Reduced Functional Selectivity</span></div><div class="casAuthors">Falgueyret, Jean-Pierre; Desmarais, Sylvie; Oballa, Renata; Black, W. Cameron; Cromlish, Wanda; Khougaz, Karine; Lamontagne, Sonia; Masse, Frederic; Riendeau, Denis; Toulmond, Sylvie; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7535-7543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The lysosomal cysteine protease cathepsin K is a target for osteoporosis therapy.  The aryl-piperazine-contg. cathepsin K inhibitor CRA-013783/L-006235 (1) displays greater than 4000-fold selectivity against the lysosomal/endosomal antitargets cathepsin B, L, and S.  However, 1 and other aryl-piperazine-contg. analogs, including balicatib (10), are ∼10-100-fold more potent in cell-based enzyme occupancy assays than against each purified enzyme.  This phenomenon arises from their basic, lipophilic nature, which results in lysosomal trapping.  Consistent with its lysosomotropic nature, 1 accumulates in cells and in rat tissues of high lysosome content.  In contrast, nonbasic aryl-morpholino-contg. analogs do not exhibit lysosomotropic properties.  Increased off-target activities of basic cathepsin K inhibitors were obsd. in a cell-based cathepsin S antigen presentation assay.  No potency increases of basic inhibitors in a functional cathepsin K bone resorption whole cell assay were detected.  Therefore, basic cathepsin K inhibitors, such as 1, suffer from reduced functional selectivities compared to those predicted using purified enzyme assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1NUHyZtwrwLVg90H21EOLACvtfcHk0lgnfp3aqPklOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKgsLbE&md5=9522026bb34984bc66b462b2e95fcbb0</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm0504961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0504961%26sid%3Dliteratum%253Aachs%26aulast%3DFalgueyret%26aufirst%3DJ.%2BP.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DKhougaz%26aufirst%3DK.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DMass%25C3%25A9%26aufirst%3DF.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DToulmond%26aufirst%3DS.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DLysosomotropism%2520of%2520Basic%2520Cathepsin%2520K%2520Inhibitors%2520Contributes%2520to%2520Increased%2520Cellular%2520Potencies%2520against%2520Off-Target%2520Cathepsins%2520and%2520Reduced%2520Functional%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7535%26epage%3D43%26doi%3D10.1021%2Fjm0504961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Schröder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oellien, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marhöfer, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duszenko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selzer, P. M.</span><span> </span><span class="NLM_article-title">Docking-based virtual screening of covalently binding ligands: an orthogonal lead discovery approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1478</span><span class="NLM_x">–</span> <span class="NLM_lpage">1490</span><span class="refDoi"> DOI: 10.1021/jm3013932</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3013932" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1478-1490&author=J.+Schr%C3%B6derauthor=A.+Klingerauthor=F.+Oellienauthor=R.+J.+Marh%C3%B6ferauthor=M.+Duszenkoauthor=P.+M.+Selzer&title=Docking-based+virtual+screening+of+covalently+binding+ligands%3A+an+orthogonal+lead+discovery+approach&doi=10.1021%2Fjm3013932"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm3013932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3013932%26sid%3Dliteratum%253Aachs%26aulast%3DSchr%25C3%25B6der%26aufirst%3DJ.%26aulast%3DKlinger%26aufirst%3DA.%26aulast%3DOellien%26aufirst%3DF.%26aulast%3DMarh%25C3%25B6fer%26aufirst%3DR.%2BJ.%26aulast%3DDuszenko%26aufirst%3DM.%26aulast%3DSelzer%26aufirst%3DP.%2BM.%26atitle%3DDocking-based%2520virtual%2520screening%2520of%2520covalently%2520binding%2520ligands%253A%2520an%2520orthogonal%2520lead%2520discovery%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1478%26epage%3D1490%26doi%3D10.1021%2Fjm3013932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Barrett, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kembhavi, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanada, K.</span><span> </span><span class="NLM_article-title">L-<i>trans</i>-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogs as inhibitors of cysteine proteinases including cathepsins B, H and L</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">201</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span><span class="refDoi"> DOI: 10.1042/bj2010189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1042%2Fbj2010189" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=201&publication_year=1982&pages=189-198&author=A.+J.+Barrettauthor=A.+A.+Kembhaviauthor=M.+A.+Brownauthor=H.+Kirschkeauthor=C.+G.+Knightauthor=M.+Tamaiauthor=K.+Hanada&title=L-trans-Epoxysuccinyl-leucylamido%284-guanidino%29butane+%28E-64%29+and+its+analogs+as+inhibitors+of+cysteine+proteinases+including+cathepsins+B%2C+H+and+L&doi=10.1042%2Fbj2010189"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1042%2Fbj2010189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2010189%26sid%3Dliteratum%253Aachs%26aulast%3DBarrett%26aufirst%3DA.%2BJ.%26aulast%3DKembhavi%26aufirst%3DA.%2BA.%26aulast%3DBrown%26aufirst%3DM.%2BA.%26aulast%3DKirschke%26aufirst%3DH.%26aulast%3DKnight%26aufirst%3DC.%2BG.%26aulast%3DTamai%26aufirst%3DM.%26aulast%3DHanada%26aufirst%3DK.%26atitle%3DL-trans-Epoxysuccinyl-leucylamido%25284-guanidino%2529butane%2520%2528E-64%2529%2520and%2520its%2520analogs%2520as%2520inhibitors%2520of%2520cysteine%2520proteinases%2520including%2520cathepsins%2520B%252C%2520H%2520and%2520L%26jtitle%3DBiochem.%2520J.%26date%3D1982%26volume%3D201%26spage%3D189%26epage%3D198%26doi%3D10.1042%2Fbj2010189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span><span class="refDoi"> DOI: 10.1006/jmbi.1996.0897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking&doi=10.1006%2Fjmbi.1996.0897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0lgnfp3aqPklOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748%26doi%3D10.1006%2Fjmbi.1996.0897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Verdonk, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartshorn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R. D.</span><span> </span><span class="NLM_article-title">Improved protein-ligand docking using GOLD</span> <span class="citation_source-journal">Proteins: Struct., Funct., Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">623</span><span class="refDoi"> DOI: 10.1002/prot.10465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1002%2Fprot.10465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=12910460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFGrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2003&pages=609-623&author=M.+L.+Verdonkauthor=J.+C.+Coleauthor=M.+J.+Hartshornauthor=C.+W.+Murrayauthor=R.+D.+Taylor&title=Improved+protein-ligand+docking+using+GOLD&doi=10.1002%2Fprot.10465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Improved protein-ligand docking using GOLD</span></div><div class="casAuthors">Verdonk, Marcel L.; Cole, Jason C.; Hartshorn, Michael J.; Murray, Christopher W.; Taylor, Richard D.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">609-623</span>CODEN:
                <span class="NLM_cas:coden">PSFGEY</span>;
        ISSN:<span class="NLM_cas:issn">0887-3585</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The Chemscore function was implemented as a scoring function for the protein-ligand docking program GOLD, and its performance compared to the original Goldscore function and two consensus docking protocols, "Goldscore-CS" and "Chemscore-GS," in terms of docking accuracy, prediction of binding affinities, and speed.  In the "Goldscore-CS" protocol, dockings produced with the Goldscore function are scored and ranked with the Chemscore function; in the "Chemscore-GS" protocol, dockings produced with the Chemscore function are scored and ranked with the Goldscore function.  Comparisons were made for a "clean" set of 224 protein-ligand complexes, and for two subsets of this set, one for which the ligands are "drug-like," the other for which they are "fragment-like.".  For "drug-like" and "fragment-like" ligands, the docking accuracies obtained with Chemscore and Goldscore functions are similar.  For larger ligands, Goldscore gives superior results.  Docking with the Chemscore function is up to three times faster than docking with the Goldscore function.  Both combined docking protocols give significant improvements in docking accuracy over the use of the Goldscore or Chemscore function alone.  "Goldscore-CS" gives success rates of up to 81% (top-ranked GOLD soln. within 2.0 Å of the exptl. binding mode) for the "clean list," but at the cost of long search times.  For most virtual screening applications, "Chemscore-GS" seems optimal; search settings that give docking speeds of around 0.25-1.3 min/compd. have success rates of about 78% for "drug-like" compds. and 85% for "fragment-like" compds.  In terms of producing binding energy ests., the Goldscore function appears to perform better than the Chemscore function and the two consensus protocols, particularly for faster search settings.  Even at docking speeds of around 1-2 min/compd., the Goldscore function predicts binding energies with a std. deviation of ∼10.5 kJ/mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKKgOct_CAcbVg90H21EOLACvtfcHk0lg7YBXJn2Ct1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFGrsLg%253D&md5=73a627d99dab6de1ae364c8e8e5f0fea</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fprot.10465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.10465%26sid%3Dliteratum%253Aachs%26aulast%3DVerdonk%26aufirst%3DM.%2BL.%26aulast%3DCole%26aufirst%3DJ.%2BC.%26aulast%3DHartshorn%26aufirst%3DM.%2BJ.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DTaylor%26aufirst%3DR.%2BD.%26atitle%3DImproved%2520protein-ligand%2520docking%2520using%2520GOLD%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2003%26volume%3D52%26spage%3D609%26epage%3D623%26doi%3D10.1002%2Fprot.10465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Nissink, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartshorn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdonk, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">A new test set for validating predictions of protein-ligand interaction</span> <span class="citation_source-journal">Proteins: Struct., Funct., Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span><span class="refDoi"> DOI: 10.1002/prot.10232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1002%2Fprot.10232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=12402356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BD38XptlGru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2002&pages=457-471&author=J.+W.+Nissinkauthor=C.+Murrayauthor=M.+Hartshornauthor=M.+L.+Verdonkauthor=J.+C.+Coleauthor=R.+Taylor&title=A+new+test+set+for+validating+predictions+of+protein-ligand+interaction&doi=10.1002%2Fprot.10232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A new test set for validating predictions of protein-ligand interaction</span></div><div class="casAuthors">Nissink, J. Willem M.; Murray, Chris; Hartshorn, Mike; Verdonk, Marcel L.; Cole, Jason C.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Genetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">457-471</span>CODEN:
                <span class="NLM_cas:coden">PSFGEY</span>;
        ISSN:<span class="NLM_cas:issn">0887-3585</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">We present a large test set of protein-ligand complexes for the purpose of validating algorithms that rely on the prediction of protein-ligand interactions.  The set consists of 305 complexes with protonation states assigned by manual inspection.  The following checks have been carried out to identify unsuitable entries in this set:.  (1) Assessing the involvement of crystallog. related protein units in ligand binding;.  (2) Identification of bad clashes between protein side chains and ligand; and.  (3) Assessment of structural errors, and/or inconsistency of ligand placement with crystal structure electron d.  In addn., the set has been pruned to assure diversity in terms of protein-ligand structures, and subsets are supplied for different protein-structure resoln. ranges.  A classification of the set by protein type is available.  As an illustration, validation results are shown for GOLD and SuperStar.  GOLD is a program that performs flexible protein-ligand docking, and SuperStar is used for the prediction of favorable interaction sites in proteins.  The new CCDC/Astex test set is freely available to the scientific community (http://www.ccdc.cam.ac.uk).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLTVTq0JGfW7Vg90H21EOLACvtfcHk0lg7YBXJn2Ct1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptlGru74%253D&md5=a8ecc21191bbf32edb10cf3d3336fab4</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2Fprot.10232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.10232%26sid%3Dliteratum%253Aachs%26aulast%3DNissink%26aufirst%3DJ.%2BW.%26aulast%3DMurray%26aufirst%3DC.%26aulast%3DHartshorn%26aufirst%3DM.%26aulast%3DVerdonk%26aufirst%3DM.%2BL.%26aulast%3DCole%26aufirst%3DJ.%2BC.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DA%2520new%2520test%2520set%2520for%2520validating%2520predictions%2520of%2520protein-ligand%2520interaction%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2002%26volume%3D49%26spage%3D457%26epage%3D471%26doi%3D10.1002%2Fprot.10232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Kirchmair, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Distinto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolber, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, T.</span><span> </span><span class="NLM_article-title">Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection - What can we learn from earlier mistakes?</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">228</span><span class="refDoi"> DOI: 10.1007/s10822-007-9163-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1007%2Fs10822-007-9163-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=18196462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjsFOnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=213-228&author=J.+Kirchmairauthor=P.+Marktauthor=S.+Distintoauthor=G.+Wolberauthor=T.+Langer&title=Evaluation+of+the+performance+of+3D+virtual+screening+protocols%3A+RMSD+comparisons%2C+enrichment+assessments%2C+and+decoy+selection+-+What+can+we+learn+from+earlier+mistakes%3F&doi=10.1007%2Fs10822-007-9163-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection-What can we learn from earlier mistakes?</span></div><div class="casAuthors">Kirchmair, Johannes; Markt, Patrick; Distinto, Simona; Wolber, Gerhard; Langer, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">213-228</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Within the last few years a considerable amt. of evaluative studies has been published that investigate the performance of 3D virtual screening approaches.  Thereby, in particular assessments of protein-ligand docking are facing remarkable interest in the scientific community.  However, comparing virtual screening approaches is a non-trivial task.  Several publications, esp. in the field of mol. docking, suffer from shortcomings that are likely to affect the significance of the results considerably.  These quality issues often arise from poor study design, biasing, by using improper or inexpressive enrichment descriptors, and from errors in interpretation of the data output.  In this review we analyze recent literature evaluating 3D virtual screening methods, with focus on mol. docking.  We highlight problematic issues and provide guidelines on how to improve the quality of computational studies.  Since 3D virtual screening protocols are in general assessed by their ability to discriminate between active and inactive compds., we summarize the impact of the compn. and prepn. of test sets on the outcome of evaluations.  Moreover, we investigate the significance of both classic enrichment parameters and advanced descriptors for the performance of 3D virtual screening methods.  Furthermore, we review the significance and suitability of RMSD as a measure for the accuracy of protein-ligand docking algorithms and of conformational space sub sampling algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3xrjPXIM177Vg90H21EOLACvtfcHk0lg7YBXJn2Ct1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjsFOnsLs%253D&md5=bb2c74856a607266d7ae5b2dafb733bd</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1007%2Fs10822-007-9163-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-007-9163-6%26sid%3Dliteratum%253Aachs%26aulast%3DKirchmair%26aufirst%3DJ.%26aulast%3DMarkt%26aufirst%3DP.%26aulast%3DDistinto%26aufirst%3DS.%26aulast%3DWolber%26aufirst%3DG.%26aulast%3DLanger%26aufirst%3DT.%26atitle%3DEvaluation%2520of%2520the%2520performance%2520of%25203D%2520virtual%2520screening%2520protocols%253A%2520RMSD%2520comparisons%252C%2520enrichment%2520assessments%252C%2520and%2520decoy%2520selection%2520-%2520What%2520can%2520we%2520learn%2520from%2520earlier%2520mistakes%253F%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2008%26volume%3D22%26spage%3D213%26epage%3D228%26doi%3D10.1007%2Fs10822-007-9163-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Carter, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alber, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bithell, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budworth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chubb, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowdell, V. C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelsey, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockyer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stables, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, K. L.</span><span> </span><span class="NLM_article-title">1,4-Benzodiazepines as inhibitors of respiratory syncytial virus</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2311</span><span class="NLM_x">–</span> <span class="NLM_lpage">2319</span><span class="refDoi"> DOI: 10.1021/jm051185t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051185t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVygtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2311-2319&author=M.+C.+Carterauthor=D.+G.+Alberauthor=R.+C.+Baxterauthor=S.+K.+Bithellauthor=J.+Budworthauthor=A.+Chubbauthor=G.+S.+Cockerillauthor=V.+C.+L.+Dowdellauthor=E.+A.+Hendersonauthor=S.+J.+Keeganauthor=R.+D.+Kelseyauthor=M.+J.+Lockyerauthor=J.+N.+Stablesauthor=L.+J.+Wilsonauthor=K.+L.+Powell&title=1%2C4-Benzodiazepines+as+inhibitors+of+respiratory+syncytial+virus&doi=10.1021%2Fjm051185t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-Benzodiazepines as Inhibitors of Respiratory Syncytial Virus</span></div><div class="casAuthors">Carter, Malcolm C.; Alber, Dagmar G.; Baxter, Robert C.; Bithell, Sian K.; Budworth, Jo; Chubb, Ann; Cockerill, G. Stuart; Dowdell, Verity C. L.; Henderson, Elisa A.; Keegan, Sally J.; Kelsey, Richard D.; Lockyer, Michael J.; Stables, Jeremy N.; Wilson, Lara J.; Powell, Kenneth L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2311-2319</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Respiratory syncytial virus (RSV) is the cause of one-fifth of all lower respiratory tract infections worldwide and is increasingly being recognized as a serious threat to patient groups with poorly functioning immune systems.  Our approach to finding a novel inhibitor of this virus was to screen a 20 000-member diverse library in a whole cell XTT assay.  Parallel assays were carried out in the absence of virus in order to quantify any assocd. cell toxicity.  This identified 100 compds. with IC50's less than 50 μM.  A-33903 (18), a 1,4-benzodiazepine analog, was chosen as the starting point for lead optimization.  This mol. was moderately active and demonstrated good pharmacokinetic properties.  The most potent compds. identified from this work were A-58568 (47), A-58569 (44), and A-62066 (46), where modifications to the arom. substitution enhanced potency, and A-58175 (42), where the amide linker was modified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsaCWk2D1PILVg90H21EOLACvtfcHk0lgjBlzziZLioA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVygtLw%253D&md5=225b3fc469eed46f697f1d08ca64e7fe</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm051185t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051185t%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DM.%2BC.%26aulast%3DAlber%26aufirst%3DD.%2BG.%26aulast%3DBaxter%26aufirst%3DR.%2BC.%26aulast%3DBithell%26aufirst%3DS.%2BK.%26aulast%3DBudworth%26aufirst%3DJ.%26aulast%3DChubb%26aufirst%3DA.%26aulast%3DCockerill%26aufirst%3DG.%2BS.%26aulast%3DDowdell%26aufirst%3DV.%2BC.%2BL.%26aulast%3DHenderson%26aufirst%3DE.%2BA.%26aulast%3DKeegan%26aufirst%3DS.%2BJ.%26aulast%3DKelsey%26aufirst%3DR.%2BD.%26aulast%3DLockyer%26aufirst%3DM.%2BJ.%26aulast%3DStables%26aufirst%3DJ.%2BN.%26aulast%3DWilson%26aufirst%3DL.%2BJ.%26aulast%3DPowell%26aufirst%3DK.%2BL.%26atitle%3D1%252C4-Benzodiazepines%2520as%2520inhibitors%2520of%2520respiratory%2520syncytial%2520virus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2311%26epage%3D2319%26doi%3D10.1021%2Fjm051185t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Bernhart, C.; Bouaboula, M.; Casellas, P.; Duclos, O.; Herbert, J. M.; Jegham, S.; Mccort, G.</span><span> </span><span class="NLM_article-title">Antineoplastic derivatives, preparation thereof, and therapeutic use thereof</span>. Patent WO2010004198 A2,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=C.+Bernhart&author=M.+Bouaboula&author=P.+Casellas&author=O.+Duclos&author=J.+M.+Herbert&author=S.+Jegham&author=G.+Mccort&title=Antineoplastic+derivatives%2C+preparation+thereof%2C+and+therapeutic+use+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBernhart%26aufirst%3DC.%26atitle%3DAntineoplastic%2520derivatives%252C%2520preparation%2520thereof%252C%2520and%2520therapeutic%2520use%2520thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Olson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, J. N.</span><span> </span><span class="NLM_article-title">Rigid Analogs of Indomethacin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span><span class="refDoi"> DOI: 10.1021/jm00248a005</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00248a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1974&pages=167-171&author=D.+R.+Olsonauthor=W.+J.+Wheelerauthor=J.+N.+Wells&title=Rigid+Analogs+of+Indomethacin&doi=10.1021%2Fjm00248a005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm00248a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00248a005%26sid%3Dliteratum%253Aachs%26aulast%3DOlson%26aufirst%3DD.%2BR.%26aulast%3DWheeler%26aufirst%3DW.%2BJ.%26aulast%3DWells%26aufirst%3DJ.%2BN.%26atitle%3DRigid%2520Analogs%2520of%2520Indomethacin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1974%26volume%3D17%26spage%3D167%26epage%3D171%26doi%3D10.1021%2Fjm00248a005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Mihelic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobersek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guncar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, D.</span><span> </span><span class="NLM_article-title">Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">14453</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span><span class="refDoi"> DOI: 10.1074/jbc.M801283200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1074%2Fjbc.M801283200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=14453-60&author=M.+Mihelicauthor=A.+Dobersekauthor=G.+Guncarauthor=D.+Turk&title=Inhibitory+fragment+from+the+p41+form+of+invariant+chain+can+regulate+activity+of+cysteine+cathepsins+in+antigen+presentation&doi=10.1074%2Fjbc.M801283200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M801283200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M801283200%26sid%3Dliteratum%253Aachs%26aulast%3DMihelic%26aufirst%3DM.%26aulast%3DDobersek%26aufirst%3DA.%26aulast%3DGuncar%26aufirst%3DG.%26aulast%3DTurk%26aufirst%3DD.%26atitle%3DInhibitory%2520fragment%2520from%2520the%2520p41%2520form%2520of%2520invariant%2520chain%2520can%2520regulate%2520activity%2520of%2520cysteine%2520cathepsins%2520in%2520antigen%2520presentation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D14453%26epage%3D60%26doi%3D10.1074%2Fjbc.M801283200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Brömme, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nallaseth, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, B.</span><span> </span><span class="NLM_article-title">Production and activation of recombinant papain-like cysteine proteases</span> <span class="citation_source-journal">Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span><span class="refDoi"> DOI: 10.1016/S1046-2023(03)00212-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1016%2FS1046-2023%2803%2900212-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=14698633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvFylsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=199-206&author=D.+Br%C3%B6mmeauthor=F.+S.+Nallasethauthor=B.+Turk&title=Production+and+activation+of+recombinant+papain-like+cysteine+proteases&doi=10.1016%2FS1046-2023%2803%2900212-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Production and activation of recombinant papain-like cysteine proteases</span></div><div class="casAuthors">Bromme, Dieter; Nallaseth, Ferez S.; Turk, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Methods (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-206</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">A review.  Papain-like cysteine proteases are the most numerous family of the cysteine protease class.  They are expressed throughout the animal and plant kingdoms as well as in viruses and bacteria.  More recently, this protease family has drawn attention as a potential pharmaceutical drug target in diseases characterized by excessive extracellular matrix degrdn. such as in osteoporosis, arthritis, vascular diseases, and cancer.  Moreover, papain-like cysteine proteases have been identified as crit. components of the life cycle and invasive potential of various human and live stock pathogens as well as major allergens.  Therefore, this protease class is rigorously studied and requires sufficient amts. of protease protein to analyze structure-activity relationships, their 3-D structures as well as to screen for and optimize potent and selective inhibitors.  This review summarizes approaches to generate active papain-like cysteine proteases by heterologous expression in a variety of expression systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzYKfIgOSvV7Vg90H21EOLACvtfcHk0lgjBlzziZLioA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvFylsrg%253D&md5=054d0d0fb925185d7e8b3aab208110ac</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS1046-2023%2803%2900212-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1046-2023%252803%252900212-3%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25B6mme%26aufirst%3DD.%26aulast%3DNallaseth%26aufirst%3DF.%2BS.%26aulast%3DTurk%26aufirst%3DB.%26atitle%3DProduction%2520and%2520activation%2520of%2520recombinant%2520papain-like%2520cysteine%2520proteases%26jtitle%3DMethods%26date%3D2004%26volume%3D32%26spage%3D199%26epage%3D206%26doi%3D10.1016%2FS1046-2023%2803%2900212-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Rozman-Pungercar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopitar-Jerala, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogyo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasiljeva, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefe, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenabeele, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brömme, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puizdar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonović, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trstenjak-Prebanda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolenc, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, B.</span><span> </span><span class="NLM_article-title">Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1038/sj.cdd.4401247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1038%2Fsj.cdd.4401247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=12867995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlsVKltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=881-8&author=J.+Rozman-Pungercarauthor=N.+Kopitar-Jeralaauthor=M.+Bogyoauthor=D.+Turkauthor=O.+Vasiljevaauthor=I.+Stefeauthor=P.+Vandenabeeleauthor=D.+Br%C3%B6mmeauthor=V.+Puizdarauthor=M.+Fonovi%C4%87author=M.+Trstenjak-Prebandaauthor=I.+Dolencauthor=V.+Turkauthor=B.+Turk&title=Inhibition+of+papain-like+cysteine+proteases+and+legumain+by+caspase-specific+inhibitors%3A+when+reaction+mechanism+is+more+important+than+specificity&doi=10.1038%2Fsj.cdd.4401247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity</span></div><div class="casAuthors">Rozman-Pungercar, J.; Kopitar-Jerala, N.; Bogyo, M.; Turk, D.; Vasiljeva, O.; Stefe, I.; Vandenabeele, P.; Broemme, D.; Puizdar, V.; Fonovic, M.; Trstenjak-Prebanda, M.; Dolenc, I.; Turk, V.; Turk, B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">881-888</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report here that a no. of commonly used small peptide caspase inhibitors consisting of a caspase recognition sequence linked to chloromethylketone, fluoromethylketone or aldehyde reactive group efficiently inhibit other cysteine proteases than caspases.  The in vitro studies included cathepsins B, H, L, S, K, F, V, X and C, papain and legumain.  Z-DEVD-cmk was shown to be the preferred irreversible inhibitor of most of the cathepsins in vitro, followed by Z-DEVD-fmk, Ac-YVAD-cmk, Z-YVAD-fmk and Z-VAD-fmk.  Inactivation of legumain by all the inhibitors investigated was moderate, whereas cathepsins H and C were poorly inhibited or not inhibited at all.  Inhibition by aldehydes was not very potent.  All the three fluoromethylketones efficiently inhibited cathepsins in Jurkat and human embryonic kidney 293 cells at concns. of 100 μM.  Furthermore, they completely inhibited cathepsins B and X activity in tissue exts. at concns. as low as 1 μM.  These results suggest that data based on the use of these inhibitors should be taken with caution and that other proteases may be implicated in the processes previously ascribed solely to caspases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGop9XTbZyjPkrVg90H21EOLACvtfcHk0lhABMVk749ykw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlsVKltr0%253D&md5=79ebc0cf9b626f818a9ea345598defdb</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4401247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4401247%26sid%3Dliteratum%253Aachs%26aulast%3DRozman-Pungercar%26aufirst%3DJ.%26aulast%3DKopitar-Jerala%26aufirst%3DN.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DTurk%26aufirst%3DD.%26aulast%3DVasiljeva%26aufirst%3DO.%26aulast%3DStefe%26aufirst%3DI.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DBr%25C3%25B6mme%26aufirst%3DD.%26aulast%3DPuizdar%26aufirst%3DV.%26aulast%3DFonovi%25C4%2587%26aufirst%3DM.%26aulast%3DTrstenjak-Prebanda%26aufirst%3DM.%26aulast%3DDolenc%26aufirst%3DI.%26aulast%3DTurk%26aufirst%3DV.%26aulast%3DTurk%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520papain-like%2520cysteine%2520proteases%2520and%2520legumain%2520by%2520caspase-specific%2520inhibitors%253A%2520when%2520reaction%2520mechanism%2520is%2520more%2520important%2520than%2520specificity%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2003%26volume%3D10%26spage%3D881%26epage%3D8%26doi%3D10.1038%2Fsj.cdd.4401247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Greco, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakala, M. T.</span><span> </span><span class="NLM_article-title">Evaluation of methods for estimating the dissociation constant of tight binding enzyme inhibitors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">254</span><span class="NLM_x">, </span> <span class="NLM_fpage">12104</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1016%2FS0021-9258%2819%2986435-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=500698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADyaL3cXitlem" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=1979&pages=12104-9&author=W.+R.+Grecoauthor=M.+T.+Hakala&title=Evaluation+of+methods+for+estimating+the+dissociation+constant+of+tight+binding+enzyme+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of methods for estimating the dissociation constant of tight binding enzyme inhibitors</span></div><div class="casAuthors">Greco, William R.; Hakala, Maire T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">254</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">12104-9</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">A Monte Carlo simulation was used to compare 11 methods for estg. the Ki of tight binding enzyme inhibitors.  The methods were evaluated for both accuracy and precision.  Parameters were chosen to simulate the inhibition of dihydrofolate reductase by methotrexate, using dihydrofolate as substrate.  These parameters were: Ki, 100 pM; turnover no., 500/min; molar equivalency of enzyme, 400 pM/unit; dihydrofolate concn., 50 μM; and Km, 0.5 μM.  Inputs of total enzyme concn. (Et) and total inhibitor concn. (It) were chosen to keep the value of Et/Ki between 4 and 20 and to allow estn. of the concn. of the inhibitor causing 50% inhibition (I50) at each Et.  Four types of error were introduced into the simulated data: small abs., large abs., small relative, and large relative error.  Computer methods based on the equations of W. W. Ackermann and V. R. Potter (1949) and J. F. Morrison (1969) which utilized nonlinear regression, proved to be significantly more precise than the methods which would require the use of only pencil and paper.  Based on these findings a review of the published Ki values for the inhibition of dihydrofolate reductase by methotrexate is also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqahqxjd5cipLVg90H21EOLACvtfcHk0lhABMVk749ykw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXitlem&md5=b238cb9e286f95a348838d70cb9908f1</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2819%2986435-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252819%252986435-9%26sid%3Dliteratum%253Aachs%26aulast%3DGreco%26aufirst%3DW.%2BR.%26aulast%3DHakala%26aufirst%3DM.%2BT.%26atitle%3DEvaluation%2520of%2520methods%2520for%2520estimating%2520the%2520dissociation%2520constant%2520of%2520tight%2520binding%2520enzyme%2520inhibitors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1979%26volume%3D254%26spage%3D12104%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Cherney, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecaille, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kienitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nallaseth, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brömme, D.</span><span> </span><span class="NLM_article-title">Structure-activity analysis of cathepsin K/chondroitin 4-sulfate interactions</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">8988</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span><span class="refDoi"> DOI: 10.1074/jbc.M110.126706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1074%2Fjbc.M110.126706" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=8988-98&author=M.+M.+Cherneyauthor=F.+Lecailleauthor=M.+Kienitzauthor=F.+S.+Nallasethauthor=Z.+Liauthor=M.+N.+Jamesauthor=D.+Br%C3%B6mme&title=Structure-activity+analysis+of+cathepsin+K%2Fchondroitin+4-sulfate+interactions&doi=10.1074%2Fjbc.M110.126706"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.126706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.126706%26sid%3Dliteratum%253Aachs%26aulast%3DCherney%26aufirst%3DM.%2BM.%26aulast%3DLecaille%26aufirst%3DF.%26aulast%3DKienitz%26aufirst%3DM.%26aulast%3DNallaseth%26aufirst%3DF.%2BS.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DJames%26aufirst%3DM.%2BN.%26aulast%3DBr%25C3%25B6mme%26aufirst%3DD.%26atitle%3DStructure-activity%2520analysis%2520of%2520cathepsin%2520K%252Fchondroitin%25204-sulfate%2520interactions%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D8988%26epage%3D98%26doi%3D10.1074%2Fjbc.M110.126706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Kirschke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlings, N. D.</span><span> </span><span class="NLM_article-title">Proteinases 1: lysosomal cysteine proteinases</span> <span class="citation_source-journal">Protein Profile</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1581</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=8771190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A280%3ADyaK28zmslSktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1995&pages=1581-643&author=H.+Kirschkeauthor=A.+J.+Barrettauthor=N.+D.+Rawlings&title=Proteinases+1%3A+lysosomal+cysteine+proteinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Proteinases 1: lysosomal cysteine proteinases</span></div><div class="casAuthors">Kirschke H; Barrett A J; Rawlings N D</div><div class="citationInfo"><span class="NLM_cas:title">Protein profile</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1581-643</span>
        ISSN:<span class="NLM_cas:issn">1070-3667</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS0OZVgEAMqxrGbPKh4T9eAfW6udTcc2ea36ODnu7GXHrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28zmslSktA%253D%253D&md5=0e4c2b201e1530f454632c47c4d5e4c1</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKirschke%26aufirst%3DH.%26aulast%3DBarrett%26aufirst%3DA.%2BJ.%26aulast%3DRawlings%26aufirst%3DN.%2BD.%26atitle%3DProteinases%25201%253A%2520lysosomal%2520cysteine%2520proteinases%26jtitle%3DProtein%2520Profile%26date%3D1995%26volume%3D2%26spage%3D1581%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Turk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colić, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoka, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, V.</span><span> </span><span class="NLM_article-title">Kinetics of inhibition of bovine cathepsin S by bovine stefin B</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span><span class="refDoi"> DOI: 10.1016/0014-5793(94)80405-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1016%2F0014-5793%2894%2980405-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=1994&pages=155-159&author=B.+Turkauthor=A.+Coli%C4%87author=V.+Stokaauthor=V.+Turk&title=Kinetics+of+inhibition+of+bovine+cathepsin+S+by+bovine+stefin+B&doi=10.1016%2F0014-5793%2894%2980405-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2894%2980405-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252894%252980405-2%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DB.%26aulast%3DColi%25C4%2587%26aufirst%3DA.%26aulast%3DStoka%26aufirst%3DV.%26aulast%3DTurk%26aufirst%3DV.%26atitle%3DKinetics%2520of%2520inhibition%2520of%2520bovine%2520cathepsin%2520S%2520by%2520bovine%2520stefin%2520B%26jtitle%3DFEBS%2520Lett.%26date%3D1994%26volume%3D339%26spage%3D155%26epage%3D159%26doi%3D10.1016%2F0014-5793%2894%2980405-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Morrison, J. F.</span><span> </span><span class="NLM_article-title">The slow-binding and slow, tight-binding inhibition of enzyme-catalysed reactions</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1016/0968-0004(82)90157-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1016%2F0968-0004%2882%2990157-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADyaL38XhslKrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1982&pages=102-105&author=J.+F.+Morrison&title=The+slow-binding+and+slow%2C+tight-binding+inhibition+of+enzyme-catalysed+reactions&doi=10.1016%2F0968-0004%2882%2990157-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">The slow-binding and slow, tight-binding inhibition of enzyme-catalyzed reactions</span></div><div class="casAuthors">Morrison, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">102-5</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    </div><div class="casAbstract">The mechanisms of enzyme inhibition by slow-binding and slow, tight-binding reversible inhibitors are discussed, as well as the kinetics of these processes as opposed to classical and tight-binding inhibitor mechanisms.  Examples of these types of inhibitors in the enzyme literature are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoun0ayjodbYrVg90H21EOLACvtfcHk0ljX45fX1eUU0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XhslKrtrw%253D&md5=1740627c1ad2adf182f4c0ae355bb4de</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0968-0004%2882%2990157-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0968-0004%252882%252990157-8%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DJ.%2BF.%26atitle%3DThe%2520slow-binding%2520and%2520slow%252C%2520tight-binding%2520inhibition%2520of%2520enzyme-catalysed%2520reactions%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D1982%26volume%3D7%26spage%3D102%26epage%3D105%26doi%3D10.1016%2F0968-0004%2882%2990157-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Invitrogen</span><span class="NLM_x">. </span><span> </span><span class="NLM_article-title">Pichia Expression Kit</span>. <a href="http://tools.thermofisher.com/content/sfs/manuals/pich_man.pdf" class="extLink">http://tools.thermofisher.com/content/sfs/manuals/pich_man.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Invitrogen.+Pichia+Expression+Kit.+http%3A%2F%2Ftools.thermofisher.com%2Fcontent%2Fsfs%2Fmanuals%2Fpich_man.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DPichia%2520Expression%2520Kit" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Mueller, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darowski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Förster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellmig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paithankar, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pühringer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zocher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. S.</span><span> </span><span class="NLM_article-title">Facilities for macromolecular crystallography at the Helmholtz-Zentrum Berlin</span> <span class="citation_source-journal">J. Synchrotron Radiat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1107/S0909049512006395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1107%2FS0909049512006395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=22514183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFGhu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=442-449&author=U.+Muellerauthor=N.+Darowskiauthor=M.+R.+Fuchsauthor=R.+F%C3%B6rsterauthor=M.+Hellmigauthor=K.+S.+Paithankarauthor=S.+P%C3%BChringerauthor=M.+Steffienauthor=G.+Zocherauthor=M.+S.+Weiss&title=Facilities+for+macromolecular+crystallography+at+the+Helmholtz-Zentrum+Berlin&doi=10.1107%2FS0909049512006395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Facilities for macromolecular crystallography at the Helmholtz-Zentrum Berlin</span></div><div class="casAuthors">Mueller, Uwe; Darowski, Nora; Fuchs, Martin R.; Foerster, Ronald; Hellmig, Michael; Paithankar, Karthik S.; Puehringer, Sandra; Steffien, Michael; Zocher, Georg; Weiss, Manfred S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Synchrotron Radiation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">442-449</span>CODEN:
                <span class="NLM_cas:coden">JSYRES</span>;
        ISSN:<span class="NLM_cas:issn">0909-0495</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Three macromol. crystallog. (MX) beamlines at the Helmholtz-Zentrum Berlin (HZB) are available for the regional, national and international structural biol. user community.  The state-of-the-art synchrotron beamlines for MX BL14.1, BL14.2 and BL14.3 are located within the low-β section of the BESSY II electron storage ring.  All beamlines are fed from a superconducting 7 T wavelength-shifter insertion device.  BL14.1 and BL14.2 are energy tunable in the range 5-16 keV, while BL14.3 is a fixed-energy side station operated at 13.8 keV.  All three beamlines are equipped with CCD detectors.  BL14.1 and BL14.2 are in regular user operation providing about 200 beam days per yr and about 600 user shifts to approx. 50 research groups across Europe.  BL14.3 has initially been used as a test facility and was brought into regular user mode operation during the year 2010.  BL14.1 has recently been upgraded with a microdiffractometer including a mini-κ goniometer and an automated sample changer.  Addnl. user facilities include office space adjacent to the beamlines, a sample prepn. lab., a biol. lab. (safety level 1) and high-end computing resources.  In this article the instrumentation of the beamlines is described, and a summary of the exptl. possibilities of the beamlines and the provided ancillary equipment for the user community is given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEtRGj9KmXzLVg90H21EOLACvtfcHk0ljX45fX1eUU0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFGhu7o%253D&md5=f065b38da0a77d30031a9db5a67eb1cc</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1107%2FS0909049512006395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0909049512006395%26sid%3Dliteratum%253Aachs%26aulast%3DMueller%26aufirst%3DU.%26aulast%3DDarowski%26aufirst%3DN.%26aulast%3DFuchs%26aufirst%3DM.%2BR.%26aulast%3DF%25C3%25B6rster%26aufirst%3DR.%26aulast%3DHellmig%26aufirst%3DM.%26aulast%3DPaithankar%26aufirst%3DK.%2BS.%26aulast%3DP%25C3%25BChringer%26aufirst%3DS.%26aulast%3DSteffien%26aufirst%3DM.%26aulast%3DZocher%26aufirst%3DG.%26aulast%3DWeiss%26aufirst%3DM.%2BS.%26atitle%3DFacilities%2520for%2520macromolecular%2520crystallography%2520at%2520the%2520Helmholtz-Zentrum%2520Berlin%26jtitle%3DJ.%2520Synchrotron%2520Radiat.%26date%3D2012%26volume%3D19%26spage%3D442%26epage%3D449%26doi%3D10.1107%2FS0909049512006395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Krug, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinemann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, U.</span><span> </span><span class="NLM_article-title">XDSAPP: a graphical user interface for the convenient processing of diffraction data using XDS</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">568</span><span class="NLM_x">–</span> <span class="NLM_lpage">572</span><span class="refDoi"> DOI: 10.1107/S0021889812011715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1107%2FS0021889812011715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsFGmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2012&pages=568-572&author=M.+Krugauthor=M.+S.+Weissauthor=U.+Heinemannauthor=U.+Mueller&title=XDSAPP%3A+a+graphical+user+interface+for+the+convenient+processing+of+diffraction+data+using+XDS&doi=10.1107%2FS0021889812011715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">XDSAPP: a graphical user interface for the convenient processing of diffraction data using XDS</span></div><div class="casAuthors">Krug, Michael; Weiss, Manfred S.; Heinemann, Udo; Mueller, Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">568-572</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">XDSAPP is a Tcl/Tk-based graphical user interface for the easy and convenient processing of diffraction data sets using XDS.  It provides easy access to all XDS functionalities, automates the data processing and generates graphical plots of various data set statistics provided by XDS.  By incorporating addnl. software, further information on certain features of the data set, such as radiation decay during data collection or the presence of pseudo-translational symmetry and/or twinning, can be obtained.  Intensity files suitable for CCP4, CNS and SHELX are generated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCqFLQ2J-k07Vg90H21EOLACvtfcHk0lhAuSxPESXuNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsFGmtLo%253D&md5=8f0b78fdea7ed6cc580de9eb561e8b9e</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1107%2FS0021889812011715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889812011715%26sid%3Dliteratum%253Aachs%26aulast%3DKrug%26aufirst%3DM.%26aulast%3DWeiss%26aufirst%3DM.%2BS.%26aulast%3DHeinemann%26aufirst%3DU.%26aulast%3DMueller%26aufirst%3DU.%26atitle%3DXDSAPP%253A%2520a%2520graphical%2520user%2520interface%2520for%2520the%2520convenient%2520processing%2520of%2520diffraction%2520data%2520using%2520XDS%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2012%26volume%3D45%26spage%3D568%26epage%3D572%26doi%3D10.1107%2FS0021889812011715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Mccoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Phaser crystallographic software</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+Mccoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lhAuSxPESXuNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMccoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skubák, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebedev, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholls, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span> </span><span class="NLM_article-title">REFMAC5 for the refinement of macromolecular crystal structures</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span><span class="refDoi"> DOI: 10.1107/S0907444911001314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1107%2FS0907444911001314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=21460454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=355-367&author=G.+N.+Murshudovauthor=P.+Skub%C3%A1kauthor=A.+A.+Lebedevauthor=N.+S.+Pannuauthor=R.+A.+Steinerauthor=R.+A.+Nichollsauthor=M.+D.+Winnauthor=F.+Longauthor=A.+A.+Vagin&title=REFMAC5+for+the+refinement+of+macromolecular+crystal+structures&doi=10.1107%2FS0907444911001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 for the refinement of macromolecular crystal structures</span></div><div class="casAuthors">Murshudov, Garib N.; Skubak, Pavol; Lebedev, Andrey A.; Pannu, Navraj S.; Steiner, Roberto A.; Nicholls, Robert A.; Winn, Martyn D.; Long, Fei; Vagin, Alexei A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">This paper describes various components of the macromol. crystallog. refinement program REFMAC5, which is distributed as part of the CCP4 suite.  REFMAC5 utilizes different likelihood functions depending on the diffraction data employed (amplitudes or intensities), the presence of twinning and the availability of SAD/SIRAS exptl. diffraction data.  To ensure chem. and structural integrity of the refined model, REFMAC5 offers several classes of restraints and choices of model parameterization.  Reliable models at resolns. at least as low as 4 Å can be achieved thanks to low-resoln. refinement tools such as secondary-structure restraints, restraints to known homologous structures, automatic global and local NCS restraints, 'jelly-body' restraints and the use of novel long-range restraints on at. displacement parameters (ADPs) based on the Kullback-Leibler divergence.  REFMAC5 addnl. offers TLS parameterization and, when high-resoln. data are available, fast refinement of anisotropic ADPs.  Refinement in the presence of twinning is performed in a fully automated fashion.  REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for refinement across the entire resoln. spectrum encountered in macromol. crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Jq-i2qIq5rVg90H21EOLACvtfcHk0lhAuSxPESXuNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D&md5=f8f3202d246908500057ad7c71015b7b</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1107%2FS0907444911001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911001314%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DSkub%25C3%25A1k%26aufirst%3DP.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26atitle%3DREFMAC5%2520for%2520the%2520refinement%2520of%2520macromolecular%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D355%26epage%3D367%26doi%3D10.1107%2FS0907444911001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Turk, D.</span><span> </span><span class="NLM_article-title">MAIN software for density averaging, model building, structure refinement and validation</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1342</span><span class="NLM_x">–</span> <span class="NLM_lpage">1357</span><span class="refDoi"> DOI: 10.1107/S0907444913008408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1107%2FS0907444913008408" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1342-1357&author=D.+Turk&title=MAIN+software+for+density+averaging%2C+model+building%2C+structure+refinement+and+validation&doi=10.1107%2FS0907444913008408"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1107%2FS0907444913008408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444913008408%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DD.%26atitle%3DMAIN%2520software%2520for%2520density%2520averaging%252C%2520model%2520building%252C%2520structure%2520refinement%2520and%2520validation%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26spage%3D1342%26epage%3D1357%26doi%3D10.1107%2FS0907444913008408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lh0YOdFRdFr6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 16 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Markus Schade, Beatrix Merla, Bernhard Lesch, Markus Wagener, Simone Timmermanns, Katrien Pletinckx, <span class="NLM_string-name hlFld-ContribAuthor">Torsten Hertrampf</span>. </span><span class="cited-content_cbyCitation_article-title">Highly Selective Sub-Nanomolar Cathepsin S Inhibitors by Merging Fragment Binders with Nitrile Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 11801-11808. <a href="https://doi.org/10.1021/acs.jmedchem.0c00949" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00949</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00949%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHighly%252BSelective%252BSub-Nanomolar%252BCathepsin%252BS%252BInhibitors%252Bby%252BMerging%252BFragment%252BBinders%252Bwith%252BNitrile%252BInhibitors%26aulast%3DSchade%26aufirst%3DMarkus%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03062020%26date%3D17092020%26date%3D03092020%26volume%3D63%26issue%3D20%26spage%3D11801%26epage%3D11808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sofia Almeida, Roger Marti, Ennio Vanoli, Stefan Abele, <span class="NLM_string-name hlFld-ContribAuthor">Simone Tortoioli</span>. </span><span class="cited-content_cbyCitation_article-title">One-Pot Synthesis of Trifluoromethylated Quinazolin-4(3H)-ones with Trifluoroacetic Acid as CF3 Source. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (9)
                                     , 5104-5113. <a href="https://doi.org/10.1021/acs.joc.8b00389" title="DOI URL">https://doi.org/10.1021/acs.joc.8b00389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b00389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b00389%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DOne-Pot%252BSynthesis%252Bof%252BTrifluoromethylated%252BQuinazolin-4%2525283H%252529-ones%252Bwith%252BTrifluoroacetic%252BAcid%252Bas%252BCF3%252BSource%26aulast%3DAlmeida%26aufirst%3DSofia%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D16022018%26date%3D12042018%26volume%3D83%26issue%3D9%26spage%3D5104%26epage%3D5113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Janina  Schmitz</span>, <span class="hlFld-ContribAuthor ">Tianwei  Li</span>, <span class="hlFld-ContribAuthor ">Ulrike  Bartz</span>, and <span class="hlFld-ContribAuthor ">Michael  Gütschow</span>  . </span><span class="cited-content_cbyCitation_article-title">Cathepsin B Inhibitors: Combining Dipeptide Nitriles with an Occluding Loop Recognition Element by Click Chemistry. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (3)
                                     , 211-216. <a href="https://doi.org/10.1021/acsmedchemlett.5b00474" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00474</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00474%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCathepsin%252BB%252BInhibitors%25253A%252BCombining%252BDipeptide%252BNitriles%252Bwith%252Ban%252BOccluding%252BLoop%252BRecognition%252BElement%252Bby%252BClick%252BChemistry%26aulast%3DSchmitz%26aufirst%3DJanina%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D09122015%26date%3D27122015%26date%3D12012016%26date%3D10032016%26date%3D28122015%26volume%3D7%26issue%3D3%26spage%3D211%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesca  Coscia</span>, <span class="hlFld-ContribAuthor ">Ajda  Taler-Verčič</span>. </span><span class="cited-content_cbyCitation_article-title">Cryo-EM: a new dawn in thyroid biology. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Endocrinology</span><span> <strong>2021,</strong> <em>491 </em>, 111309. <a href="https://doi.org/10.1016/j.mce.2021.111309" title="DOI URL">https://doi.org/10.1016/j.mce.2021.111309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mce.2021.111309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mce.2021.111309%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Endocrinology%26atitle%3DCryo-EM%25253A%252Ba%252Bnew%252Bdawn%252Bin%252Bthyroid%252Bbiology%26aulast%3DCoscia%26aufirst%3DFrancesca%26date%3D2021%26volume%3D491%26spage%3D111309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rafael Pinto  Vieira</span>, <span class="hlFld-ContribAuthor ">Viviane Corrêa  Santos</span>, <span class="hlFld-ContribAuthor ">Rafaela Salgado  Ferreira</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based Approaches Targeting Parasite Cysteine Proteases. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2019,</strong> <em>26 </em>
                                    (23)
                                     , 4435-4453. <a href="https://doi.org/10.2174/0929867324666170810165302" title="DOI URL">https://doi.org/10.2174/0929867324666170810165302</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867324666170810165302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867324666170810165302%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252BApproaches%252BTargeting%252BParasite%252BCysteine%252BProteases%26aulast%3DVieira%26aufirst%3DRafael%2BPinto%26date%3D2019%26volume%3D26%26issue%3D23%26spage%3D4435%26epage%3D4453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nejc  Petek</span>, <span class="hlFld-ContribAuthor ">Bogdan  Štefane</span>, <span class="hlFld-ContribAuthor ">Marko  Novinec</span>, <span class="hlFld-ContribAuthor ">Jurij  Svete</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 7-(aminoalkyl)pyrazolo[1,5-a]pyrimidine derivatives as cathepsin K inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>, 226-238. <a href="https://doi.org/10.1016/j.bioorg.2018.11.029" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.11.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.11.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.11.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B7-%252528aminoalkyl%252529pyrazolo%25255B1%25252C5-a%25255Dpyrimidine%252Bderivatives%252Bas%252Bcathepsin%252BK%252Binhibitors%26aulast%3DPetek%26aufirst%3DNejc%26date%3D2019%26volume%3D84%26spage%3D226%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeffery D.  Zwicker</span>, <span class="hlFld-ContribAuthor ">Nicolas A.  Diaz</span>, <span class="hlFld-ContribAuthor ">Alfredo J.  Guerra</span>, <span class="hlFld-ContribAuthor ">Paul D.  Kirchhoff</span>, <span class="hlFld-ContribAuthor ">Bo  Wen</span>, <span class="hlFld-ContribAuthor ">Duxin  Sun</span>, <span class="hlFld-ContribAuthor ">Vern B.  Carruthers</span>, <span class="hlFld-ContribAuthor ">Scott D.  Larsen</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of dipeptidic inhibitors of cathepsin L for improved Toxoplasma gondii selectivity and CNS permeability. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (10)
                                     , 1972-1980. <a href="https://doi.org/10.1016/j.bmcl.2018.03.020" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.03.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.03.020%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DOptimization%252Bof%252Bdipeptidic%252Binhibitors%252Bof%252Bcathepsin%252BL%252Bfor%252Bimproved%252BToxoplasma%252Bgondii%252Bselectivity%252Band%252BCNS%252Bpermeability%26aulast%3DZwicker%26aufirst%3DJeffery%2BD.%26date%3D2018%26volume%3D28%26issue%3D10%26spage%3D1972%26epage%3D1980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Lu</span>, <span class="hlFld-ContribAuthor ">Maolin  Wang</span>, <span class="hlFld-ContribAuthor ">Ziyue  Wang</span>, <span class="hlFld-ContribAuthor ">Zhongqi  Fu</span>, <span class="hlFld-ContribAuthor ">Aiping  Lu</span>, <span class="hlFld-ContribAuthor ">Ge  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the discovery of cathepsin K inhibitors on bone resorption. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2018,</strong> <em>33 </em>
                                    (1)
                                     , 890-904. <a href="https://doi.org/10.1080/14756366.2018.1465417" title="DOI URL">https://doi.org/10.1080/14756366.2018.1465417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2018.1465417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2018.1465417%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DAdvances%252Bin%252Bthe%252Bdiscovery%252Bof%252Bcathepsin%252BK%252Binhibitors%252Bon%252Bbone%252Bresorption%26aulast%3DLu%26aufirst%3DJun%26date%3D2018%26date%3D2018%26volume%3D33%26issue%3D1%26spage%3D890%26epage%3D904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neera  Raghav</span>, <span class="hlFld-ContribAuthor ">Mamta  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">SAR studies of some acetophenone phenylhydrazone based pyrazole derivatives as anticathepsin agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2017,</strong> <em>75 </em>, 38-49. <a href="https://doi.org/10.1016/j.bioorg.2017.08.006" title="DOI URL">https://doi.org/10.1016/j.bioorg.2017.08.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2017.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2017.08.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSAR%252Bstudies%252Bof%252Bsome%252Bacetophenone%252Bphenylhydrazone%252Bbased%252Bpyrazole%252Bderivatives%252Bas%252Banticathepsin%252Bagents%26aulast%3DRaghav%26aufirst%3DNeera%26date%3D2017%26volume%3D75%26spage%3D38%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emir  Salas-Sarduy</span>, <span class="hlFld-ContribAuthor ">Lionel Urán  Landaburu</span>, <span class="hlFld-ContribAuthor ">Joel  Karpiak</span>, <span class="hlFld-ContribAuthor ">Kevin P.  Madauss</span>, <span class="hlFld-ContribAuthor ">Juan José  Cazzulo</span>, <span class="hlFld-ContribAuthor ">Fernán  Agüero</span>, <span class="hlFld-ContribAuthor ">Vanina Eder  Alvarez</span>. </span><span class="cited-content_cbyCitation_article-title">Novel scaffolds for inhibition of Cruzipain identified from high-throughput screening of anti-kinetoplastid chemical boxes. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-12170-4" title="DOI URL">https://doi.org/10.1038/s41598-017-12170-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-12170-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-12170-4%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DNovel%252Bscaffolds%252Bfor%252Binhibition%252Bof%252BCruzipain%252Bidentified%252Bfrom%252Bhigh-throughput%252Bscreening%252Bof%252Banti-kinetoplastid%252Bchemical%252Bboxes%26aulast%3DSalas-Sarduy%26aufirst%3DEmir%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lovro  Kramer</span>, <span class="hlFld-ContribAuthor ">Dušan  Turk</span>, <span class="hlFld-ContribAuthor ">Boris  Turk</span>. </span><span class="cited-content_cbyCitation_article-title">The Future of Cysteine Cathepsins in Disease Management. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2017,</strong> <em>38 </em>
                                    (10)
                                     , 873-898. <a href="https://doi.org/10.1016/j.tips.2017.06.003" title="DOI URL">https://doi.org/10.1016/j.tips.2017.06.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2017.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2017.06.003%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DThe%252BFuture%252Bof%252BCysteine%252BCathepsins%252Bin%252BDisease%252BManagement%26aulast%3DKramer%26aufirst%3DLovro%26date%3D2017%26volume%3D38%26issue%3D10%26spage%3D873%26epage%3D898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tanja  Schirmeister</span>, <span class="hlFld-ContribAuthor ">Janina  Schmitz</span>, <span class="hlFld-ContribAuthor ">Sascha  Jung</span>, <span class="hlFld-ContribAuthor ">Torsten  Schmenger</span>, <span class="hlFld-ContribAuthor ">R. Luise  Krauth-Siegel</span>, <span class="hlFld-ContribAuthor ">Michael  Gütschow</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of dipeptide nitriles as inhibitors of rhodesain, a major cysteine protease of Trypanosoma brucei. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (1)
                                     , 45-50. <a href="https://doi.org/10.1016/j.bmcl.2016.11.036" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.11.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.11.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.11.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DEvaluation%252Bof%252Bdipeptide%252Bnitriles%252Bas%252Binhibitors%252Bof%252Brhodesain%25252C%252Ba%252Bmajor%252Bcysteine%252Bprotease%252Bof%252BTrypanosoma%252Bbrucei%26aulast%3DSchirmeister%26aufirst%3DTanja%26date%3D2017%26volume%3D27%26issue%3D1%26spage%3D45%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marjana  Novič</span>, <span class="hlFld-ContribAuthor ">Tjaša  Tibaut</span>, <span class="hlFld-ContribAuthor ">Marko  Anderluh</span>, <span class="hlFld-ContribAuthor ">Jure  Borišek</span>, <span class="hlFld-ContribAuthor ">Tihomir  Tomašič</span>. </span><span class="cited-content_cbyCitation_article-title">The Comparison of Docking Search Algorithms and Scoring Functions. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 820-849. <a href="https://doi.org/10.4018/978-1-5225-1762-7.ch032" title="DOI URL">https://doi.org/10.4018/978-1-5225-1762-7.ch032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4018/978-1-5225-1762-7.ch032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4018%2F978-1-5225-1762-7.ch032%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BComparison%252Bof%252BDocking%252BSearch%252BAlgorithms%252Band%252BScoring%252BFunctions%26aulast%3DNovi%25C4%258D%26aufirst%3DMarjana%26date%3D2017%26spage%3D820%26epage%3D849%26pub%3DIGI%2520Global%26atitle%3DPharmaceutical%252BSciences%26aulast%3DManagement%2BAssociation%26aufirst%3DInformation%2BResources%26date%3D2017%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yali  Wang</span>, <span class="hlFld-ContribAuthor ">Ruolan  Li</span>, <span class="hlFld-ContribAuthor ">Zhihui  Zheng</span>, <span class="hlFld-ContribAuthor ">Hong  Yi</span>, <span class="hlFld-ContribAuthor ">Zhuorong  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel cathepsin K inhibitors using ligand-based virtual screening and structure-based docking. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (86)
                                     , 82961-82968. <a href="https://doi.org/10.1039/C6RA14251F" title="DOI URL">https://doi.org/10.1039/C6RA14251F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA14251F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA14251F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DIdentification%252Bof%252Bnovel%252Bcathepsin%252BK%252Binhibitors%252Busing%252Bligand-based%252Bvirtual%252Bscreening%252Band%252Bstructure-based%252Bdocking%26aulast%3DWang%26aufirst%3DYali%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D86%26spage%3D82961%26epage%3D82968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marjana  Novič</span>, <span class="hlFld-ContribAuthor ">Tjaša  Tibaut</span>, <span class="hlFld-ContribAuthor ">Marko  Anderluh</span>, <span class="hlFld-ContribAuthor ">Jure  Borišek</span>, <span class="hlFld-ContribAuthor ">Tihomir  Tomašič</span>. </span><span class="cited-content_cbyCitation_article-title">The Comparison of Docking Search Algorithms and Scoring Functions. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 99-127. <a href="https://doi.org/10.4018/978-1-5225-0115-2.ch004" title="DOI URL">https://doi.org/10.4018/978-1-5225-0115-2.ch004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4018/978-1-5225-0115-2.ch004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4018%2F978-1-5225-0115-2.ch004%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BComparison%252Bof%252BDocking%252BSearch%252BAlgorithms%252Band%252BScoring%252BFunctions%26aulast%3DNovi%25C4%258D%26aufirst%3DMarjana%26date%3D2016%26spage%3D99%26epage%3D127%26pub%3DIGI%2520Global%26atitle%3DMethods%252Band%252BAlgorithms%252Bfor%252BMolecular%252BDocking-Based%252BDrug%252BDesign%252Band%252BDiscovery%26aulast%3DDastmalchi%26aufirst%3DSiavoush%26date%3D2016%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N.K.  Terrett</span>. </span><span class="cited-content_cbyCitation_article-title">Combinatorial Chemistry Online Volume 17, Issue 12, December 2015. </span><span class="cited-content_cbyCitation_journal-name">Combinatorial Chemistry - an Online Journal</span><span> <strong>2015,</strong> <em>17 </em>
                                    (12)
                                     , 47-50. <a href="https://doi.org/10.1016/j.comche.2015.11.001" title="DOI URL">https://doi.org/10.1016/j.comche.2015.11.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.comche.2015.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.comche.2015.11.001%26sid%3Dliteratum%253Aachs%26jtitle%3DCombinatorial%2520Chemistry%2520-%2520an%2520Online%2520Journal%26atitle%3DCombinatorial%252BChemistry%252BOnline%252BVolume%252B17%25252C%252BIssue%252B12%25252C%252BDecember%252B2015%26aulast%3DTerrett%26aufirst%3DN.K.%26date%3D2015%26volume%3D17%26issue%3D12%26spage%3D47%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/medium/jm-2015-007468_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00746&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/medium/jm-2015-007468_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) Representative Cat K inhibitors. (b) Binding of <i>N</i>-(functionalized benzoyl)-homocycloleucyl-glycinonitriles within the Cat K active site indicated by S1–S3 subsites.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00746&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/medium/jm-2015-007468_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Close view of the natively present and GOLD-calculated covalently bound combinatorial Cat K ligands within <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DMX">4DMX</a>. The 0LB ligand conformation is depicted in red, and the molecular docking-calculated binding poses for the 4 valid combinatorial compounds are colored as following: compound <b>4</b> in green, compound <b>5</b> in magenta, compound <b>6</b> in yellow, and compound <b>10</b> in cyan. The key attachment point is Cys25 and the amino acid residues Gly66 and Asn161 are important for the stabilization of the ligand through H-bonding.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00746&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/medium/jm-2015-007468_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of <i>N</i>-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles <b>4</b>–<b>10</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00746&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/medium/jm-2015-007468_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Attempt to Prepare Functionalized Benzoic Acid <b>11</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00746&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/medium/jm-2015-007468_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Human Cat K–inhibitor complexes. The blue electron density map is contoured: (a) around compound <b>5</b> at 2.0σ; (b) around compound <b>6</b> at 1.0σ; (c) around compound <b>9</b> at 1.5σ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00746&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/medium/jm-2015-007468_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Superimposition of crystal structures of compounds <b>5</b>, <b>6</b>, and <b>9</b> on 0LB (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DMX">4DMX</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00746/20150904/images/large/jm-2015-007468_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00746&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i45">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11076" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11076" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 64 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Fonovic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, B.</span><span> </span><span class="NLM_article-title">Cysteine cathepsins and extracellular matrix degradation</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Gen. Subj.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1840</span><span class="NLM_x">, </span> <span class="NLM_fpage">2560</span><span class="NLM_x">–</span> <span class="NLM_lpage">2570</span><span class="refDoi"> DOI: 10.1016/j.bbagen.2014.03.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1016%2Fj.bbagen.2014.03.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1840&publication_year=2014&pages=2560-2570&author=M.+Fonovicauthor=B.+Turk&title=Cysteine+cathepsins+and+extracellular+matrix+degradation&doi=10.1016%2Fj.bbagen.2014.03.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2014.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2014.03.017%26sid%3Dliteratum%253Aachs%26aulast%3DFonovic%26aufirst%3DM.%26aulast%3DTurk%26aufirst%3DB.%26atitle%3DCysteine%2520cathepsins%2520and%2520extracellular%2520matrix%2520degradation%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2014%26volume%3D1840%26spage%3D2560%26epage%3D2570%26doi%3D10.1016%2Fj.bbagen.2014.03.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Novinec, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenarcic, B.</span><span> </span><span class="NLM_article-title">Cathepsin K: a unique collagenolytic cysteine peptidase</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">394</span><span class="NLM_x">, </span> <span class="NLM_fpage">1163</span><span class="NLM_x">–</span> <span class="NLM_lpage">1179</span><span class="refDoi"> DOI: 10.1515/hsz-2013-0134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1515%2Fhsz-2013-0134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=23629523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvFylsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=394&publication_year=2013&pages=1163-1179&author=M.+Novinecauthor=B.+Lenarcic&title=Cathepsin+K%3A+a+unique+collagenolytic+cysteine+peptidase&doi=10.1515%2Fhsz-2013-0134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin K: a unique collagenolytic cysteine peptidase</span></div><div class="casAuthors">Novinec, Marko; Lenarcic, Brigita</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">394</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1163-1179</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">A review.  Cathepsin K has emerged as a promising target for the treatment of osteoporosis in recent years.  Initially identified as a papain-like cysteine peptidase expressed in high levels in osteoclasts, the important role of this enzyme in bone metab. was highlighted by the finding that mutations in the CTSK gene cause the rare recessive disorder pycnodysostosis, which is characterized by severe bone anomalies.  At the mol. level, the physiol. role of cathepsin K is reflected by its unique cleavage pattern of type I collagen mols., which is fundamentally different from that of other endogenous collagenases.  Several cathepsin K inhibitors have been developed to reduce the excessive bone matrix degrdn. assocd. with osteoporosis, with the frontrunner odanacatib about to successfully conclude Phase 3 clin. trials.  Apart from osteoclasts, cathepsin K is expressed in different cell types throughout the body and is involved in processes of adipogenesis, thyroxine liberation and peptide hormone regulation.  Elevated activity of cathepsin K has been assocd. with arthritis, atherosclerosis, obesity, schizophrenia, and tumor metastasis.  Accordingly, its activity is tightly regulated via multiple mechanisms, including competitive inhibition by endogenous macromol. inhibitors and allosteric regulation by glycosaminoglycans.  This review provides a state-of-the-art description of the activity of cathepsin K at the mol. level, its biol. functions and the mechanisms involved in its regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnGDT8B0IwW7Vg90H21EOLACvtfcHk0lhdSsaThKpQhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvFylsL4%253D&md5=7608c0877f60fdd9265b797f3f423835</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2013-0134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2013-0134%26sid%3Dliteratum%253Aachs%26aulast%3DNovinec%26aufirst%3DM.%26aulast%3DLenarcic%26aufirst%3DB.%26atitle%3DCathepsin%2520K%253A%2520a%2520unique%2520collagenolytic%2520cysteine%2520peptidase%26jtitle%3DBiol.%2520Chem.%26date%3D2013%26volume%3D394%26spage%3D1163%26epage%3D1179%26doi%3D10.1515%2Fhsz-2013-0134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Deaton, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span> </span><span class="NLM_article-title">6. Cathepsin K inhibitors: their potential as anti-osteoporosis agents</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span><span class="refDoi"> DOI: 10.1016/S0079-6468(04)42006-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1016%2FS0079-6468%2804%2942006-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=15003723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksF2qs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2004&pages=245-375&author=D.+M.+Deatonauthor=S.+Kumar&title=6.+Cathepsin+K+inhibitors%3A+their+potential+as+anti-osteoporosis+agents&doi=10.1016%2FS0079-6468%2804%2942006-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin K inhibitors: their potential as anti-osteoporosis agents</span></div><div class="casAuthors">Deaton, David N.; Kumar, Sanjay</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">245-375</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5lac51vejU7Vg90H21EOLACvtfcHk0ljf7pBY7JylOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksF2qs7g%253D&md5=c1b2a00cf0aa73abbb2491012b3e78cd</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2804%2942006-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252804%252942006-2%26sid%3Dliteratum%253Aachs%26aulast%3DDeaton%26aufirst%3DD.%2BM.%26aulast%3DKumar%26aufirst%3DS.%26atitle%3D6.%2520Cathepsin%2520K%2520inhibitors%253A%2520their%2520potential%2520as%2520anti-osteoporosis%2520agents%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D42%26spage%3D245%26epage%3D375%26doi%3D10.1016%2FS0079-6468%2804%2942006-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Katunuma, N.</span><span> </span><span class="NLM_article-title">Structure-based development of specific inhibitors for individual cathepsins and their medical applications</span> <span class="citation_source-journal">Proc. Jpn. Acad., Ser. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.2183/pjab.87.29</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.2183%2Fpjab.87.29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt1alsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2011&pages=29-39&author=N.+Katunuma&title=Structure-based+development+of+specific+inhibitors+for+individual+cathepsins+and+their+medical+applications&doi=10.2183%2Fpjab.87.29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based development of specific inhibitors for individual cathepsins and their medical applications</span></div><div class="casAuthors">Katunuma, Nobuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Japan Academy, Series B: Physical and Biological Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">29-39</span>CODEN:
                <span class="NLM_cas:coden">PJABDW</span>;
        ISSN:<span class="NLM_cas:issn">0386-2208</span>.
    
            (<span class="NLM_cas:orgname">Nippon Gakushiin</span>)
        </div><div class="casAbstract">A review.  Specific inhibitors for individual cathepsins have been developed based on their tertiary structures of X-ray crystallog.  Cathepsin B-specific inhibitors, CA-074 and CA-030, and cathepsin L specific inhibitors, CLIK-148 and CLIK-195, were designed as the epoxysuccinate derivs.  Cathepsin S inhibitor, CLIK-060, and cathepsin K inhibitor, CLIK-166, were synthesized.  These inhibitors can use in vitro and also in vivo, and show no toxicity for exptl. animals by the amts. used as the cathepsin inhibitor.  Various cathepsins are used in the processing of antigenic proteins.  The CLIK-060 treatment to the autoimmune disease, Sjogren model mice, led to strongly suppress the expression of the pathol. symptoms.  Cathepsins L or K participates to the degrdn. of bone collagen.  The CLIK-148 protects osteoporosis in animals and also protects the bone metastasis of cancer cells.  Cathepsin L also enhances insulin-induced glucose uptake into 3T3-L1 adipocytes, suggesting cathepsin L plays the roles in adipogenesis and glucose tolerance in type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl9gYdvAtAJ7Vg90H21EOLACvtfcHk0ljf7pBY7JylOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt1alsL8%253D&md5=75d9e6e6b75de8093775dd148b808d44</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2183%2Fpjab.87.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2183%252Fpjab.87.29%26sid%3Dliteratum%253Aachs%26aulast%3DKatunuma%26aufirst%3DN.%26atitle%3DStructure-based%2520development%2520of%2520specific%2520inhibitors%2520for%2520individual%2520cathepsins%2520and%2520their%2520medical%2520applications%26jtitle%3DProc.%2520Jpn.%2520Acad.%252C%2520Ser.%2520B%26date%3D2011%26volume%3D87%26spage%3D29%26epage%3D39%26doi%3D10.2183%2Fpjab.87.29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Nomura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katunuma, N.</span><span> </span><span class="NLM_article-title">Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells</span> <span class="citation_source-journal">J. Med. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.2152/jmi.52.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.2152%2Fjmi.52.1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=1-9&author=T.+Nomuraauthor=N.+Katunuma&title=Involvement+of+cathepsins+in+the+invasion%2C+metastasis+and+proliferation+of+cancer+cells&doi=10.2152%2Fjmi.52.1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2152%2Fjmi.52.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2152%252Fjmi.52.1%26sid%3Dliteratum%253Aachs%26aulast%3DNomura%26aufirst%3DT.%26aulast%3DKatunuma%26aufirst%3DN.%26atitle%3DInvolvement%2520of%2520cathepsins%2520in%2520the%2520invasion%252C%2520metastasis%2520and%2520proliferation%2520of%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Invest.%26date%3D2005%26volume%3D52%26spage%3D1%26epage%3D9%26doi%3D10.2152%2Fjmi.52.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Turk, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, D.</span><span> </span><span class="NLM_article-title">Lysosomal cysteine proteases: facts and opportunities</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4629</span><span class="NLM_x">–</span> <span class="NLM_lpage">4633</span><span class="refDoi"> DOI: 10.1093/emboj/20.17.4629</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1093%2Femboj%2F20.17.4629" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=11532926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnt1CmtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=4629-4633&author=V.+Turkauthor=B.+Turkauthor=D.+Turk&title=Lysosomal+cysteine+proteases%3A+facts+and+opportunities&doi=10.1093%2Femboj%2F20.17.4629"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomal cysteine proteases: facts and opportunities</span></div><div class="casAuthors">Turk, Vito; Turk, Boris; Turk, Dusan</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4629-4633</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with 45 refs.  From their discovery in the 1st half of the 20th century, lysosomal cysteine proteases have come a long way: from being the enzymes nonselectively degrading proteins in lysosomes to being those responsible for a no. of important cellular processes.  Some of the features and roles of their structures, specificity, regulation and physiol. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0zs_42JgTMLVg90H21EOLACvtfcHk0ljf7pBY7JylOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnt1CmtrY%253D&md5=c9d0d915891974839ecf3862698cd093</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F20.17.4629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F20.17.4629%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DV.%26aulast%3DTurk%26aufirst%3DB.%26aulast%3DTurk%26aufirst%3DD.%26atitle%3DLysosomal%2520cysteine%2520proteases%253A%2520facts%2520and%2520opportunities%26jtitle%3DEMBO%2520J.%26date%3D2001%26volume%3D20%26spage%3D4629%26epage%3D4633%26doi%3D10.1093%2Femboj%2F20.17.4629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Turk, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoka, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasiljeva, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, D.</span><span> </span><span class="NLM_article-title">Cysteine cathepsins: from structure, function and regulation to new frontiers</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Proteins Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1824</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span><span class="refDoi"> DOI: 10.1016/j.bbapap.2011.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1016%2Fj.bbapap.2011.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=22024571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFOns7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1824&publication_year=2012&pages=68-88&author=V.+Turkauthor=V.+Stokaauthor=O.+Vasiljevaauthor=M.+Renkoauthor=T.+Sunauthor=B.+Turkauthor=D.+Turk&title=Cysteine+cathepsins%3A+from+structure%2C+function+and+regulation+to+new+frontiers&doi=10.1016%2Fj.bbapap.2011.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cysteine cathepsins: From structure, function and regulation to new frontiers</span></div><div class="casAuthors">Turk, Vito; Stoka, Veronika; Vasiljeva, Olga; Renko, Miha; Sun, Tao; Turk, Boris; Turk, Dusan</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1824</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">68-88</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  It is more than 50 years since the lysosome was discovered.  Since then its hydrolytic machinery, including proteases and other hydrolases, has been fairly well identified and characterized.  Among these are the cysteine cathepsins, members of the family of papain-like cysteine proteases.  They have unique reactive-site properties and an uneven tissue-specific expression pattern.  In living organisms, their activity is a delicate balance of expression, targeting, zymogen activation, inhibition by protein inhibitors and degrdn.  The specificity of their substrate binding sites, small-mol. inhibitor repertoire and crystal structures are providing new tools for research and development.  Their unique reactive-site properties have made it possible to confine the targets simply by the use of appropriate reactive groups.  The epoxysuccinyls still dominate the field, but now nitriles seem to be the most appropriate "warhead".  The view of cysteine cathepsins as lysosomal proteases is changing as there is now clear evidence of their localization in other cellular compartments.  Besides being involved in protein turnover, they build an important part of endosomal antigen presentation.  Together with the growing no. of non-endosomal roles of cysteine cathepsins is growing also the knowledge of their involvement in diseases such as cancer and rheumatoid arthritis, among others.  Finally, cysteine cathepsins are important regulators and signaling mols. of an unimaginable no. of biol. processes.  The current challenge is to identify their endogenous substrates, in order to gain an insight into the mechanisms of substrate degrdn. and processing.  In this review, some of the remarkable advances that have taken place in the past decade are presented.  This article is part of a Special Issue entitled: Proteolysis 50 years after the discovery of lysosome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUEZ0u2P21D7Vg90H21EOLACvtfcHk0ljddwWJX6xCuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFOns7rI&md5=8615c1f0205d66b0fad932d6ff874390</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2011.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2011.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DV.%26aulast%3DStoka%26aufirst%3DV.%26aulast%3DVasiljeva%26aufirst%3DO.%26aulast%3DRenko%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DT.%26aulast%3DTurk%26aufirst%3DB.%26aulast%3DTurk%26aufirst%3DD.%26atitle%3DCysteine%2520cathepsins%253A%2520from%2520structure%252C%2520function%2520and%2520regulation%2520to%2520new%2520frontiers%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2012%26volume%3D1824%26spage%3D68%26epage%3D88%26doi%3D10.1016%2Fj.bbapap.2011.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Aguda, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panwar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brayer, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brömme, D.</span><span> </span><span class="NLM_article-title">Structural basis of collagen fiber degradation by cathepsin K</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">17474</span><span class="NLM_x">–</span> <span class="NLM_lpage">17479</span><span class="refDoi"> DOI: 10.1073/pnas.1414126111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1073%2Fpnas.1414126111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=25422423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKmu7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=17474-17479&author=A.+H.+Agudaauthor=P.+Panwarauthor=X.+Duauthor=N.+T.+Nguyenauthor=G.+D.+Brayerauthor=D.+Br%C3%B6mme&title=Structural+basis+of+collagen+fiber+degradation+by+cathepsin+K&doi=10.1073%2Fpnas.1414126111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of collagen fiber degradation by cathepsin K</span></div><div class="casAuthors">Aguda, Adeleke H.; Panwar, Preety; Du, Xin; Nguyen, Nham T.; Brayer, Gary D.; Bromme, Dieter</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">17474-17479</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Cathepsin K (I) is the major collagenolytic protease in bone that facilitates physiol. as well as pathol. bone degrdn.  Despite its key role in bone remodeling and for being a highly sought-after drug target for the treatment of osteoporosis, the mechanism of collagen fiber degrdn. by I remained elusive.  Here, the authors report the structure of a collagenolytically active I protein dimer.  I is organized into elongated C-shaped protease dimers that reveal a putative collagen-binding interface aided by glycosaminoglycans.  Mol. modeling of collagen binding to the dimer indicated the participation of non-active site residues, Gln-21 and Gln-92, in collagen unfolding.  Mutations at these sites as well as perturbation of the dimer protein-protein interface completely inhibited I-mediated fiber degrdn. without affecting the hydrolysis of gelatin or synthetic peptides.  Using SEM, the authors demonstrated the specific binding of I at the edge of the fibrillar gap region of collagen fibers, which suggested initial cleavage events at the N- and C-terminal ends of tropocollagen mols.  Edman degrdn. anal. of collagen fiber degrdn. products revealed those initial cleavage sites.  The authors propose that one I mol. binds to collagen-bound glycosaminoglycans at the gap region and recruits a 2nd protease mol. that provides an unfolding and cleavage mechanism for triple helical collagen.  Removal of collagen-assocd. glycosaminoglycans prevents I binding and subsequently fiber hydrolysis.  I dimer and glycosaminoglycan binding sites represent novel targeting sites for the development of non-active site-directed 2nd-generation inhibitors of this important drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrq5uozwCNg7Vg90H21EOLACvtfcHk0ljddwWJX6xCuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKmu7rM&md5=25e4c1be01bc9b16fa126134659a7441</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1414126111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1414126111%26sid%3Dliteratum%253Aachs%26aulast%3DAguda%26aufirst%3DA.%2BH.%26aulast%3DPanwar%26aufirst%3DP.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DNguyen%26aufirst%3DN.%2BT.%26aulast%3DBrayer%26aufirst%3DG.%2BD.%26aulast%3DBr%25C3%25B6mme%26aufirst%3DD.%26atitle%3DStructural%2520basis%2520of%2520collagen%2520fiber%2520degradation%2520by%2520cathepsin%2520K%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D17474%26epage%3D17479%26doi%3D10.1073%2Fpnas.1414126111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Hua, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, S.</span><span> </span><span class="NLM_article-title">Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Basis Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">1852</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span><span class="refDoi"> DOI: 10.1016/j.bbadis.2014.04.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1016%2Fj.bbadis.2014.04.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=24815358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotlOqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1852&publication_year=2015&pages=195-208&author=Y.+Huaauthor=S.+Nair&title=Proteases+in+cardiometabolic+diseases%3A+Pathophysiology%2C+molecular+mechanisms+and+clinical+applications&doi=10.1016%2Fj.bbadis.2014.04.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications</span></div><div class="casAuthors">Hua, Yinan; Nair, Sreejayan</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1852</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-208</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Cardiovascular disease is the leading cause of death in the U.S. and other developed countries.  Metabolic syndrome, including obesity, diabetes/insulin resistance, hypertension and dyslipidemia is a major threat for public health in the modern society.  It is well established that metabolic syndrome contributes to the development of cardiovascular disease collective called as cardiometabolic disease.  Despite documented studies in the research field of cardiometabolic disease, the underlying mechanisms are far from clear.  Proteases are enzymes that break down proteins, many of which have been implicated in various diseases including cardiac disease.  Matrix metalloproteinase (MMP), calpain, cathepsin and caspase are among the major proteases involved in cardiac remodeling.  Recent studies have also implicated proteases in the pathogenesis of cardiometabolic disease.  Elevated expression and activities of proteases in atherosclerosis, coronary heart disease, obesity/insulin-assocd. heart disease as well as hypertensive heart disease have been documented.  Furthermore, transgenic animals that are deficient in or over-express proteases allow scientists to understand the causal relationship between proteases and cardiometabolic disease.  Mechanistically, MMPs and cathepsins exert their effect on cardiometabolic diseases mainly through modifying the extracellular matrix.  However, MMP and cathepsin are also reported to affect intracellular proteins, by which they contribute to the development of cardiometabolic diseases.  On the other hand, activation of calpain and caspases has been shown to influence intracellular signaling cascade including the NF-κB and apoptosis pathways.  Clin., proteases are reported to function as biomarkers of cardiometabolic diseases.  More importantly, the inhibitors of proteases are credited with beneficial cardiometabolic profile, although the exact mol. mechanisms underlying these salutary effects are still under investigation.  A better understanding of the role of MMPs, cathepsins, calpains and caspases in cardiometabolic diseases process may yield novel therapeutic targets for treating or controlling these diseases.  This article is part of a Special Issue entitled: Autophagy and protein quality control in cardiometabolic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWm9CSuGAt77Vg90H21EOLACvtfcHk0ljddwWJX6xCuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotlOqt7s%253D&md5=e23b20735ac3c18cb1332cb64af81eef</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2014.04.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2014.04.032%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DY.%26aulast%3DNair%26aufirst%3DS.%26atitle%3DProteases%2520in%2520cardiometabolic%2520diseases%253A%2520Pathophysiology%252C%2520molecular%2520mechanisms%2520and%2520clinical%2520applications%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2015%26volume%3D1852%26spage%3D195%26epage%3D208%26doi%3D10.1016%2Fj.bbadis.2014.04.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Nagase, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manako, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, S.</span><span> </span><span class="NLM_article-title">Bone turnover markers and pharmacokinetics of a new sustained-release formulation of the cathepsin K inhibitor, ONO-5334, in healthy post-menopausal women</span> <span class="citation_source-journal">J. Bone Miner. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span><span class="refDoi"> DOI: 10.1007/s00774-013-0558-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1007%2Fs00774-013-0558-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2015&pages=93-100&author=S.+Nagaseauthor=M.+Ohyamaauthor=Y.+Hashimotoauthor=M.+Smallauthor=J.+Sharpeauthor=J.+Manakoauthor=T.+Kuwayamaauthor=S.+Deacon&title=Bone+turnover+markers+and+pharmacokinetics+of+a+new+sustained-release+formulation+of+the+cathepsin+K+inhibitor%2C+ONO-5334%2C+in+healthy+post-menopausal+women&doi=10.1007%2Fs00774-013-0558-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs00774-013-0558-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00774-013-0558-2%26sid%3Dliteratum%253Aachs%26aulast%3DNagase%26aufirst%3DS.%26aulast%3DOhyama%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DSmall%26aufirst%3DM.%26aulast%3DSharpe%26aufirst%3DJ.%26aulast%3DManako%26aufirst%3DJ.%26aulast%3DKuwayama%26aufirst%3DT.%26aulast%3DDeacon%26aufirst%3DS.%26atitle%3DBone%2520turnover%2520markers%2520and%2520pharmacokinetics%2520of%2520a%2520new%2520sustained-release%2520formulation%2520of%2520the%2520cathepsin%2520K%2520inhibitor%252C%2520ONO-5334%252C%2520in%2520healthy%2520post-menopausal%2520women%26jtitle%3DJ.%2520Bone%2520Miner.%2520Metab.%26date%3D2015%26volume%3D33%26spage%3D93%26epage%3D100%26doi%3D10.1007%2Fs00774-013-0558-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Cheng, X. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuzuya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murohara, T.</span><span> </span><span class="NLM_article-title">Role for cysteine protease cathepsins in heart disease: focus on biology and mechanisms with clinical implication</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">1551</span><span class="NLM_x">–</span> <span class="NLM_lpage">1562</span><span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.111.066712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1161%2FCIRCULATIONAHA.111.066712" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2012&pages=1551-1562&author=X.+W.+Chengauthor=G.+P.+Shiauthor=M.+Kuzuyaauthor=T.+Sasakiauthor=K.+Okumuraauthor=T.+Murohara&title=Role+for+cysteine+protease+cathepsins+in+heart+disease%3A+focus+on+biology+and+mechanisms+with+clinical+implication&doi=10.1161%2FCIRCULATIONAHA.111.066712"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.111.066712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.111.066712%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DX.%2BW.%26aulast%3DShi%26aufirst%3DG.%2BP.%26aulast%3DKuzuya%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DOkumura%26aufirst%3DK.%26aulast%3DMurohara%26aufirst%3DT.%26atitle%3DRole%2520for%2520cysteine%2520protease%2520cathepsins%2520in%2520heart%2520disease%253A%2520focus%2520on%2520biology%2520and%2520mechanisms%2520with%2520clinical%2520implication%26jtitle%3DCirculation%26date%3D2012%26volume%3D125%26spage%3D1551%26epage%3D1562%26doi%3D10.1161%2FCIRCULATIONAHA.111.066712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Brömme, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecaille, F.</span><span> </span><span class="NLM_article-title">Cathepsin K inhibitors for osteoporosis and potential off-target effects</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">585</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span><span class="refDoi"> DOI: 10.1517/13543780902832661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1517%2F13543780902832661" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=585-600&author=D.+Br%C3%B6mmeauthor=F.+Lecaille&title=Cathepsin+K+inhibitors+for+osteoporosis+and+potential+off-target+effects&doi=10.1517%2F13543780902832661"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1517%2F13543780902832661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543780902832661%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25B6mme%26aufirst%3DD.%26aulast%3DLecaille%26aufirst%3DF.%26atitle%3DCathepsin%2520K%2520inhibitors%2520for%2520osteoporosis%2520and%2520potential%2520off-target%2520effects%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D18%26spage%3D585%26epage%3D600%26doi%3D10.1517%2F13543780902832661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Vassalle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iervasi, G.</span><span> </span><span class="NLM_article-title">Cathepsin K - A classical bone biomarker in cardiovascular disease: The heart is not alone anymore</span> <span class="citation_source-journal">Atherosclerosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">228</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span><span class="refDoi"> DOI: 10.1016/j.atherosclerosis.2013.01.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1016%2Fj.atherosclerosis.2013.01.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2013&pages=36-37&author=C.+Vassalleauthor=G.+Iervasi&title=Cathepsin+K+-+A+classical+bone+biomarker+in+cardiovascular+disease%3A+The+heart+is+not+alone+anymore&doi=10.1016%2Fj.atherosclerosis.2013.01.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.atherosclerosis.2013.01.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.atherosclerosis.2013.01.042%26sid%3Dliteratum%253Aachs%26aulast%3DVassalle%26aufirst%3DC.%26aulast%3DIervasi%26aufirst%3DG.%26atitle%3DCathepsin%2520K%2520-%2520A%2520classical%2520bone%2520biomarker%2520in%2520cardiovascular%2520disease%253A%2520The%2520heart%2520is%2520not%2520alone%2520anymore%26jtitle%3DAtherosclerosis%26date%3D2013%26volume%3D228%26spage%3D36%26epage%3D37%26doi%3D10.1016%2Fj.atherosclerosis.2013.01.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Hua, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolence, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, S.</span><span> </span><span class="NLM_article-title">Cathepsin K knockout mitigates high-fat diet-induced cardiac hypertrophy and contractile dysfunction</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span><span class="refDoi"> DOI: 10.2337/db12-0350</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.2337%2Fdb12-0350" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=498-509&author=Y.+Huaauthor=Y.+Zhangauthor=J.+Dolenceauthor=G.+P.+Shiauthor=J.+Renauthor=S.+Nair&title=Cathepsin+K+knockout+mitigates+high-fat+diet-induced+cardiac+hypertrophy+and+contractile+dysfunction&doi=10.2337%2Fdb12-0350"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2337%2Fdb12-0350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb12-0350%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDolence%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DG.%2BP.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DNair%26aufirst%3DS.%26atitle%3DCathepsin%2520K%2520knockout%2520mitigates%2520high-fat%2520diet-induced%2520cardiac%2520hypertrophy%2520and%2520contractile%2520dysfunction%26jtitle%3DDiabetes%26date%3D2013%26volume%3D62%26spage%3D498%26epage%3D509%26doi%3D10.2337%2Fdb12-0350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Frizler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirnberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisay, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gütschow, M.</span><span> </span><span class="NLM_article-title">Development of Nitrile-Based Peptidic Inhibitors of Cysteine Cathepsins</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span><span class="refDoi"> DOI: 10.2174/156802610790725452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.2174%2F156802610790725452" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=20166952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1entL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=294-322&author=M.+Frizlerauthor=M.+Stirnbergauthor=M.+T.+Sisayauthor=M.+G%C3%BCtschow&title=Development+of+Nitrile-Based+Peptidic+Inhibitors+of+Cysteine+Cathepsins&doi=10.2174%2F156802610790725452"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Development of nitrile-based peptidic inhibitors of cysteine cathepsins</span></div><div class="casAuthors">Frizler, Maxim; Stirnberg, Marit; Sisay, Mihiret Tekeste; Guetschow, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">294-322</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  It is now becoming clear that several papain-like cysteine cathepsins are involved in the pathophysiol. of diseases such as osteoporosis, autoimmune disorders, and cancer.  Therefore, the development of potent and selective cathepsin inhibitors is an attractive subject for medicinal chemists.  New advances have been made for nitrile-based inhibitors, leading to the identification of the cathepsin K inhibitor odanacatib and other candidates with potential for therapeutic use.  This review summarizes the development of peptidic and peptidomimetic compds. with an electrophilic nitrile 'warhead' as inhibitors of the cysteine cathepsins B, S, L, C, and K.  Peptide nitriles have been shown to reversibly react with the active site cysteine under formation of a covalent thioimidate adduct.  The structural optimization with respect to the positions P3, P2, P1, P1', and P2' resulted in the identification of potent and selective inhibitors of the corresponding cathepsins.  The underlying structure-activity relationships are discussed herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxV5N3L7sVS7Vg90H21EOLACvtfcHk0lj_cswk3T6ApA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1entL8%253D&md5=8b0004f6aca64540b7f206ecc8527ff4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F156802610790725452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610790725452%26sid%3Dliteratum%253Aachs%26aulast%3DFrizler%26aufirst%3DM.%26aulast%3DStirnberg%26aufirst%3DM.%26aulast%3DSisay%26aufirst%3DM.%2BT.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520Nitrile-Based%2520Peptidic%2520Inhibitors%2520of%2520Cysteine%2520Cathepsins%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D294%26epage%3D322%26doi%3D10.2174%2F156802610790725452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Wijkmans, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gossen, J.</span><span> </span><span class="NLM_article-title">Inhibitors of cathepsin K: a patent review (2004 - 2010)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1611</span><span class="NLM_x">–</span> <span class="NLM_lpage">1629</span><span class="refDoi"> DOI: 10.1517/13543776.2011.616283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1517%2F13543776.2011.616283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=21923554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2jsLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1611-1629&author=J.+Wijkmansauthor=J.+Gossen&title=Inhibitors+of+cathepsin+K%3A+a+patent+review+%282004+-+2010%29&doi=10.1517%2F13543776.2011.616283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of cathepsin K: a patent review (2004 - 2010)</span></div><div class="casAuthors">Wijkmans, Jac; Gossen, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1611-1629</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction:Cathepsin K is a lysosomal cysteine protease involved in osteoclast-mediated bone resorption.  Inhibition of cathepsin K represents a potentially attractive therapeutic approach for treating diseases characterized by excessive bone resorption, such as osteoporosis.  Areas covered:The present review provides an overview of low mol. wt. cathepsin K inhibitors published in the patent literature from July 2004 to 2010.  Different chemotypes are surveyed and listed according to electrophilic warhead type.  Relevant information from original research articles in peer-reviewed journals and clin. investigations is also described.  Expert opinion:Between 2004 and 2010, more than 50 patent applications have appeared, underlining the continued interest in small mol. cathepsin K inhibition for therapeutic intervention.  Most compds. claimed are peptide-derived inhibitors displaying a reversible binding nitrile or ketone warhead.  The success of these compds. in the clinic will be detd. by the selectivity that can be achieved against other off-target cathepsin.  In this respect, eliminating lysosomotropic characteristics may prove to be crucial in the design of selective cathepsin K inhibitors.  During the review period, ONO-5334 and odanacatib have progressed to Phase II and Phase III clin. trials, resp.  The results of these studies are eagerly awaited and may det. the future of these agents as disease-modifying therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpewEY2N2yCN7Vg90H21EOLACvtfcHk0ljbvDUPJoJk8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2jsLnN&md5=7d46cbea0f4fcbf6bb5565272dd5a3a9</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.616283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.616283%26sid%3Dliteratum%253Aachs%26aulast%3DWijkmans%26aufirst%3DJ.%26aulast%3DGossen%26aufirst%3DJ.%26atitle%3DInhibitors%2520of%2520cathepsin%2520K%253A%2520a%2520patent%2520review%2520%25282004%2520-%25202010%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D1611%26epage%3D1629%26doi%3D10.1517%2F13543776.2011.616283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Chapurlat, R. D.</span><span> </span><span class="NLM_article-title">Treatment of postmenopausal osteoporosis with odanacatib</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1517/14656566.2014.881470</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1517%2F14656566.2014.881470" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=24456412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFamtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=559-564&author=R.+D.+Chapurlat&title=Treatment+of+postmenopausal+osteoporosis+with+odanacatib&doi=10.1517%2F14656566.2014.881470"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of postmenopausal osteoporosis with odanacatib</span></div><div class="casAuthors">Chapurlat, Roland D.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">559-564</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The market of antiosteoporosis drugs has been declining in recent years, possibly in part due to the publicity around adverse events obsd. with bisphosphonates.  Also, the proportion of patients with clin. fracture who receive adequate treatment remains low.  So there are still unmet needs in this field. is a cathepsin K inhibitor currently being developed for the treatment of postmenopausal osteoporosis that could be an advance in this context.  Areas covered: Odanacatib is a bone resorption inhibitor, but it preserves some degree of bone formation, which differentiates this new family of drugs from existing therapies.  Odanacatib increases bone mineral d. at the spine and hip, improves estd. bone strength using finite element anal. at the spine and hip as well as at the distal tibia and radius.  The safety profile has been satisfactory so far.  A robust antifracture efficacy has been announced when the Phase III pivotal trial was terminated after interim anal., but we do not yet have access to the complete results.  Expert opinion: Odanacatib may have an important role in future guidelines if it provides a substantial advantage compared to the effective and inexpensive current generic drugs, in terms of antifracture efficacy or safety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopvs10g2jS8bVg90H21EOLACvtfcHk0ljbvDUPJoJk8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFamtrY%253D&md5=c102af0fc54035b87cb7051060a83c06</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F14656566.2014.881470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2014.881470%26sid%3Dliteratum%253Aachs%26aulast%3DChapurlat%26aufirst%3DR.%2BD.%26atitle%3DTreatment%2520of%2520postmenopausal%2520osteoporosis%2520with%2520odanacatib%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2014%26volume%3D15%26spage%3D559%26epage%3D564%26doi%3D10.1517%2F14656566.2014.881470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Engelke, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagase, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuerst, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genant, H. K.</span><span> </span><span class="NLM_article-title">The Effect of the Cathepsin K Inhibitor ONO-5334 on Trabecular and Cortical Bone in Postmenopausal Osteoporosis: The OCEAN Study</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">629</span><span class="NLM_x">–</span> <span class="NLM_lpage">638</span><span class="refDoi"> DOI: 10.1002/jbmr.2080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1002%2Fjbmr.2080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=24038152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjt1Sgsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2014&pages=629-638&author=K.+Engelkeauthor=S.+Nagaseauthor=T.+Fuerstauthor=M.+Smallauthor=T.+Kuwayamaauthor=S.+Deaconauthor=R.+Eastellauthor=H.+K.+Genant&title=The+Effect+of+the+Cathepsin+K+Inhibitor+ONO-5334+on+Trabecular+and+Cortical+Bone+in+Postmenopausal+Osteoporosis%3A+The+OCEAN+Study&doi=10.1002%2Fjbmr.2080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The Effect of the Cathepsin K Inhibitor ONO-5334 on Trabecular and Cortical Bone in Postmenopausal Osteoporosis: The OCEAN Study</span></div><div class="casAuthors">Engelke, Klaus; Nagase, Shinichi; Fuerst, Thomas; Small, Maria; Kuwayama, Tomohiro; Deacon, Stephen; Eastell, Richard; Genant, Harry K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">629-638</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">ONO-5334 (Ono Pharmaceutical Co., Ltd., Osaka, Japan) inhibits cathepsin K and has been shown to increase areal bone mineral d. (BMD) at the hip and spine in postmenopausal osteoporosis.  Quant. computed tomog. (QCT) allows the study of the cortical and trabecular bone sep. and provides structural information such as cortical thickness.  We investigated the impact of 2 years of cathepsin K inhibition on these different bone compartments with ONO-5334.  The clin. study was a randomized, double-blind, placebo, and active controlled parallel group study conducted in 13 centers in six European countries.  The original study period of 12 mo was extended by another 12 mo.  A total of 147 subjects (age 55-75 years) of the QCT substudy who participated in the extension period were included.  Subjects had been randomized into one of five treatment arms: placebo; ONO-5334 50 mg twice per day (BID); ONO-5334 100 mg once daily (QD); ONO-5334 300 mg QD; or alendronate 70 mg once weekly (QW).  QCT was obtained to evaluate bone structure at the lumbar spine and proximal femur.  After 24 mo ONO-5334 showed statistically significant increases vs. placebo for integral, trabecular, and cortical BMD at the spine and the hip (for ONO-5334 300 mg QD, BMD increases were 10.5%, 7.1%, and 13.4% for integral, cortical, and trabecular BMD at the spine, resp., and 6.2%, 3.4%, and 14.6% for integral, cortical, and trabecular total femur BMD, resp.).  Changes in cortical and trabecular BMD in the spine and hip were similar for alendronate as for ONO-5334.  Integral vol. did not demonstrate statistically significant changes under ONO-5334 treatment, thus there was no evidence of periosteal apposition, neither at the spine nor at the femur.  Cortical thickness changes were not statistically significant for ONO-5334 in the spine and hip, with exception of a 2.1% increase after month 24 in the intertrochanter for ONO-5334 300 mg QD.  Over 2 years ONO-5334 showed a statistically significant and persistent increase of trabecular and integral BMD at the spine and the hip.  Cortical BMD also progressively increased but at a lower rate.  Changes in bone size and of periosteal apposition were not obsd. 2014 American Society for Bone and Mineral Research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx-HiYdqkuWrVg90H21EOLACvtfcHk0ljbvDUPJoJk8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjt1Sgsbc%253D&md5=91d8549ae224522b701668e864f00a34</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fjbmr.2080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjbmr.2080%26sid%3Dliteratum%253Aachs%26aulast%3DEngelke%26aufirst%3DK.%26aulast%3DNagase%26aufirst%3DS.%26aulast%3DFuerst%26aufirst%3DT.%26aulast%3DSmall%26aufirst%3DM.%26aulast%3DKuwayama%26aufirst%3DT.%26aulast%3DDeacon%26aufirst%3DS.%26aulast%3DEastell%26aufirst%3DR.%26aulast%3DGenant%26aufirst%3DH.%2BK.%26atitle%3DThe%2520Effect%2520of%2520the%2520Cathepsin%2520K%2520Inhibitor%2520ONO-5334%2520on%2520Trabecular%2520and%2520Cortical%2520Bone%2520in%2520Postmenopausal%2520Osteoporosis%253A%2520The%2520OCEAN%2520Study%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2014%26volume%3D29%26spage%3D629%26epage%3D638%26doi%3D10.1002%2Fjbmr.2080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Duong, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickarski, M.</span><span> </span><span class="NLM_article-title">Efficacy of a Cathepsin K Inhibitor in a Preclinical Model for Prevention and Treatment of Breast Cancer Bone Metastasis</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2898</span><span class="NLM_x">–</span> <span class="NLM_lpage">2909</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-14-0253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1158%2F1535-7163.MCT-14-0253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=25249554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVCju7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=2898-2909&author=L.+T.+Duongauthor=G.+A.+Wesolowskiauthor=P.+Leungauthor=R.+Oballaauthor=M.+Pickarski&title=Efficacy+of+a+Cathepsin+K+Inhibitor+in+a+Preclinical+Model+for+Prevention+and+Treatment+of+Breast+Cancer+Bone+Metastasis&doi=10.1158%2F1535-7163.MCT-14-0253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of a Cathepsin K Inhibitor in a Preclinical Model for Prevention and Treatment of Breast Cancer Bone Metastasis</span></div><div class="casAuthors">Duong, Le T.; Wesolowski, Gregg A.; Leung, Patrick; Oballa, Renata; Pickarski, Maureen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2898-2909</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cathepsin K (CatK) is essential for osteoclast-mediated bone resorption.  CatK expression is also detected in breast cancer cells that metastasize to bone.  Here, the CatK inhibitor L-235 dosed in prevention (10, 30, and 100 mg/kg, p.o., b.i.d.) or treatment regimen (30 mg/kg) was compared with the bisphosphonate zoledronic acid (ZOL, 7.5 μg/kg/wk, s.c.) in the intratibial injection model of MDA-MB-231 breast carcinoma in nude rats.  Progression of osteolysis, skeletal tumor burden, and local metastasis was evaluated by radiog. through 42 days and ex vivo μCT and histol.  IHC and RT-PCR confirmed the increases in CatK protein and mRNA levels in human breast cancer primary and metastatic tumors.  In the exptl. model of breast cancer bone metastasis, L-235 dosed in preventive mode resulted in a dose-related redn. of osteolysis of 72%, 75%, and 87% resp., compared with ZOL by 86% vs. intact.  Similarly, L-235 significantly reduced intratibial tumor vol. by 29%, 40%, and 63%, resp., compared with 56% by ZOL vs. vehicle.  Efficacy of L-235 and ZOL on redn. of osteolytic lesions and tumor burden was comparable in treatment vs. preventive regimens.  All L-235 doses inhibited cortical disruption and extraskeletal tumor growth to a level comparable with ZOL.  Assessment of local metastasis demonstrated that treatment with the CatK inhibitor was more effective than ZOL in reducing breast cancer invasion.  These data support the role of CatK in breast cancer skeletal growth and metastasis and CatK inhibitors may represent a novel oral therapy for treatment of metastatic breast cancer.  Mol Cancer Ther; 13(12); 2898-909. 2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhrElug3rOBrVg90H21EOLACvtfcHk0lhL_jNObd5A0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVCju7vE&md5=42c6bca739efd821458aea99c403fd8e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-14-0253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-14-0253%26sid%3Dliteratum%253Aachs%26aulast%3DDuong%26aufirst%3DL.%2BT.%26aulast%3DWesolowski%26aufirst%3DG.%2BA.%26aulast%3DLeung%26aufirst%3DP.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DPickarski%26aufirst%3DM.%26atitle%3DEfficacy%2520of%2520a%2520Cathepsin%2520K%2520Inhibitor%2520in%2520a%2520Preclinical%2520Model%2520for%2520Prevention%2520and%2520Treatment%2520of%2520Breast%2520Cancer%2520Bone%2520Metastasis%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2014%26volume%3D13%26spage%3D2898%26epage%3D2909%26doi%3D10.1158%2F1535-7163.MCT-14-0253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukunaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomomitsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santora, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagomi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsubouchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchida, S.</span><span> </span><span class="NLM_article-title">Effect of the cathepsin K inhibitor odanacatib administered once weekly on bone mineral density in Japanese patients with osteoporosis-a double-blind, randomized, dose-finding study</span> <span class="citation_source-journal">Osteoporosis Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">376</span><span class="refDoi"> DOI: 10.1007/s00198-013-2398-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1007%2Fs00198-013-2398-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=23716037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlCksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2014&pages=367-376&author=T.+Nakamuraauthor=M.+Shirakiauthor=M.+Fukunagaauthor=T.+Tomomitsuauthor=A.+C.+Santoraauthor=R.+Tsaiauthor=G.+Fujimotoauthor=M.+Nakagomiauthor=H.+Tsubouchiauthor=E.+Rosenbergauthor=S.+Uchida&title=Effect+of+the+cathepsin+K+inhibitor+odanacatib+administered+once+weekly+on+bone+mineral+density+in+Japanese+patients+with+osteoporosis-a+double-blind%2C+randomized%2C+dose-finding+study&doi=10.1007%2Fs00198-013-2398-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the cathepsin K inhibitor odanacatib administered once weekly on bone mineral density in Japanese patients with osteoporosis-a double-blind, randomized, dose-finding study</span></div><div class="casAuthors">Nakamura, T.; Shiraki, M.; Fukunaga, M.; Tomomitsu, T.; Santora, A. C.; Tsai, R.; Fujimoto, G.; Nakagomi, M.; Tsubouchi, H.; Rosenberg, E.; Uchida, S.</div><div class="citationInfo"><span class="NLM_cas:title">Osteoporosis International</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">367-376</span>CODEN:
                <span class="NLM_cas:coden">OSINEP</span>;
        ISSN:<span class="NLM_cas:issn">0937-941X</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag London Ltd.</span>)
        </div><div class="casAbstract">Summary: The efficacy and safety of oral placebo or odanacatib 10, 25, or 50 mg once weekly for 52 wk were evaluated in a double-blind, randomized, multi-center study in Japanese female and male patients with osteoporosis.  Introduction: Odanacatib is a selective and reversible cathepsin K inhibitor that decreases bone resorption and increases bone mineral d. (BMD).  Methods: The primary efficacy endpoint was percent change from baseline to week 52 in lumbar spine BMD.  Secondary endpoints included percent change in total hip, femoral neck, and trochanter BMD and in bone biomarkers after treatment for 52 wk.  Results: In this study, 286 patients [94 % female, mean age (SD) 68.2 (7.1) years] were included in the anal.  The least-squares mean percent changes from baseline to week 52 in the groups receiving placebo, 10, 25 and 50 mg of odanacatib for lumbar spine (L1∼L4) BMD were 0.5, 4.1, 5.7, and 5.9 % and for total hip BMD were -0.4, 1.3, 1.8, and 2.7 %, resp.  The changes in femoral neck and trochanter BMD were similar to those at the total hip.  Bone turnover markers were reduced in a dose-dependent manner.  However, the effects of odanacatib on bone formation markers were less compared with the effects on bone resorption markers.  Tolerability and safety profiles were similar among all treatment groups with no dose-related trends in any adverse events.  Conclusions: Weekly odanacatib treatment for 52 wk increased BMD at the lumbar spine and at all hip sites in a dose-dependent manner and was well tolerated in Japanese patients with osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoemcWV-4GgxrVg90H21EOLACvtfcHk0lhL_jNObd5A0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlCksQ%253D%253D&md5=4240c5cdad454936bffede88656ba191</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs00198-013-2398-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00198-013-2398-2%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DShiraki%26aufirst%3DM.%26aulast%3DFukunaga%26aufirst%3DM.%26aulast%3DTomomitsu%26aufirst%3DT.%26aulast%3DSantora%26aufirst%3DA.%2BC.%26aulast%3DTsai%26aufirst%3DR.%26aulast%3DFujimoto%26aufirst%3DG.%26aulast%3DNakagomi%26aufirst%3DM.%26aulast%3DTsubouchi%26aufirst%3DH.%26aulast%3DRosenberg%26aufirst%3DE.%26aulast%3DUchida%26aufirst%3DS.%26atitle%3DEffect%2520of%2520the%2520cathepsin%2520K%2520inhibitor%2520odanacatib%2520administered%2520once%2520weekly%2520on%2520bone%2520mineral%2520density%2520in%2520Japanese%2520patients%2520with%2520osteoporosis-a%2520double-blind%252C%2520randomized%252C%2520dose-finding%2520study%26jtitle%3DOsteoporosis%2520Int.%26date%3D2014%26volume%3D25%26spage%3D367%26epage%3D376%26doi%3D10.1007%2Fs00198-013-2398-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Brixen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapurlat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keaveny, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuerst, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelke, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dardzinski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbruggen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ather, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Papp, A. E.</span><span> </span><span class="NLM_article-title">Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trial</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span><span class="refDoi"> DOI: 10.1210/jc.2012-2972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1210%2Fjc.2012-2972" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=23337728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlOks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2013&pages=571-580&author=K.+Brixenauthor=R.+Chapurlatauthor=A.+M.+Cheungauthor=T.+M.+Keavenyauthor=T.+Fuerstauthor=K.+Engelkeauthor=R.+Reckerauthor=B.+Dardzinskiauthor=N.+Verbruggenauthor=S.+Atherauthor=E.+Rosenbergauthor=A.+E.+de+Papp&title=Bone+density%2C+turnover%2C+and+estimated+strength+in+postmenopausal+women+treated+with+odanacatib%3A+a+randomized+trial&doi=10.1210%2Fjc.2012-2972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trial</span></div><div class="casAuthors">Brixen, Kim; Chapurlat, Roland; Cheung, Angela M.; Keaveny, Tony M.; Fuers, Thomas; Engelke, Klaus; Recker, Robert; Dardzinski, Bernard; Verbruggen, Nadia; Ather, Shabana; Rosenberg, Elizabeth; de Papp, Anne E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">571-580</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Context: Odanacatib, a cathepsin K inhibitor, increases spine and hip areal bone mineral d. (BMD) in postmenopausal women with low BMD and cortical thickness in ovariectomized monkeys.  Objective: The objective of the study was to examine the impact of odanacatib on the trabecular and cortical bone compartments and estd. strength at the hip and spine.  Design: This was a randomized, double-blind, 2-yr trial.  Setting: The study was conducted at a private or institutional practice.  Participants: Participants included 214 postmenopausal women with low areal BMD.  Intervention: The intervention included odanacatib 50 mg or placebo weekly.  Main Outcome Measures: Changes in areal BMD by dual-energy x-ray absorptiometry (primary end point, 1 yr areal BMD change at lumbar spine), bone turnover markers, volumetric BMD by quant. computed tomog. (QCT), and bone strength estd. by finite element anal. were measured.  Results: Year 1 lumbar spine areal BMD percent change from baseline was 3.5% greater with odanacatib than placebo (P < .001).  Bone-resorption marker C-telopeptide of type 1 collagen was significantly lower with odanacatib vs placebo at 6 mo and 2 years (P < .001).  Bone-formation marker procollagen I N-terminal peptide initially decreased with odanacatib but by 2 years did not differ from placebo.  After 6 mo, odanacatib-treated women had greater increases in trabecular volumetric BMD and estd. compressive strength at the spine and integral and trabecular volumetric BMD and estd. strength at the hip (P < .001).  At the cortical envelope of the femoral neck, bone mineral content, thickness, vol., and cross-sectional area also increased from baseline with odanacatib vs placebo (P < .001 at 24 mo).  Adverse experiences were similar between groups.  Conclusions: Over 2 years, odanacatib decreased bone resorption, maintained bone formation, increased areal and volumetric BMD, and increased estd. bone strength at both the hip and spine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5IgjyjsYm47Vg90H21EOLACvtfcHk0lhL_jNObd5A0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlOks74%253D&md5=2dc289cb3ccc6576fb66711b6f69be8d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1210%2Fjc.2012-2972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2012-2972%26sid%3Dliteratum%253Aachs%26aulast%3DBrixen%26aufirst%3DK.%26aulast%3DChapurlat%26aufirst%3DR.%26aulast%3DCheung%26aufirst%3DA.%2BM.%26aulast%3DKeaveny%26aufirst%3DT.%2BM.%26aulast%3DFuerst%26aufirst%3DT.%26aulast%3DEngelke%26aufirst%3DK.%26aulast%3DRecker%26aufirst%3DR.%26aulast%3DDardzinski%26aufirst%3DB.%26aulast%3DVerbruggen%26aufirst%3DN.%26aulast%3DAther%26aufirst%3DS.%26aulast%3DRosenberg%26aufirst%3DE.%26aulast%3Dde%2BPapp%26aufirst%3DA.%2BE.%26atitle%3DBone%2520density%252C%2520turnover%252C%2520and%2520estimated%2520strength%2520in%2520postmenopausal%2520women%2520treated%2520with%2520odanacatib%253A%2520a%2520randomized%2520trial%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2013%26volume%3D98%26spage%3D571%26epage%3D580%26doi%3D10.1210%2Fjc.2012-2972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Stoch, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Bortel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lasseter, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pramanik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cilissen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panebianco, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesdiener, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J. A.</span><span> </span><span class="NLM_article-title">Odanacatib, a Selective Cathepsin K inhibitor to Treat Osteoporosis: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics - Results from Single Oral Dose Studies in Healthy Volunteers</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">1240</span><span class="NLM_x">–</span> <span class="NLM_lpage">1254</span><span class="refDoi"> DOI: 10.1111/j.1365-2125.2012.04471.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1111%2Fj.1365-2125.2012.04471.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=23013236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC3sXps1CqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2013&pages=1240-1254&author=S.+A.+Stochauthor=S.+Zajicauthor=J.+A.+Stoneauthor=D.+L.+Millerauthor=L.+van+Bortelauthor=K.+C.+Lasseterauthor=B.+Pramanikauthor=C.+Cilissenauthor=Q.+Liuauthor=L.+Liuauthor=B.+B.+Scottauthor=D.+Panebiancoauthor=Y.+Dingauthor=K.+Gottesdienerauthor=J.+A.+Wagner&title=Odanacatib%2C+a+Selective+Cathepsin+K+inhibitor+to+Treat+Osteoporosis%3A+Safety%2C+Tolerability%2C+Pharmacokinetics+and+Pharmacodynamics+-+Results+from+Single+Oral+Dose+Studies+in+Healthy+Volunteers&doi=10.1111%2Fj.1365-2125.2012.04471.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics - results from single oral dose studies in healthy volunteers</span></div><div class="casAuthors">Stoch, S. Aubrey; Zajic, Stefan; Stone, Julie A.; Miller, Deborah L.; van Bortel, Lucas; Lasseter, Kenneth C.; Pramanik, Barnali; Cilissen, Caroline; Liu, Qi; Liu, Lida; Scott, Boyd B.; Panebianco, Deborah; Ding, Yu; Gottesdiener, Keith; Wagner, John A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1240-1254</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">1365-2125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">AIMS: To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of odanacatib (ODN), a cathepsin K inhibitor, in humans.  METHODS: Two double-blind, randomized, placebo-controlled, single oral dose studies were performed with ODN (2-600 mg) in 44 healthy volunteers (36 men and eight postmenopausal women).  RESULTS: Adverse experiences (AEs) with single doses of ODN were transient and mild to moderate, with the exception of one severe AE of gastroenteritis.  Headache was the most frequent AE.  After absorption of ODN (initial peak concns. 4-6 h postdose), plasma concns. exhibited a monophasic decline, with an apparent terminal half-life of -40-80 h.  The area under the curve0-24 h (AUC0-24 h), concn. at 24 h (C24 h) and max. concn. (Cmax,overall) increased in a less than dose-proportional manner from 2 to 600 mg.  Administration of ODN with a high-fat meal led to -100% increases in AUC0-24 h, Cmax,day1, Cmax,overall and C24 h relative to the fasted state, while administration with a low-fat meal led to a -30% increase in those parameters.  Redn. of biomarkers of bone resorption, the C- and N-telopeptides of cross-links of type I collagen, (CTx and NTx, resp.), was noted at 24 h for doses ≥5 mg and at 168 h postdose for ≥ 10 mg.  In postmenopausal women administered 50 mg ODN, redns. in serum CTx of -66% and urine NTx/creatinine (uNTx/Cr) of -51% relative to placebo were obsd. at 24 h.  At 168 h, redns. in serum CTx (-70%) and uNTx/Cr (-78%) were obsd. relative to baseline.  Pharmacokinetic/pharmacodynamic modeling characterized the ODN concn./uNTx/Cr relation, with a modeled EC50 value of 43.8 nM and -80% maximal redn.  CONCLUSIONS: Odanacatib was well tolerated and has a pharmacokinetic and pharmacodynamic profile suitable for once weekly dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxIvJw_wnUo7Vg90H21EOLACvtfcHk0ljGW0TPp8kQeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXps1CqsLs%253D&md5=ebaccd5e624479a5cd237386e5fc58e5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2012.04471.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2012.04471.x%26sid%3Dliteratum%253Aachs%26aulast%3DStoch%26aufirst%3DS.%2BA.%26aulast%3DZajic%26aufirst%3DS.%26aulast%3DStone%26aufirst%3DJ.%2BA.%26aulast%3DMiller%26aufirst%3DD.%2BL.%26aulast%3Dvan%2BBortel%26aufirst%3DL.%26aulast%3DLasseter%26aufirst%3DK.%2BC.%26aulast%3DPramanik%26aufirst%3DB.%26aulast%3DCilissen%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DScott%26aufirst%3DB.%2BB.%26aulast%3DPanebianco%26aufirst%3DD.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DGottesdiener%26aufirst%3DK.%26aulast%3DWagner%26aufirst%3DJ.%2BA.%26atitle%3DOdanacatib%252C%2520a%2520Selective%2520Cathepsin%2520K%2520inhibitor%2520to%2520Treat%2520Osteoporosis%253A%2520Safety%252C%2520Tolerability%252C%2520Pharmacokinetics%2520and%2520Pharmacodynamics%2520-%2520Results%2520from%2520Single%2520Oral%2520Dose%2520Studies%2520in%2520Healthy%2520Volunteers%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2013%26volume%3D75%26spage%3D1240%26epage%3D1254%26doi%3D10.1111%2Fj.1365-2125.2012.04471.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Nagase, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, S.</span><span> </span><span class="NLM_article-title">Serum and urine bone resorption markers and pharmacokinetics of the cathepsin K inhibitor ONO-5334 after ascending single doses in post menopausal women</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">959</span><span class="NLM_x">–</span> <span class="NLM_lpage">970</span><span class="refDoi"> DOI: 10.1111/j.1365-2125.2012.04307.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1111%2Fj.1365-2125.2012.04307.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=22533981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqtr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2012&pages=959-970&author=S.+Nagaseauthor=Y.+Hashimotoauthor=M.+Smallauthor=M.+Ohyamaauthor=T.+Kuwayamaauthor=S.+Deacon&title=Serum+and+urine+bone+resorption+markers+and+pharmacokinetics+of+the+cathepsin+K+inhibitor+ONO-5334+after+ascending+single+doses+in+post+menopausal+women&doi=10.1111%2Fj.1365-2125.2012.04307.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Serum and urine bone resorption markers and pharmacokinetics of the cathepsin K inhibitor ONO-5334 after ascending single doses in post menopausal women</span></div><div class="casAuthors">Nagase, Shinichi; Hashimoto, Yoshitaka; Small, Maria; Ohyama, Michiyo; Kuwayama, Tomohiro; Deacon, Steve</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">959-970</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">AIMS : To investigate the safety, pharmacokinetics and pharmacodynamics of the new cathepsin K inhibitor, ONO-5334.  METHODS : A double-blind, placebo-controlled, randomized study was carried out in 52 healthy post menopausal females.  Single ascending doses of ONO-5334 (3-600 mg) were evaluated in six cohorts.  The effect of food was studied at ONO-5334 100 mg.  RESULTS : Across the doses tested, mean ONO-5334 Cmax occurred 0.5-1.0 h after dosing and the the t1/2 ranged from 9.1 to 22 h.  Linear increases in Cmax and AUC(0,∞) were obsd. in the 3-300 mg and 3-600 mg dose range, resp.  After food, the geometric mean ratio (95% CI) Cmax and AUC(0,∞) for ONO-5334 were 0.78 (0.31, 1.94) and 0.95 (0.67, 1.35)-fold greater than fasted, resp.  ONO-5334 significantly reduced serum bone resorption markers within 4 h vs. placebo.  Statistical significance was achieved for ONO-5334 doses ≥30 mg for C-terminal telopeptide of type 1 collagen (CTX) and ≥300 mg for N-terminal telopeptide of type 1 collagen (NTX).  Statistical significance was still evident at 24 h for ONO-5334 100 mg with serum CTX and 600 mg with serum NTX.  The max. suppression in serum CTX occurred at 4 h post dose with difference compared with placebo of -32%, -59%, -60% and -66% for 30, 100, 300 and 600 mg ONO-5334, resp.  Second morning urine void 24 h post dose showed statistically significant suppression of urinary CTX and NTX at 100 mg and above vs. placebo.  ONO-5334 600 mg showed statistically significant suppression up to 72 h for serum CTX, urinary CTX and urinary NTX and 48 h for serum NTX vs. placebo.  Adverse events were transient with no evidence of dose relationship.  CONCLUSIONS : ONO-5334 displayed linear plasma pharmacokinetics over the (predicted therapeutic) dose range, 3-300 mg, with clear suppression of urinary bone resorption markers at doses ≥100 mg for serum markers at 24 h.  ONO-5334 was well tolerated up to 600 mg day-1 when administered to healthy post menopausal women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG1J-vZCPMobVg90H21EOLACvtfcHk0ljcLacAzxyI1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqtr%252FF&md5=ebf7f40d9859b67aa11355d4667eef90</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2012.04307.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2012.04307.x%26sid%3Dliteratum%253Aachs%26aulast%3DNagase%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DSmall%26aufirst%3DM.%26aulast%3DOhyama%26aufirst%3DM.%26aulast%3DKuwayama%26aufirst%3DT.%26aulast%3DDeacon%26aufirst%3DS.%26atitle%3DSerum%2520and%2520urine%2520bone%2520resorption%2520markers%2520and%2520pharmacokinetics%2520of%2520the%2520cathepsin%2520K%2520inhibitor%2520ONO-5334%2520after%2520ascending%2520single%2520doses%2520in%2520post%2520menopausal%2520women%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2012%26volume%3D74%26spage%3D959%26epage%3D970%26doi%3D10.1111%2Fj.1365-2125.2012.04307.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Ng, K. W.</span><span> </span><span class="NLM_article-title">Potential role of odanacatib in the treatment of osteoporosis</span> <span class="citation_source-journal">Clin. Interventions Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">247</span><span class="refDoi"> DOI: 10.2147/CIA.S26729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.2147%2FCIA.S26729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=22866001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVyis77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=235-247&author=K.+W.+Ng&title=Potential+role+of+odanacatib+in+the+treatment+of+osteoporosis&doi=10.2147%2FCIA.S26729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Potential role of odanacatib in the treatment of osteoporosis</span></div><div class="casAuthors">Ng, Kong Wah</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Interventions in Aging</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">235-247</span>CODEN:
                <span class="NLM_cas:coden">CIALBC</span>;
        ISSN:<span class="NLM_cas:issn">1178-1998</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Cathepsin K is a key enzyme involved in the degrdn. of org. bone matrix by osteoclasts.  Inhibition of bone resorption obsd. in human and animal models deficient for cathepsin K has identified this enzyme as a suitable target for intervention by small mols. with the potential to be used as therapeutic agents in the treatment of osteoporosis.  Odanacatib (ODN) is a nonbasic selective cathepsin K inhibitor with good pharmacokinetic parameters such as minimal in vitro metab., long half-life, and oral bioavailability.  In preclin. studies, ovariectomized monkeys and rabbits treated with ODN showed substantial inhibition of bone resorption markers along with increases in bone mineral d. (BMD).  Significant differences were obsd. in the effects of ODN treatment compared with those of other antiresorptive agents such as bisphosphonates and denosumab.  ODN displayed compartment-specific effects on trabecular vs. cortical bone formation, with treatment resulting in marked increases in periosteal bone formation and cortical thickness in ovariectomized monkeys whereas trabecular bone formation was reduced.  Furthermore, osteoclasts remained viable.  Phase I and II studies conducted in postmenopausal women showed ODN to be safe and well tolerated.  After 5 years, women who received ODN 50 mg weekly continuously from year 1 (n = 13), showed BMD increases from baseline of 11.9% at the lumbar spine, 9.8% at the femoral neck, 10.9% at the hip trochanter, and 8.5% at the total hip.  Addnl., these subjects maintained a low level of the urine bone resorption marker N-terminal telopeptide/creatinine (-67.4% from baseline) through 5 years of treatment, while levels of serum bone-specific alk. phosphatase remained only slightly reduced relative to baseline (-15.3%).  In women who were switched from ODN to placebo after 2 years, bone turnover markers were transiently increased and BMD gains reversed after 12 mo off medication.  Adverse experiences in the ODN-treated group were not significantly different from the placebo group.  In conclusion, available data suggests that cathepsin K inhibition could be a promising intervention with which to treat osteoporosis.  Ongoing studies are expected to provide information on the long-term efficacy in fracture redn. and safety of prolonged treatment with ODN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyDx4-oCZx97Vg90H21EOLACvtfcHk0ljcLacAzxyI1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVyis77N&md5=12c276abdb01d5a5d9a6b96f630cf8bd</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2147%2FCIA.S26729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FCIA.S26729%26sid%3Dliteratum%253Aachs%26aulast%3DNg%26aufirst%3DK.%2BW.%26atitle%3DPotential%2520role%2520of%2520odanacatib%2520in%2520the%2520treatment%2520of%2520osteoporosis%26jtitle%3DClin.%2520Interventions%2520Aging%26date%3D2012%26volume%3D7%26spage%3D235%26epage%3D247%26doi%3D10.2147%2FCIA.S26729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Ochi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayasuga, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunishige, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugitani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabata, K.</span><span> </span><span class="NLM_article-title">Effects of ONO-5334, a novel orally-active inhibitor of cathepsin K, on bone metabolism</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1351</span><span class="NLM_x">–</span> <span class="NLM_lpage">1356</span><span class="refDoi"> DOI: 10.1016/j.bone.2011.09.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1016%2Fj.bone.2011.09.041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2011&pages=1351-1356&author=Y.+Ochiauthor=H.+Yamadaauthor=H.+Moriauthor=Y.+Nakanishiauthor=S.+Nishikawaauthor=R.+Kayasugaauthor=N.+Kawadaauthor=A.+Kunishigeauthor=Y.+Hashimotoauthor=M.+Tanakaauthor=M.+Sugitaniauthor=K.+Kawabata&title=Effects+of+ONO-5334%2C+a+novel+orally-active+inhibitor+of+cathepsin+K%2C+on+bone+metabolism&doi=10.1016%2Fj.bone.2011.09.041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bone.2011.09.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bone.2011.09.041%26sid%3Dliteratum%253Aachs%26aulast%3DOchi%26aufirst%3DY.%26aulast%3DYamada%26aufirst%3DH.%26aulast%3DMori%26aufirst%3DH.%26aulast%3DNakanishi%26aufirst%3DY.%26aulast%3DNishikawa%26aufirst%3DS.%26aulast%3DKayasuga%26aufirst%3DR.%26aulast%3DKawada%26aufirst%3DN.%26aulast%3DKunishige%26aufirst%3DA.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DSugitani%26aufirst%3DM.%26aulast%3DKawabata%26aufirst%3DK.%26atitle%3DEffects%2520of%2520ONO-5334%252C%2520a%2520novel%2520orally-active%2520inhibitor%2520of%2520cathepsin%2520K%252C%2520on%2520bone%2520metabolism%26jtitle%3DBone%26date%3D2011%26volume%3D49%26spage%3D1351%26epage%3D1356%26doi%3D10.1016%2Fj.bone.2011.09.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Rünger, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamou, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czerwiński, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrerons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendler, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mindeholm, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Realdi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, V.</span><span> </span><span class="NLM_article-title">Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatib</span> <span class="citation_source-journal">J. Am. Acad. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">e89</span><span class="NLM_x">–</span> <span class="NLM_lpage">e96</span><span class="refDoi"> DOI: 10.1016/j.jaad.2010.11.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1016%2Fj.jaad.2010.11.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2012&pages=e89-e96&author=T.+M.+R%C3%BCngerauthor=S.+Adamiauthor=C.+L.+Benhamouauthor=E.+Czerwi%C5%84skiauthor=J.+Farreronsauthor=D.+L.+Kendlerauthor=L.+Mindeholmauthor=G.+Realdiauthor=C.+Rouxauthor=V.+Smith&title=Morphea-like+skin+reactions+in+patients+treated+with+the+cathepsin+K+inhibitor+balicatib&doi=10.1016%2Fj.jaad.2010.11.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.jaad.2010.11.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaad.2010.11.033%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25BCnger%26aufirst%3DT.%2BM.%26aulast%3DAdami%26aufirst%3DS.%26aulast%3DBenhamou%26aufirst%3DC.%2BL.%26aulast%3DCzerwi%25C5%2584ski%26aufirst%3DE.%26aulast%3DFarrerons%26aufirst%3DJ.%26aulast%3DKendler%26aufirst%3DD.%2BL.%26aulast%3DMindeholm%26aufirst%3DL.%26aulast%3DRealdi%26aufirst%3DG.%26aulast%3DRoux%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DV.%26atitle%3DMorphea-like%2520skin%2520reactions%2520in%2520patients%2520treated%2520with%2520the%2520cathepsin%2520K%2520inhibitor%2520balicatib%26jtitle%3DJ.%2520Am.%2520Acad.%2520Dermatol.%26date%3D2012%26volume%3D66%26spage%3De89%26epage%3De96%26doi%3D10.1016%2Fj.jaad.2010.11.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Falgueyret, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khougaz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toulmond, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span> </span><span class="NLM_article-title">Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7535</span><span class="NLM_x">–</span> <span class="NLM_lpage">7543</span><span class="refDoi"> DOI: 10.1021/jm0504961</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0504961" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKgsLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7535-7543&author=J.+P.+Falgueyretauthor=S.+Desmaraisauthor=R.+Oballaauthor=W.+C.+Blackauthor=W.+Cromlishauthor=K.+Khougazauthor=S.+Lamontagneauthor=F.+Mass%C3%A9author=D.+Riendeauauthor=S.+Toulmondauthor=M.+D.+Percival&title=Lysosomotropism+of+basic+cathepsin+K+inhibitors+contributes+to+increased+cellular+potencies+against+off-target+cathepsins+and+reduced+functional+selectivity&doi=10.1021%2Fjm0504961"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomotropism of Basic Cathepsin K Inhibitors Contributes to Increased Cellular Potencies against Off-Target Cathepsins and Reduced Functional Selectivity</span></div><div class="casAuthors">Falgueyret, Jean-Pierre; Desmarais, Sylvie; Oballa, Renata; Black, W. Cameron; Cromlish, Wanda; Khougaz, Karine; Lamontagne, Sonia; Masse, Frederic; Riendeau, Denis; Toulmond, Sylvie; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7535-7543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The lysosomal cysteine protease cathepsin K is a target for osteoporosis therapy.  The aryl-piperazine-contg. cathepsin K inhibitor CRA-013783/L-006235 (1) displays greater than 4000-fold selectivity against the lysosomal/endosomal antitargets cathepsin B, L, and S.  However, 1 and other aryl-piperazine-contg. analogs, including balicatib (10), are ∼10-100-fold more potent in cell-based enzyme occupancy assays than against each purified enzyme.  This phenomenon arises from their basic, lipophilic nature, which results in lysosomal trapping.  Consistent with its lysosomotropic nature, 1 accumulates in cells and in rat tissues of high lysosome content.  In contrast, nonbasic aryl-morpholino-contg. analogs do not exhibit lysosomotropic properties.  Increased off-target activities of basic cathepsin K inhibitors were obsd. in a cell-based cathepsin S antigen presentation assay.  No potency increases of basic inhibitors in a functional cathepsin K bone resorption whole cell assay were detected.  Therefore, basic cathepsin K inhibitors, such as 1, suffer from reduced functional selectivities compared to those predicted using purified enzyme assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1NUHyZtwrwLVg90H21EOLACvtfcHk0lhCedVbe4HXuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKgsLbE&md5=9522026bb34984bc66b462b2e95fcbb0</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm0504961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0504961%26sid%3Dliteratum%253Aachs%26aulast%3DFalgueyret%26aufirst%3DJ.%2BP.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DKhougaz%26aufirst%3DK.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DMass%25C3%25A9%26aufirst%3DF.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DToulmond%26aufirst%3DS.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DLysosomotropism%2520of%2520basic%2520cathepsin%2520K%2520inhibitors%2520contributes%2520to%2520increased%2520cellular%2520potencies%2520against%2520off-target%2520cathepsins%2520and%2520reduced%2520functional%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7535%26epage%3D7543%26doi%3D10.1021%2Fjm0504961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">McGrath, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brömme, D.</span><span> </span><span class="NLM_article-title">Crystal structure of human cathepsin K complexed with a potent inhibitor</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span><span class="refDoi"> DOI: 10.1038/nsb0297-105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1038%2Fnsb0297-105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1997&pages=105-109&author=M.+E.+McGrathauthor=J.+L.+Klausauthor=M.+G.+Barnesauthor=D.+Br%C3%B6mme&title=Crystal+structure+of+human+cathepsin+K+complexed+with+a+potent+inhibitor&doi=10.1038%2Fnsb0297-105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnsb0297-105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb0297-105%26sid%3Dliteratum%253Aachs%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DKlaus%26aufirst%3DJ.%2BL.%26aulast%3DBarnes%26aufirst%3DM.%2BG.%26aulast%3DBr%25C3%25B6mme%26aufirst%3DD.%26atitle%3DCrystal%2520structure%2520of%2520human%2520cathepsin%2520K%2520complexed%2520with%2520a%2520potent%2520inhibitor%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D1997%26volume%3D4%26spage%3D105%26epage%3D109%26doi%3D10.1038%2Fnsb0297-105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Turk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guncar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podobnik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, B.</span><span> </span><span class="NLM_article-title">Revised definition of substrate binding sites of papain-like cysteine proteases</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">379</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span><span class="refDoi"> DOI: 10.1515/bchm.1998.379.2.137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1515%2Fbchm.1998.379.2.137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=9524065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADyaK1cXhtF2mtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=1998&pages=137-147&author=D.+Turkauthor=G.+Guncarauthor=M.+Podobnikauthor=B.+Turk&title=Revised+definition+of+substrate+binding+sites+of+papain-like+cysteine+proteases&doi=10.1515%2Fbchm.1998.379.2.137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Revised definition of substrate binding sites of papain-like cysteine proteases</span></div><div class="casAuthors">Turk, Dusan; Guncar, Gregor; Podobnik, Marjetka; Turk, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-147</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter & Co.</span>)
        </div><div class="casAbstract">Data of kinetics and structure of papain-like Cys proteases were reviewed and the authors reconsider the definition of substrate binding sites in papain-like Cys proteases.  Only 3 substrate binding sites, S2, S1 and S1', involve main as well as side chain contacts between substrate and enzyme residues.  Interactions between the enzymes and the substrate P3 and P2' residues are based on side chains (an exception is cathepsin B which is a carboxydipeptidase), so their interaction surface spreads over a relatively wide area.  The location and definition of substrate binding sites beyond S3 and S2' is even more questionable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcF-RPqg1WzLVg90H21EOLACvtfcHk0lhCedVbe4HXuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtF2mtLg%253D&md5=7967ae6285405cab9a5ba1857a26f18e</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1515%2Fbchm.1998.379.2.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fbchm.1998.379.2.137%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DD.%26aulast%3DGuncar%26aufirst%3DG.%26aulast%3DPodobnik%26aufirst%3DM.%26aulast%3DTurk%26aufirst%3DB.%26atitle%3DRevised%2520definition%2520of%2520substrate%2520binding%2520sites%2520of%2520papain-like%2520cysteine%2520proteases%26jtitle%3DBiol.%2520Chem.%26date%3D1998%26volume%3D379%26spage%3D137%26epage%3D147%26doi%3D10.1515%2Fbchm.1998.379.2.137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Minovski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perdih, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solmajer, T.</span><span> </span><span class="NLM_article-title">Combinatorially-generated library of 6-fluoroquinolone analogs as potential novel antitubercular agents: a chemometric and molecular modeling assessment</span> <span class="citation_source-journal">J. Mol. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1735</span><span class="NLM_x">–</span> <span class="NLM_lpage">1753</span><span class="refDoi"> DOI: 10.1007/s00894-011-1179-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1007%2Fs00894-011-1179-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=21833830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVais78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=1735-1753&author=N.+Minovskiauthor=A.+Perdihauthor=T.+Solmajer&title=Combinatorially-generated+library+of+6-fluoroquinolone+analogs+as+potential+novel+antitubercular+agents%3A+a+chemometric+and+molecular+modeling+assessment&doi=10.1007%2Fs00894-011-1179-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Combinatorially-generated library of 6-fluoroquinolone analogs as potential novel antitubercular agents: a chemometric and molecular modeling assessment</span></div><div class="casAuthors">Minovski, Nikola; Perdih, Andrej; Solmajer, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1735-1753</span>CODEN:
                <span class="NLM_cas:coden">JMMOFK</span>;
        ISSN:<span class="NLM_cas:issn">0948-5023</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The virtual combinatorial chem. approach as a methodol. for generating chem. libraries of structurally-similar analogs in a virtual environment was employed for building a general mixed virtual combinatorial library with a total of 53.871 6-FQ structural analogs, introducing the real synthetic pathways of three well known 6-FQ inhibitors.  The druggability properties of the generated combinatorial 6-FQs were assessed using an inhouse developed drug-likeness filter integrating the Lipinski/Veber rule-sets.  The compds. recognized as drug-like were used as an external set for prediction of the biol. activity values using a neural-networks (NN) model based on an exptl.-detd. set of active 6-FQs.  Furthermore, a subset of compds. was extd. from the pool of drug-like 6-FQs, with predicted biol. activity, and subsequently used in virtual screening (VS) campaign combining pharmacophore modeling and mol. docking studies.  This complex scheme, a powerful combination of chemometric and mol. modeling approaches provided novel QSAR guidelines that could aid in the further lead development of 6-FQs agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuyWBPCN5PdLVg90H21EOLACvtfcHk0lhCedVbe4HXuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVais78%253D&md5=3fa3a38f493232c74ea8a271f7a908f7</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2Fs00894-011-1179-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00894-011-1179-0%26sid%3Dliteratum%253Aachs%26aulast%3DMinovski%26aufirst%3DN.%26aulast%3DPerdih%26aufirst%3DA.%26aulast%3DSolmajer%26aufirst%3DT.%26atitle%3DCombinatorially-generated%2520library%2520of%25206-fluoroquinolone%2520analogs%2520as%2520potential%2520novel%2520antitubercular%2520agents%253A%2520a%2520chemometric%2520and%2520molecular%2520modeling%2520assessment%26jtitle%3DJ.%2520Mol.%2520Model.%26date%3D2012%26volume%3D18%26spage%3D1735%26epage%3D1753%26doi%3D10.1007%2Fs00894-011-1179-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Minovski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perdih, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solmajer, T.</span><span> </span><span class="NLM_article-title">Cluster-based molecular docking study for in silico identification of novel 6-fluoroquinolones as potential inhibitors against mycobacterium tuberculosis</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">790</span><span class="NLM_x">–</span> <span class="NLM_lpage">801</span><span class="refDoi"> DOI: 10.1002/jcc.23205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1002%2Fjcc.23205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=23280926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVyiu7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=790-801&author=N.+Minovskiauthor=A.+Perdihauthor=M.+Novicauthor=T.+Solmajer&title=Cluster-based+molecular+docking+study+for+in+silico+identification+of+novel+6-fluoroquinolones+as+potential+inhibitors+against+mycobacterium+tuberculosis&doi=10.1002%2Fjcc.23205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Cluster-based molecular docking study for in silico identification of novel 6-fluoroquinolones as potential inhibitors against Mycobacterium tuberculosis</span></div><div class="casAuthors">Minovski, Nikola; Perdih, Andrej; Novic, Marjana; Solmajer, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">790-801</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A classical protein sequence alignment and homol. modeling strategy were used for building three Mycobacterium tuberculosis-DNA gyrase protein models using the available topoII-DNA-6FQ crystal structure complexes originating from different organisms.  The recently detd. M. tuberculosis-DNA gyrase apoprotein structures and topoII-DNA-6FQ complexes were used for defining the 6-fluoroquinolones (6-FQs) binding pockets.  The quality of the generated models was initially validated by docking of the cocrystd. ligands into their binding site, and subsequently by quant. evaluation of their discriminatory performances (identification of active/inactive 6-FQs) for a set of 145 6-FQs with known biol. activity values.  The M. tuberculosis-DNA gyrase model with the highest estd. discriminatory power was selected and used afterwards in an addnl. mol. docking expt. on a mixed combinatorial set of 427 drug-like 6-FQ analogs for which the biol. activity values were predicted using a prebuilt counter-propagation artificial neural network model.  A novel three-level Boolean-based [T/F (true/false)] clustering algorithm was used to assess the generated binding poses: Level 1 (geometry properties assessment), Level 2 (score-based clustering and selection of the (T)-signed highly scored Level 1 poses), and Level 3 (activity-based clustering and selection of the most "active" (T)-signed Level 2 hits).  The frequency anal. of occurrence of the fragments attached at R1 and R7 position of the (T)-signed 6-FQs selected in Level 3 revealed several novel attractive fragments and confirmed some previous findings.  We believe that this methodol. could be successfully used in establishing novel possible structure-activity relationship recommendations in the 6-FQs optimization, which could be of great importance in the current antimycobacterial hit-to-lead processes. © 2012 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOpvcTVL2K37Vg90H21EOLACvtfcHk0litFTf-vBhAVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVyiu7nM&md5=6d46127b35a889f04646a892655beb81</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fjcc.23205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.23205%26sid%3Dliteratum%253Aachs%26aulast%3DMinovski%26aufirst%3DN.%26aulast%3DPerdih%26aufirst%3DA.%26aulast%3DNovic%26aufirst%3DM.%26aulast%3DSolmajer%26aufirst%3DT.%26atitle%3DCluster-based%2520molecular%2520docking%2520study%2520for%2520in%2520silico%2520identification%2520of%2520novel%25206-fluoroquinolones%2520as%2520potential%2520inhibitors%2520against%2520mycobacterium%2520tuberculosis%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2013%26volume%3D34%26spage%3D790%26epage%3D801%26doi%3D10.1002%2Fjcc.23205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Borišek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drgan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minovski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novič, M.</span><span> </span><span class="NLM_article-title">Mechanistic interpretation of artificial neural network-based QSAR model for prediction of cathepsin K inhibition potency</span> <span class="citation_source-journal">J. Chemom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">272</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span><span class="refDoi"> DOI: 10.1002/cem.2617</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1002%2Fcem.2617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFKrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=272-281&author=J.+Bori%C5%A1ekauthor=V.+Drganauthor=N.+Minovskiauthor=M.+Novi%C4%8D&title=Mechanistic+interpretation+of+artificial+neural+network-based+QSAR+model+for+prediction+of+cathepsin+K+inhibition+potency&doi=10.1002%2Fcem.2617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic interpretation of artificial neural network-based QSAR model for prediction of cathepsin K inhibition potency</span></div><div class="casAuthors">Borisek, Jure; Drgan, Viktor; Minovski, Nikola; Novic, Marjana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemometrics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">272-281</span>CODEN:
                <span class="NLM_cas:coden">JOCHEU</span>;
        ISSN:<span class="NLM_cas:issn">0886-9383</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Cathepsin K (Cat K) is a lysosomal cysteine protease that plays an important role in many bone diseases including osteoporosis, which makes Cat K an interesting drug target.  Several compds., including balicatib, were tested in clin. trials for their potency as Cat K inhibitors.  Balicatib was found as a potent inhibitor; however, the side effects caused by the lysosomotropic drug candidate behavior as a consequence of its basic nature prevented further drug development.  Here, we present a counter-propagation artificial neural network (CP-ANN) quant. structure-activity relationship model of benzamide-contg. aminonitriles with good predictive ability.  The quality of all models developed was evaluated internally by leave-one-out cross-validation (LOOCV) on the training set and externally by an independent validation set.  The best model performed with the LOOCV and external validation squared correlation coeff. of 0.81 and 0.84, resp.  In order to interpret the selection of variables and consequently discuss the mechanism of inhibition, the layer of the CP-ANN model representing the distribution of individual mol. descriptors was compared with the output layer representing the response surface.  The measures indicating the overlap/similarity of the response surface with selected levels in the input layer were introduced.  The results signify not only the importance of the covalent bonding parameters, which are responsible for the S1 binding pocket of the enzyme, but also the impact of 3D shapes of the mols. on the inhibitor-enzyme interactions implying the stabilization of the inhibitors poses within the S2 and S3 binding sites.  Copyright © 2014 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEJCMH0esjI7Vg90H21EOLACvtfcHk0litFTf-vBhAVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFKrs70%253D&md5=26ed295244b7e23b54213f131dd29930</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fcem.2617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcem.2617%26sid%3Dliteratum%253Aachs%26aulast%3DBori%25C5%25A1ek%26aufirst%3DJ.%26aulast%3DDrgan%26aufirst%3DV.%26aulast%3DMinovski%26aufirst%3DN.%26aulast%3DNovi%25C4%258D%26aufirst%3DM.%26atitle%3DMechanistic%2520interpretation%2520of%2520artificial%2520neural%2520network-based%2520QSAR%2520model%2520for%2520prediction%2520of%2520cathepsin%2520K%2520inhibition%2520potency%26jtitle%3DJ.%2520Chemom.%26date%3D2014%26volume%3D28%26spage%3D272%26epage%3D281%26doi%3D10.1002%2Fcem.2617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span>Enamine fragment database. URL: <a href="http://www.enamine.net/index.php?option=com_content&amp;task=view&amp;id=117" class="extLink">http://www.enamine.net/index.php?option=com_content&task=view&id=117</a> (accessed Feb., 15,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Enamine+fragment+database.+URL%3A+http%3A%2F%2Fwww.enamine.net%2Findex.php%3Foption%3Dcom_content%26task%3Dview%26id%3D117+%28accessed+Feb.%2C+15%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhoti, H.</span><span> </span><span class="NLM_article-title">A rule of three for fragment-based lead discovery?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">876</span><span class="NLM_x">–</span> <span class="NLM_lpage">877</span><span class="refDoi"> DOI: 10.1016/S1359-6446(03)02831-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1016%2FS1359-6446%2803%2902831-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=14554012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A280%3ADC%252BD3svns1Cnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=876-877&author=M.+Congreveauthor=R.+Carrauthor=C.+Murrayauthor=H.+Jhoti&title=A+rule+of+three+for+fragment-based+lead+discovery%3F&doi=10.1016%2FS1359-6446%2803%2902831-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A 'rule of three' for fragment-based lead discovery?</span></div><div class="casAuthors">Congreve Miles; Carr Robin; Murray Chris; Jhoti Harren</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">876-7</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfFswFSn5vb43yKPtYViAGfW6udTcc2ea6YRB4yL_Trbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svns1Cnsw%253D%253D&md5=137886dbb2062f7a3ad39277dd888df3</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2803%2902831-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252803%252902831-9%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DCarr%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DC.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DA%2520rule%2520of%2520three%2520for%2520fragment-based%2520lead%2520discovery%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2003%26volume%3D8%26spage%3D876%26epage%3D877%26doi%3D10.1016%2FS1359-6446%2803%2902831-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopple, K. D.</span><span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2615</span><span class="NLM_x">–</span> <span class="NLM_lpage">2623</span><span class="refDoi"> DOI: 10.1021/jm020017n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.+Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates&doi=10.1021%2Fjm020017n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0lixrmWR2XSYAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.%2BY.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623%26doi%3D10.1021%2Fjm020017n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Dossetter, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beeley, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finlayson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heron, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Highton, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jestel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacFaul, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morley, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawney, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbacher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickers, M.</span><span> </span><span class="NLM_article-title">(1R,2R)-N-(1-cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b]indole −2-carbonyl)cyclohexanecarboxamide (AZD4996): a potent and highly selective cathepsin K inhibitor for the treatment of osteoarthritis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6363</span><span class="NLM_x">–</span> <span class="NLM_lpage">6374</span><span class="refDoi"> DOI: 10.1021/jm3007257</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3007257" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6363-6374&author=A.+G.+Dossetterauthor=H.+Beeleyauthor=J.+Bowyerauthor=C.+R.+Cookauthor=J.+J.+Crawfordauthor=J.+E.+Finlaysonauthor=N.+M.+Heronauthor=C.+Heyesauthor=A.+J.+Hightonauthor=J.+A.+Hudsonauthor=A.+Jestelauthor=P.+W.+Kennyauthor=S.+Krappauthor=S.+Martinauthor=P.+A.+MacFaulauthor=T.+M.+McGuireauthor=P.+M.+Gutierrezauthor=A.+D.+Morleyauthor=J.+J.+Morrisauthor=K.+M.+Pageauthor=L.+R.+Ribeiroauthor=H.+Sawneyauthor=S.+Steinbacherauthor=C.+Smithauthor=M.+Vickers&title=%281R%2C2R%29-N-%281-cyanocyclopropyl%29-2-%286-methoxy-1%2C3%2C4%2C5-tetrahydropyrido%5B4%2C3-b%5Dindole+%E2%88%922-carbonyl%29cyclohexanecarboxamide+%28AZD4996%29%3A+a+potent+and+highly+selective+cathepsin+K+inhibitor+for+the+treatment+of+osteoarthritis&doi=10.1021%2Fjm3007257"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm3007257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3007257%26sid%3Dliteratum%253Aachs%26aulast%3DDossetter%26aufirst%3DA.%2BG.%26aulast%3DBeeley%26aufirst%3DH.%26aulast%3DBowyer%26aufirst%3DJ.%26aulast%3DCook%26aufirst%3DC.%2BR.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26aulast%3DFinlayson%26aufirst%3DJ.%2BE.%26aulast%3DHeron%26aufirst%3DN.%2BM.%26aulast%3DHeyes%26aufirst%3DC.%26aulast%3DHighton%26aufirst%3DA.%2BJ.%26aulast%3DHudson%26aufirst%3DJ.%2BA.%26aulast%3DJestel%26aufirst%3DA.%26aulast%3DKenny%26aufirst%3DP.%2BW.%26aulast%3DKrapp%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DMacFaul%26aufirst%3DP.%2BA.%26aulast%3DMcGuire%26aufirst%3DT.%2BM.%26aulast%3DGutierrez%26aufirst%3DP.%2BM.%26aulast%3DMorley%26aufirst%3DA.%2BD.%26aulast%3DMorris%26aufirst%3DJ.%2BJ.%26aulast%3DPage%26aufirst%3DK.%2BM.%26aulast%3DRibeiro%26aufirst%3DL.%2BR.%26aulast%3DSawney%26aufirst%3DH.%26aulast%3DSteinbacher%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DVickers%26aufirst%3DM.%26atitle%3D%25281R%252C2R%2529-N-%25281-cyanocyclopropyl%2529-2-%25286-methoxy-1%252C3%252C4%252C5-tetrahydropyrido%255B4%252C3-b%255Dindole%2520%25E2%2588%25922-carbonyl%2529cyclohexanecarboxamide%2520%2528AZD4996%2529%253A%2520a%2520potent%2520and%2520highly%2520selective%2520cathepsin%2520K%2520inhibitor%2520for%2520the%2520treatment%2520of%2520osteoarthritis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6363%26epage%3D6374%26doi%3D10.1021%2Fjm3007257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setti, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rydzewski, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Z. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrill, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janc, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somoza, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enriquez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickley, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venuti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G.</span><span> </span><span class="NLM_article-title">Design and synthesis of tri-ring P3 benzamide-containing aminonitriles as potent, selective, orally effective inhibitors of cathepsin K</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7520</span><span class="NLM_x">–</span> <span class="NLM_lpage">7534</span><span class="refDoi"> DOI: 10.1021/jm058198r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm058198r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7520-7534&author=J.+T.+Palmerauthor=C.+Bryantauthor=D.+X.+Wangauthor=D.+E.+Davisauthor=E.+L.+Settiauthor=R.+M.+Rydzewskiauthor=S.+Venkatramanauthor=Z.+Q.+Tianauthor=L.+C.+Burrillauthor=R.+V.+Mendoncaauthor=E.+Springmanauthor=J.+McCarterauthor=T.+Chungauthor=H.+Cheungauthor=J.+W.+Jancauthor=M.+McGrathauthor=J.+R.+Somozaauthor=P.+Enriquezauthor=Z.+W.+Yuauthor=R.+M.+Strickleyauthor=L.+Liuauthor=M.+C.+Venutiauthor=M.+D.+Percivalauthor=J.+P.+Falgueyretauthor=P.+Prasitauthor=R.+Oballaauthor=D.+Riendeauauthor=R.+N.+Youngauthor=G.+Wesolowskiauthor=S.+B.+Rodanauthor=C.+Johnsonauthor=D.+B.+Kimmelauthor=G.+Rodan&title=Design+and+synthesis+of+tri-ring+P3+benzamide-containing+aminonitriles+as+potent%2C+selective%2C+orally+effective+inhibitors+of+cathepsin+K&doi=10.1021%2Fjm058198r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm058198r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058198r%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DBryant%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DD.%2BX.%26aulast%3DDavis%26aufirst%3DD.%2BE.%26aulast%3DSetti%26aufirst%3DE.%2BL.%26aulast%3DRydzewski%26aufirst%3DR.%2BM.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DZ.%2BQ.%26aulast%3DBurrill%26aufirst%3DL.%2BC.%26aulast%3DMendonca%26aufirst%3DR.%2BV.%26aulast%3DSpringman%26aufirst%3DE.%26aulast%3DMcCarter%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DT.%26aulast%3DCheung%26aufirst%3DH.%26aulast%3DJanc%26aufirst%3DJ.%2BW.%26aulast%3DMcGrath%26aufirst%3DM.%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DEnriquez%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DZ.%2BW.%26aulast%3DStrickley%26aufirst%3DR.%2BM.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DVenuti%26aufirst%3DM.%2BC.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DFalgueyret%26aufirst%3DJ.%2BP.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DJohnson%26aufirst%3DC.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DRodan%26aufirst%3DG.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520tri-ring%2520P3%2520benzamide-containing%2520aminonitriles%2520as%2520potent%252C%2520selective%252C%2520orally%2520effective%2520inhibitors%2520of%2520cathepsin%2520K%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7520%26epage%3D7534%26doi%3D10.1021%2Fjm058198r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Frizler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohr, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furtmann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kläs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gütschow, M.</span><span> </span><span class="NLM_article-title">Structural Optimization of Azadipeptide Nitriles Strongly Increases Association Rates and Allows the Development of Selective Cathepsin Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">396</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span><span class="refDoi"> DOI: 10.1021/jm101272p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101272p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=396-400&author=M.+Frizlerauthor=F.+Lohrauthor=N.+Furtmannauthor=J.+Kl%C3%A4sauthor=M.+G%C3%BCtschow&title=Structural+Optimization+of+Azadipeptide+Nitriles+Strongly+Increases+Association+Rates+and+Allows+the+Development+of+Selective+Cathepsin+Inhibitors&doi=10.1021%2Fjm101272p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm101272p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101272p%26sid%3Dliteratum%253Aachs%26aulast%3DFrizler%26aufirst%3DM.%26aulast%3DLohr%26aufirst%3DF.%26aulast%3DFurtmann%26aufirst%3DN.%26aulast%3DKl%25C3%25A4s%26aufirst%3DJ.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26atitle%3DStructural%2520Optimization%2520of%2520Azadipeptide%2520Nitriles%2520Strongly%2520Increases%2520Association%2520Rates%2520and%2520Allows%2520the%2520Development%2520of%2520Selective%2520Cathepsin%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D396%26epage%3D400%26doi%3D10.1021%2Fjm101272p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Frizler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohr, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lülsdorff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gütschow, M.</span><span> </span><span class="NLM_article-title">Facing the gem-Dialkyl Effect in Enzyme Inhibitor Design: Preparation of Homocycloleucine-Based Azadipeptide Nitriles</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">11419</span><span class="NLM_x">–</span> <span class="NLM_lpage">11423</span><span class="refDoi"> DOI: 10.1002/chem.201101350</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1002%2Fchem.201101350" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=21898616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFers73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=11419-11423&author=M.+Frizlerauthor=F.+Lohrauthor=M.+L%C3%BClsdorffauthor=M.+G%C3%BCtschow&title=Facing+the+gem-Dialkyl+Effect+in+Enzyme+Inhibitor+Design%3A+Preparation+of+Homocycloleucine-Based+Azadipeptide+Nitriles&doi=10.1002%2Fchem.201101350"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Facing the gem-Dialkyl Effect in Enzyme Inhibitor Design: Preparation of Homocycloleucine-Based Azadipeptide Nitriles</span></div><div class="casAuthors">Frizler, Maxim; Lohr, Friederike; Luelsdorff, Michael; Guetschow, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">11419-11423, S11419/1-S11419/41</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors confirmed that homocycloleucine is a particularly suitable building block for the design of cathepsin K inhibitors.  The incorporation of this amino acid into the azadipeptide nitrile scaffold afforded remarkable selectivity, and when combined with the triaryl motif at the P3 position, excellent inhibitory potency of cathepsin enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGisGXRel3DrVg90H21EOLACvtfcHk0ljZ1_DatT2Qqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFers73O&md5=e58d21cd363f7548920e34ce33fa5879</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fchem.201101350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201101350%26sid%3Dliteratum%253Aachs%26aulast%3DFrizler%26aufirst%3DM.%26aulast%3DLohr%26aufirst%3DF.%26aulast%3DL%25C3%25BClsdorff%26aufirst%3DM.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26atitle%3DFacing%2520the%2520gem-Dialkyl%2520Effect%2520in%2520Enzyme%2520Inhibitor%2520Design%253A%2520Preparation%2520of%2520Homocycloleucine-Based%2520Azadipeptide%2520Nitriles%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2011%26volume%3D17%26spage%3D11419%26epage%3D11423%26doi%3D10.1002%2Fchem.201101350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Falgueyret, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khougaz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toulmond, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span> </span><span class="NLM_article-title">Lysosomotropism of Basic Cathepsin K Inhibitors Contributes to Increased Cellular Potencies against Off-Target Cathepsins and Reduced Functional Selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7535</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span><span class="refDoi"> DOI: 10.1021/jm0504961</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0504961" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKgsLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7535-43&author=J.+P.+Falgueyretauthor=S.+Desmaraisauthor=R.+Oballaauthor=W.+C.+Blackauthor=W.+Cromlishauthor=K.+Khougazauthor=S.+Lamontagneauthor=F.+Mass%C3%A9author=D.+Riendeauauthor=S.+Toulmondauthor=M.+D.+Percival&title=Lysosomotropism+of+Basic+Cathepsin+K+Inhibitors+Contributes+to+Increased+Cellular+Potencies+against+Off-Target+Cathepsins+and+Reduced+Functional+Selectivity&doi=10.1021%2Fjm0504961"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomotropism of Basic Cathepsin K Inhibitors Contributes to Increased Cellular Potencies against Off-Target Cathepsins and Reduced Functional Selectivity</span></div><div class="casAuthors">Falgueyret, Jean-Pierre; Desmarais, Sylvie; Oballa, Renata; Black, W. Cameron; Cromlish, Wanda; Khougaz, Karine; Lamontagne, Sonia; Masse, Frederic; Riendeau, Denis; Toulmond, Sylvie; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7535-7543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The lysosomal cysteine protease cathepsin K is a target for osteoporosis therapy.  The aryl-piperazine-contg. cathepsin K inhibitor CRA-013783/L-006235 (1) displays greater than 4000-fold selectivity against the lysosomal/endosomal antitargets cathepsin B, L, and S.  However, 1 and other aryl-piperazine-contg. analogs, including balicatib (10), are ∼10-100-fold more potent in cell-based enzyme occupancy assays than against each purified enzyme.  This phenomenon arises from their basic, lipophilic nature, which results in lysosomal trapping.  Consistent with its lysosomotropic nature, 1 accumulates in cells and in rat tissues of high lysosome content.  In contrast, nonbasic aryl-morpholino-contg. analogs do not exhibit lysosomotropic properties.  Increased off-target activities of basic cathepsin K inhibitors were obsd. in a cell-based cathepsin S antigen presentation assay.  No potency increases of basic inhibitors in a functional cathepsin K bone resorption whole cell assay were detected.  Therefore, basic cathepsin K inhibitors, such as 1, suffer from reduced functional selectivities compared to those predicted using purified enzyme assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1NUHyZtwrwLVg90H21EOLACvtfcHk0ljZ1_DatT2Qqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKgsLbE&md5=9522026bb34984bc66b462b2e95fcbb0</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm0504961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0504961%26sid%3Dliteratum%253Aachs%26aulast%3DFalgueyret%26aufirst%3DJ.%2BP.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DKhougaz%26aufirst%3DK.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DMass%25C3%25A9%26aufirst%3DF.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DToulmond%26aufirst%3DS.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DLysosomotropism%2520of%2520Basic%2520Cathepsin%2520K%2520Inhibitors%2520Contributes%2520to%2520Increased%2520Cellular%2520Potencies%2520against%2520Off-Target%2520Cathepsins%2520and%2520Reduced%2520Functional%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7535%26epage%3D43%26doi%3D10.1021%2Fjm0504961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Schröder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oellien, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marhöfer, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duszenko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selzer, P. M.</span><span> </span><span class="NLM_article-title">Docking-based virtual screening of covalently binding ligands: an orthogonal lead discovery approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1478</span><span class="NLM_x">–</span> <span class="NLM_lpage">1490</span><span class="refDoi"> DOI: 10.1021/jm3013932</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3013932" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1478-1490&author=J.+Schr%C3%B6derauthor=A.+Klingerauthor=F.+Oellienauthor=R.+J.+Marh%C3%B6ferauthor=M.+Duszenkoauthor=P.+M.+Selzer&title=Docking-based+virtual+screening+of+covalently+binding+ligands%3A+an+orthogonal+lead+discovery+approach&doi=10.1021%2Fjm3013932"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm3013932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3013932%26sid%3Dliteratum%253Aachs%26aulast%3DSchr%25C3%25B6der%26aufirst%3DJ.%26aulast%3DKlinger%26aufirst%3DA.%26aulast%3DOellien%26aufirst%3DF.%26aulast%3DMarh%25C3%25B6fer%26aufirst%3DR.%2BJ.%26aulast%3DDuszenko%26aufirst%3DM.%26aulast%3DSelzer%26aufirst%3DP.%2BM.%26atitle%3DDocking-based%2520virtual%2520screening%2520of%2520covalently%2520binding%2520ligands%253A%2520an%2520orthogonal%2520lead%2520discovery%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1478%26epage%3D1490%26doi%3D10.1021%2Fjm3013932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Barrett, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kembhavi, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanada, K.</span><span> </span><span class="NLM_article-title">L-<i>trans</i>-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogs as inhibitors of cysteine proteinases including cathepsins B, H and L</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">201</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span><span class="refDoi"> DOI: 10.1042/bj2010189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1042%2Fbj2010189" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=201&publication_year=1982&pages=189-198&author=A.+J.+Barrettauthor=A.+A.+Kembhaviauthor=M.+A.+Brownauthor=H.+Kirschkeauthor=C.+G.+Knightauthor=M.+Tamaiauthor=K.+Hanada&title=L-trans-Epoxysuccinyl-leucylamido%284-guanidino%29butane+%28E-64%29+and+its+analogs+as+inhibitors+of+cysteine+proteinases+including+cathepsins+B%2C+H+and+L&doi=10.1042%2Fbj2010189"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1042%2Fbj2010189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2010189%26sid%3Dliteratum%253Aachs%26aulast%3DBarrett%26aufirst%3DA.%2BJ.%26aulast%3DKembhavi%26aufirst%3DA.%2BA.%26aulast%3DBrown%26aufirst%3DM.%2BA.%26aulast%3DKirschke%26aufirst%3DH.%26aulast%3DKnight%26aufirst%3DC.%2BG.%26aulast%3DTamai%26aufirst%3DM.%26aulast%3DHanada%26aufirst%3DK.%26atitle%3DL-trans-Epoxysuccinyl-leucylamido%25284-guanidino%2529butane%2520%2528E-64%2529%2520and%2520its%2520analogs%2520as%2520inhibitors%2520of%2520cysteine%2520proteinases%2520including%2520cathepsins%2520B%252C%2520H%2520and%2520L%26jtitle%3DBiochem.%2520J.%26date%3D1982%26volume%3D201%26spage%3D189%26epage%3D198%26doi%3D10.1042%2Fbj2010189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span><span class="refDoi"> DOI: 10.1006/jmbi.1996.0897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking&doi=10.1006%2Fjmbi.1996.0897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0lgl_PFM7-c1dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748%26doi%3D10.1006%2Fjmbi.1996.0897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Verdonk, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartshorn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R. D.</span><span> </span><span class="NLM_article-title">Improved protein-ligand docking using GOLD</span> <span class="citation_source-journal">Proteins: Struct., Funct., Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">623</span><span class="refDoi"> DOI: 10.1002/prot.10465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1002%2Fprot.10465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=12910460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFGrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2003&pages=609-623&author=M.+L.+Verdonkauthor=J.+C.+Coleauthor=M.+J.+Hartshornauthor=C.+W.+Murrayauthor=R.+D.+Taylor&title=Improved+protein-ligand+docking+using+GOLD&doi=10.1002%2Fprot.10465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Improved protein-ligand docking using GOLD</span></div><div class="casAuthors">Verdonk, Marcel L.; Cole, Jason C.; Hartshorn, Michael J.; Murray, Christopher W.; Taylor, Richard D.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">609-623</span>CODEN:
                <span class="NLM_cas:coden">PSFGEY</span>;
        ISSN:<span class="NLM_cas:issn">0887-3585</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The Chemscore function was implemented as a scoring function for the protein-ligand docking program GOLD, and its performance compared to the original Goldscore function and two consensus docking protocols, "Goldscore-CS" and "Chemscore-GS," in terms of docking accuracy, prediction of binding affinities, and speed.  In the "Goldscore-CS" protocol, dockings produced with the Goldscore function are scored and ranked with the Chemscore function; in the "Chemscore-GS" protocol, dockings produced with the Chemscore function are scored and ranked with the Goldscore function.  Comparisons were made for a "clean" set of 224 protein-ligand complexes, and for two subsets of this set, one for which the ligands are "drug-like," the other for which they are "fragment-like.".  For "drug-like" and "fragment-like" ligands, the docking accuracies obtained with Chemscore and Goldscore functions are similar.  For larger ligands, Goldscore gives superior results.  Docking with the Chemscore function is up to three times faster than docking with the Goldscore function.  Both combined docking protocols give significant improvements in docking accuracy over the use of the Goldscore or Chemscore function alone.  "Goldscore-CS" gives success rates of up to 81% (top-ranked GOLD soln. within 2.0 Å of the exptl. binding mode) for the "clean list," but at the cost of long search times.  For most virtual screening applications, "Chemscore-GS" seems optimal; search settings that give docking speeds of around 0.25-1.3 min/compd. have success rates of about 78% for "drug-like" compds. and 85% for "fragment-like" compds.  In terms of producing binding energy ests., the Goldscore function appears to perform better than the Chemscore function and the two consensus protocols, particularly for faster search settings.  Even at docking speeds of around 1-2 min/compd., the Goldscore function predicts binding energies with a std. deviation of ∼10.5 kJ/mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKKgOct_CAcbVg90H21EOLACvtfcHk0lgl_PFM7-c1dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFGrsLg%253D&md5=73a627d99dab6de1ae364c8e8e5f0fea</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fprot.10465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.10465%26sid%3Dliteratum%253Aachs%26aulast%3DVerdonk%26aufirst%3DM.%2BL.%26aulast%3DCole%26aufirst%3DJ.%2BC.%26aulast%3DHartshorn%26aufirst%3DM.%2BJ.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DTaylor%26aufirst%3DR.%2BD.%26atitle%3DImproved%2520protein-ligand%2520docking%2520using%2520GOLD%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2003%26volume%3D52%26spage%3D609%26epage%3D623%26doi%3D10.1002%2Fprot.10465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Nissink, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartshorn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdonk, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">A new test set for validating predictions of protein-ligand interaction</span> <span class="citation_source-journal">Proteins: Struct., Funct., Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span><span class="refDoi"> DOI: 10.1002/prot.10232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1002%2Fprot.10232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=12402356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BD38XptlGru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2002&pages=457-471&author=J.+W.+Nissinkauthor=C.+Murrayauthor=M.+Hartshornauthor=M.+L.+Verdonkauthor=J.+C.+Coleauthor=R.+Taylor&title=A+new+test+set+for+validating+predictions+of+protein-ligand+interaction&doi=10.1002%2Fprot.10232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A new test set for validating predictions of protein-ligand interaction</span></div><div class="casAuthors">Nissink, J. Willem M.; Murray, Chris; Hartshorn, Mike; Verdonk, Marcel L.; Cole, Jason C.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Genetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">457-471</span>CODEN:
                <span class="NLM_cas:coden">PSFGEY</span>;
        ISSN:<span class="NLM_cas:issn">0887-3585</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">We present a large test set of protein-ligand complexes for the purpose of validating algorithms that rely on the prediction of protein-ligand interactions.  The set consists of 305 complexes with protonation states assigned by manual inspection.  The following checks have been carried out to identify unsuitable entries in this set:.  (1) Assessing the involvement of crystallog. related protein units in ligand binding;.  (2) Identification of bad clashes between protein side chains and ligand; and.  (3) Assessment of structural errors, and/or inconsistency of ligand placement with crystal structure electron d.  In addn., the set has been pruned to assure diversity in terms of protein-ligand structures, and subsets are supplied for different protein-structure resoln. ranges.  A classification of the set by protein type is available.  As an illustration, validation results are shown for GOLD and SuperStar.  GOLD is a program that performs flexible protein-ligand docking, and SuperStar is used for the prediction of favorable interaction sites in proteins.  The new CCDC/Astex test set is freely available to the scientific community (http://www.ccdc.cam.ac.uk).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLTVTq0JGfW7Vg90H21EOLACvtfcHk0lgl_PFM7-c1dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptlGru74%253D&md5=a8ecc21191bbf32edb10cf3d3336fab4</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2Fprot.10232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.10232%26sid%3Dliteratum%253Aachs%26aulast%3DNissink%26aufirst%3DJ.%2BW.%26aulast%3DMurray%26aufirst%3DC.%26aulast%3DHartshorn%26aufirst%3DM.%26aulast%3DVerdonk%26aufirst%3DM.%2BL.%26aulast%3DCole%26aufirst%3DJ.%2BC.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DA%2520new%2520test%2520set%2520for%2520validating%2520predictions%2520of%2520protein-ligand%2520interaction%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2002%26volume%3D49%26spage%3D457%26epage%3D471%26doi%3D10.1002%2Fprot.10232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Kirchmair, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Distinto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolber, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, T.</span><span> </span><span class="NLM_article-title">Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection - What can we learn from earlier mistakes?</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">228</span><span class="refDoi"> DOI: 10.1007/s10822-007-9163-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1007%2Fs10822-007-9163-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=18196462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjsFOnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=213-228&author=J.+Kirchmairauthor=P.+Marktauthor=S.+Distintoauthor=G.+Wolberauthor=T.+Langer&title=Evaluation+of+the+performance+of+3D+virtual+screening+protocols%3A+RMSD+comparisons%2C+enrichment+assessments%2C+and+decoy+selection+-+What+can+we+learn+from+earlier+mistakes%3F&doi=10.1007%2Fs10822-007-9163-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection-What can we learn from earlier mistakes?</span></div><div class="casAuthors">Kirchmair, Johannes; Markt, Patrick; Distinto, Simona; Wolber, Gerhard; Langer, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">213-228</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Within the last few years a considerable amt. of evaluative studies has been published that investigate the performance of 3D virtual screening approaches.  Thereby, in particular assessments of protein-ligand docking are facing remarkable interest in the scientific community.  However, comparing virtual screening approaches is a non-trivial task.  Several publications, esp. in the field of mol. docking, suffer from shortcomings that are likely to affect the significance of the results considerably.  These quality issues often arise from poor study design, biasing, by using improper or inexpressive enrichment descriptors, and from errors in interpretation of the data output.  In this review we analyze recent literature evaluating 3D virtual screening methods, with focus on mol. docking.  We highlight problematic issues and provide guidelines on how to improve the quality of computational studies.  Since 3D virtual screening protocols are in general assessed by their ability to discriminate between active and inactive compds., we summarize the impact of the compn. and prepn. of test sets on the outcome of evaluations.  Moreover, we investigate the significance of both classic enrichment parameters and advanced descriptors for the performance of 3D virtual screening methods.  Furthermore, we review the significance and suitability of RMSD as a measure for the accuracy of protein-ligand docking algorithms and of conformational space sub sampling algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3xrjPXIM177Vg90H21EOLACvtfcHk0lhKijchVYnzqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjsFOnsLs%253D&md5=bb2c74856a607266d7ae5b2dafb733bd</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1007%2Fs10822-007-9163-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-007-9163-6%26sid%3Dliteratum%253Aachs%26aulast%3DKirchmair%26aufirst%3DJ.%26aulast%3DMarkt%26aufirst%3DP.%26aulast%3DDistinto%26aufirst%3DS.%26aulast%3DWolber%26aufirst%3DG.%26aulast%3DLanger%26aufirst%3DT.%26atitle%3DEvaluation%2520of%2520the%2520performance%2520of%25203D%2520virtual%2520screening%2520protocols%253A%2520RMSD%2520comparisons%252C%2520enrichment%2520assessments%252C%2520and%2520decoy%2520selection%2520-%2520What%2520can%2520we%2520learn%2520from%2520earlier%2520mistakes%253F%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2008%26volume%3D22%26spage%3D213%26epage%3D228%26doi%3D10.1007%2Fs10822-007-9163-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Carter, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alber, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bithell, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budworth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chubb, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowdell, V. C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelsey, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockyer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stables, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, K. L.</span><span> </span><span class="NLM_article-title">1,4-Benzodiazepines as inhibitors of respiratory syncytial virus</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2311</span><span class="NLM_x">–</span> <span class="NLM_lpage">2319</span><span class="refDoi"> DOI: 10.1021/jm051185t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051185t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVygtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2311-2319&author=M.+C.+Carterauthor=D.+G.+Alberauthor=R.+C.+Baxterauthor=S.+K.+Bithellauthor=J.+Budworthauthor=A.+Chubbauthor=G.+S.+Cockerillauthor=V.+C.+L.+Dowdellauthor=E.+A.+Hendersonauthor=S.+J.+Keeganauthor=R.+D.+Kelseyauthor=M.+J.+Lockyerauthor=J.+N.+Stablesauthor=L.+J.+Wilsonauthor=K.+L.+Powell&title=1%2C4-Benzodiazepines+as+inhibitors+of+respiratory+syncytial+virus&doi=10.1021%2Fjm051185t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-Benzodiazepines as Inhibitors of Respiratory Syncytial Virus</span></div><div class="casAuthors">Carter, Malcolm C.; Alber, Dagmar G.; Baxter, Robert C.; Bithell, Sian K.; Budworth, Jo; Chubb, Ann; Cockerill, G. Stuart; Dowdell, Verity C. L.; Henderson, Elisa A.; Keegan, Sally J.; Kelsey, Richard D.; Lockyer, Michael J.; Stables, Jeremy N.; Wilson, Lara J.; Powell, Kenneth L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2311-2319</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Respiratory syncytial virus (RSV) is the cause of one-fifth of all lower respiratory tract infections worldwide and is increasingly being recognized as a serious threat to patient groups with poorly functioning immune systems.  Our approach to finding a novel inhibitor of this virus was to screen a 20 000-member diverse library in a whole cell XTT assay.  Parallel assays were carried out in the absence of virus in order to quantify any assocd. cell toxicity.  This identified 100 compds. with IC50's less than 50 μM.  A-33903 (18), a 1,4-benzodiazepine analog, was chosen as the starting point for lead optimization.  This mol. was moderately active and demonstrated good pharmacokinetic properties.  The most potent compds. identified from this work were A-58568 (47), A-58569 (44), and A-62066 (46), where modifications to the arom. substitution enhanced potency, and A-58175 (42), where the amide linker was modified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsaCWk2D1PILVg90H21EOLACvtfcHk0lhKijchVYnzqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVygtLw%253D&md5=225b3fc469eed46f697f1d08ca64e7fe</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm051185t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051185t%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DM.%2BC.%26aulast%3DAlber%26aufirst%3DD.%2BG.%26aulast%3DBaxter%26aufirst%3DR.%2BC.%26aulast%3DBithell%26aufirst%3DS.%2BK.%26aulast%3DBudworth%26aufirst%3DJ.%26aulast%3DChubb%26aufirst%3DA.%26aulast%3DCockerill%26aufirst%3DG.%2BS.%26aulast%3DDowdell%26aufirst%3DV.%2BC.%2BL.%26aulast%3DHenderson%26aufirst%3DE.%2BA.%26aulast%3DKeegan%26aufirst%3DS.%2BJ.%26aulast%3DKelsey%26aufirst%3DR.%2BD.%26aulast%3DLockyer%26aufirst%3DM.%2BJ.%26aulast%3DStables%26aufirst%3DJ.%2BN.%26aulast%3DWilson%26aufirst%3DL.%2BJ.%26aulast%3DPowell%26aufirst%3DK.%2BL.%26atitle%3D1%252C4-Benzodiazepines%2520as%2520inhibitors%2520of%2520respiratory%2520syncytial%2520virus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2311%26epage%3D2319%26doi%3D10.1021%2Fjm051185t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Bernhart, C.; Bouaboula, M.; Casellas, P.; Duclos, O.; Herbert, J. M.; Jegham, S.; Mccort, G.</span><span> </span><span class="NLM_article-title">Antineoplastic derivatives, preparation thereof, and therapeutic use thereof</span>. Patent WO2010004198 A2,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=C.+Bernhart&author=M.+Bouaboula&author=P.+Casellas&author=O.+Duclos&author=J.+M.+Herbert&author=S.+Jegham&author=G.+Mccort&title=Antineoplastic+derivatives%2C+preparation+thereof%2C+and+therapeutic+use+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBernhart%26aufirst%3DC.%26atitle%3DAntineoplastic%2520derivatives%252C%2520preparation%2520thereof%252C%2520and%2520therapeutic%2520use%2520thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Olson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, J. N.</span><span> </span><span class="NLM_article-title">Rigid Analogs of Indomethacin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span><span class="refDoi"> DOI: 10.1021/jm00248a005</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00248a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1974&pages=167-171&author=D.+R.+Olsonauthor=W.+J.+Wheelerauthor=J.+N.+Wells&title=Rigid+Analogs+of+Indomethacin&doi=10.1021%2Fjm00248a005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm00248a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00248a005%26sid%3Dliteratum%253Aachs%26aulast%3DOlson%26aufirst%3DD.%2BR.%26aulast%3DWheeler%26aufirst%3DW.%2BJ.%26aulast%3DWells%26aufirst%3DJ.%2BN.%26atitle%3DRigid%2520Analogs%2520of%2520Indomethacin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1974%26volume%3D17%26spage%3D167%26epage%3D171%26doi%3D10.1021%2Fjm00248a005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Mihelic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobersek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guncar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, D.</span><span> </span><span class="NLM_article-title">Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">14453</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span><span class="refDoi"> DOI: 10.1074/jbc.M801283200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1074%2Fjbc.M801283200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=14453-60&author=M.+Mihelicauthor=A.+Dobersekauthor=G.+Guncarauthor=D.+Turk&title=Inhibitory+fragment+from+the+p41+form+of+invariant+chain+can+regulate+activity+of+cysteine+cathepsins+in+antigen+presentation&doi=10.1074%2Fjbc.M801283200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M801283200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M801283200%26sid%3Dliteratum%253Aachs%26aulast%3DMihelic%26aufirst%3DM.%26aulast%3DDobersek%26aufirst%3DA.%26aulast%3DGuncar%26aufirst%3DG.%26aulast%3DTurk%26aufirst%3DD.%26atitle%3DInhibitory%2520fragment%2520from%2520the%2520p41%2520form%2520of%2520invariant%2520chain%2520can%2520regulate%2520activity%2520of%2520cysteine%2520cathepsins%2520in%2520antigen%2520presentation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D14453%26epage%3D60%26doi%3D10.1074%2Fjbc.M801283200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Brömme, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nallaseth, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, B.</span><span> </span><span class="NLM_article-title">Production and activation of recombinant papain-like cysteine proteases</span> <span class="citation_source-journal">Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span><span class="refDoi"> DOI: 10.1016/S1046-2023(03)00212-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1016%2FS1046-2023%2803%2900212-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=14698633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvFylsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=199-206&author=D.+Br%C3%B6mmeauthor=F.+S.+Nallasethauthor=B.+Turk&title=Production+and+activation+of+recombinant+papain-like+cysteine+proteases&doi=10.1016%2FS1046-2023%2803%2900212-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Production and activation of recombinant papain-like cysteine proteases</span></div><div class="casAuthors">Bromme, Dieter; Nallaseth, Ferez S.; Turk, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Methods (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-206</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">A review.  Papain-like cysteine proteases are the most numerous family of the cysteine protease class.  They are expressed throughout the animal and plant kingdoms as well as in viruses and bacteria.  More recently, this protease family has drawn attention as a potential pharmaceutical drug target in diseases characterized by excessive extracellular matrix degrdn. such as in osteoporosis, arthritis, vascular diseases, and cancer.  Moreover, papain-like cysteine proteases have been identified as crit. components of the life cycle and invasive potential of various human and live stock pathogens as well as major allergens.  Therefore, this protease class is rigorously studied and requires sufficient amts. of protease protein to analyze structure-activity relationships, their 3-D structures as well as to screen for and optimize potent and selective inhibitors.  This review summarizes approaches to generate active papain-like cysteine proteases by heterologous expression in a variety of expression systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzYKfIgOSvV7Vg90H21EOLACvtfcHk0lhrbzAzBgHbdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvFylsrg%253D&md5=054d0d0fb925185d7e8b3aab208110ac</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS1046-2023%2803%2900212-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1046-2023%252803%252900212-3%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25B6mme%26aufirst%3DD.%26aulast%3DNallaseth%26aufirst%3DF.%2BS.%26aulast%3DTurk%26aufirst%3DB.%26atitle%3DProduction%2520and%2520activation%2520of%2520recombinant%2520papain-like%2520cysteine%2520proteases%26jtitle%3DMethods%26date%3D2004%26volume%3D32%26spage%3D199%26epage%3D206%26doi%3D10.1016%2FS1046-2023%2803%2900212-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Rozman-Pungercar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopitar-Jerala, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogyo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasiljeva, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefe, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenabeele, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brömme, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puizdar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonović, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trstenjak-Prebanda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolenc, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, B.</span><span> </span><span class="NLM_article-title">Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1038/sj.cdd.4401247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1038%2Fsj.cdd.4401247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=12867995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlsVKltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=881-8&author=J.+Rozman-Pungercarauthor=N.+Kopitar-Jeralaauthor=M.+Bogyoauthor=D.+Turkauthor=O.+Vasiljevaauthor=I.+Stefeauthor=P.+Vandenabeeleauthor=D.+Br%C3%B6mmeauthor=V.+Puizdarauthor=M.+Fonovi%C4%87author=M.+Trstenjak-Prebandaauthor=I.+Dolencauthor=V.+Turkauthor=B.+Turk&title=Inhibition+of+papain-like+cysteine+proteases+and+legumain+by+caspase-specific+inhibitors%3A+when+reaction+mechanism+is+more+important+than+specificity&doi=10.1038%2Fsj.cdd.4401247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity</span></div><div class="casAuthors">Rozman-Pungercar, J.; Kopitar-Jerala, N.; Bogyo, M.; Turk, D.; Vasiljeva, O.; Stefe, I.; Vandenabeele, P.; Broemme, D.; Puizdar, V.; Fonovic, M.; Trstenjak-Prebanda, M.; Dolenc, I.; Turk, V.; Turk, B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">881-888</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report here that a no. of commonly used small peptide caspase inhibitors consisting of a caspase recognition sequence linked to chloromethylketone, fluoromethylketone or aldehyde reactive group efficiently inhibit other cysteine proteases than caspases.  The in vitro studies included cathepsins B, H, L, S, K, F, V, X and C, papain and legumain.  Z-DEVD-cmk was shown to be the preferred irreversible inhibitor of most of the cathepsins in vitro, followed by Z-DEVD-fmk, Ac-YVAD-cmk, Z-YVAD-fmk and Z-VAD-fmk.  Inactivation of legumain by all the inhibitors investigated was moderate, whereas cathepsins H and C were poorly inhibited or not inhibited at all.  Inhibition by aldehydes was not very potent.  All the three fluoromethylketones efficiently inhibited cathepsins in Jurkat and human embryonic kidney 293 cells at concns. of 100 μM.  Furthermore, they completely inhibited cathepsins B and X activity in tissue exts. at concns. as low as 1 μM.  These results suggest that data based on the use of these inhibitors should be taken with caution and that other proteases may be implicated in the processes previously ascribed solely to caspases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGop9XTbZyjPkrVg90H21EOLACvtfcHk0lhrbzAzBgHbdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlsVKltr0%253D&md5=79ebc0cf9b626f818a9ea345598defdb</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4401247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4401247%26sid%3Dliteratum%253Aachs%26aulast%3DRozman-Pungercar%26aufirst%3DJ.%26aulast%3DKopitar-Jerala%26aufirst%3DN.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DTurk%26aufirst%3DD.%26aulast%3DVasiljeva%26aufirst%3DO.%26aulast%3DStefe%26aufirst%3DI.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DBr%25C3%25B6mme%26aufirst%3DD.%26aulast%3DPuizdar%26aufirst%3DV.%26aulast%3DFonovi%25C4%2587%26aufirst%3DM.%26aulast%3DTrstenjak-Prebanda%26aufirst%3DM.%26aulast%3DDolenc%26aufirst%3DI.%26aulast%3DTurk%26aufirst%3DV.%26aulast%3DTurk%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520papain-like%2520cysteine%2520proteases%2520and%2520legumain%2520by%2520caspase-specific%2520inhibitors%253A%2520when%2520reaction%2520mechanism%2520is%2520more%2520important%2520than%2520specificity%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2003%26volume%3D10%26spage%3D881%26epage%3D8%26doi%3D10.1038%2Fsj.cdd.4401247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Greco, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakala, M. T.</span><span> </span><span class="NLM_article-title">Evaluation of methods for estimating the dissociation constant of tight binding enzyme inhibitors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">254</span><span class="NLM_x">, </span> <span class="NLM_fpage">12104</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1016%2FS0021-9258%2819%2986435-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=500698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADyaL3cXitlem" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=1979&pages=12104-9&author=W.+R.+Grecoauthor=M.+T.+Hakala&title=Evaluation+of+methods+for+estimating+the+dissociation+constant+of+tight+binding+enzyme+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of methods for estimating the dissociation constant of tight binding enzyme inhibitors</span></div><div class="casAuthors">Greco, William R.; Hakala, Maire T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">254</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">12104-9</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">A Monte Carlo simulation was used to compare 11 methods for estg. the Ki of tight binding enzyme inhibitors.  The methods were evaluated for both accuracy and precision.  Parameters were chosen to simulate the inhibition of dihydrofolate reductase by methotrexate, using dihydrofolate as substrate.  These parameters were: Ki, 100 pM; turnover no., 500/min; molar equivalency of enzyme, 400 pM/unit; dihydrofolate concn., 50 μM; and Km, 0.5 μM.  Inputs of total enzyme concn. (Et) and total inhibitor concn. (It) were chosen to keep the value of Et/Ki between 4 and 20 and to allow estn. of the concn. of the inhibitor causing 50% inhibition (I50) at each Et.  Four types of error were introduced into the simulated data: small abs., large abs., small relative, and large relative error.  Computer methods based on the equations of W. W. Ackermann and V. R. Potter (1949) and J. F. Morrison (1969) which utilized nonlinear regression, proved to be significantly more precise than the methods which would require the use of only pencil and paper.  Based on these findings a review of the published Ki values for the inhibition of dihydrofolate reductase by methotrexate is also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqahqxjd5cipLVg90H21EOLACvtfcHk0lhrbzAzBgHbdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXitlem&md5=b238cb9e286f95a348838d70cb9908f1</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2819%2986435-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252819%252986435-9%26sid%3Dliteratum%253Aachs%26aulast%3DGreco%26aufirst%3DW.%2BR.%26aulast%3DHakala%26aufirst%3DM.%2BT.%26atitle%3DEvaluation%2520of%2520methods%2520for%2520estimating%2520the%2520dissociation%2520constant%2520of%2520tight%2520binding%2520enzyme%2520inhibitors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1979%26volume%3D254%26spage%3D12104%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Cherney, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecaille, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kienitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nallaseth, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brömme, D.</span><span> </span><span class="NLM_article-title">Structure-activity analysis of cathepsin K/chondroitin 4-sulfate interactions</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">8988</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span><span class="refDoi"> DOI: 10.1074/jbc.M110.126706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1074%2Fjbc.M110.126706" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=8988-98&author=M.+M.+Cherneyauthor=F.+Lecailleauthor=M.+Kienitzauthor=F.+S.+Nallasethauthor=Z.+Liauthor=M.+N.+Jamesauthor=D.+Br%C3%B6mme&title=Structure-activity+analysis+of+cathepsin+K%2Fchondroitin+4-sulfate+interactions&doi=10.1074%2Fjbc.M110.126706"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.126706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.126706%26sid%3Dliteratum%253Aachs%26aulast%3DCherney%26aufirst%3DM.%2BM.%26aulast%3DLecaille%26aufirst%3DF.%26aulast%3DKienitz%26aufirst%3DM.%26aulast%3DNallaseth%26aufirst%3DF.%2BS.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DJames%26aufirst%3DM.%2BN.%26aulast%3DBr%25C3%25B6mme%26aufirst%3DD.%26atitle%3DStructure-activity%2520analysis%2520of%2520cathepsin%2520K%252Fchondroitin%25204-sulfate%2520interactions%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D8988%26epage%3D98%26doi%3D10.1074%2Fjbc.M110.126706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Kirschke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlings, N. D.</span><span> </span><span class="NLM_article-title">Proteinases 1: lysosomal cysteine proteinases</span> <span class="citation_source-journal">Protein Profile</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1581</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=8771190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A280%3ADyaK28zmslSktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1995&pages=1581-643&author=H.+Kirschkeauthor=A.+J.+Barrettauthor=N.+D.+Rawlings&title=Proteinases+1%3A+lysosomal+cysteine+proteinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Proteinases 1: lysosomal cysteine proteinases</span></div><div class="casAuthors">Kirschke H; Barrett A J; Rawlings N D</div><div class="citationInfo"><span class="NLM_cas:title">Protein profile</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1581-643</span>
        ISSN:<span class="NLM_cas:issn">1070-3667</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS0OZVgEAMqxrGbPKh4T9eAfW6udTcc2ebmfEfptE1wzLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28zmslSktA%253D%253D&md5=0e4c2b201e1530f454632c47c4d5e4c1</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKirschke%26aufirst%3DH.%26aulast%3DBarrett%26aufirst%3DA.%2BJ.%26aulast%3DRawlings%26aufirst%3DN.%2BD.%26atitle%3DProteinases%25201%253A%2520lysosomal%2520cysteine%2520proteinases%26jtitle%3DProtein%2520Profile%26date%3D1995%26volume%3D2%26spage%3D1581%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Turk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colić, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoka, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, V.</span><span> </span><span class="NLM_article-title">Kinetics of inhibition of bovine cathepsin S by bovine stefin B</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span><span class="refDoi"> DOI: 10.1016/0014-5793(94)80405-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1016%2F0014-5793%2894%2980405-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=1994&pages=155-159&author=B.+Turkauthor=A.+Coli%C4%87author=V.+Stokaauthor=V.+Turk&title=Kinetics+of+inhibition+of+bovine+cathepsin+S+by+bovine+stefin+B&doi=10.1016%2F0014-5793%2894%2980405-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2894%2980405-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252894%252980405-2%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DB.%26aulast%3DColi%25C4%2587%26aufirst%3DA.%26aulast%3DStoka%26aufirst%3DV.%26aulast%3DTurk%26aufirst%3DV.%26atitle%3DKinetics%2520of%2520inhibition%2520of%2520bovine%2520cathepsin%2520S%2520by%2520bovine%2520stefin%2520B%26jtitle%3DFEBS%2520Lett.%26date%3D1994%26volume%3D339%26spage%3D155%26epage%3D159%26doi%3D10.1016%2F0014-5793%2894%2980405-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Morrison, J. F.</span><span> </span><span class="NLM_article-title">The slow-binding and slow, tight-binding inhibition of enzyme-catalysed reactions</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1016/0968-0004(82)90157-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1016%2F0968-0004%2882%2990157-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADyaL38XhslKrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1982&pages=102-105&author=J.+F.+Morrison&title=The+slow-binding+and+slow%2C+tight-binding+inhibition+of+enzyme-catalysed+reactions&doi=10.1016%2F0968-0004%2882%2990157-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">The slow-binding and slow, tight-binding inhibition of enzyme-catalyzed reactions</span></div><div class="casAuthors">Morrison, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">102-5</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    </div><div class="casAbstract">The mechanisms of enzyme inhibition by slow-binding and slow, tight-binding reversible inhibitors are discussed, as well as the kinetics of these processes as opposed to classical and tight-binding inhibitor mechanisms.  Examples of these types of inhibitors in the enzyme literature are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoun0ayjodbYrVg90H21EOLACvtfcHk0lhzm5mvGzQMng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XhslKrtrw%253D&md5=1740627c1ad2adf182f4c0ae355bb4de</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0968-0004%2882%2990157-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0968-0004%252882%252990157-8%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DJ.%2BF.%26atitle%3DThe%2520slow-binding%2520and%2520slow%252C%2520tight-binding%2520inhibition%2520of%2520enzyme-catalysed%2520reactions%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D1982%26volume%3D7%26spage%3D102%26epage%3D105%26doi%3D10.1016%2F0968-0004%2882%2990157-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Invitrogen</span><span class="NLM_x">. </span><span> </span><span class="NLM_article-title">Pichia Expression Kit</span>. <a href="http://tools.thermofisher.com/content/sfs/manuals/pich_man.pdf" class="extLink">http://tools.thermofisher.com/content/sfs/manuals/pich_man.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Invitrogen.+Pichia+Expression+Kit.+http%3A%2F%2Ftools.thermofisher.com%2Fcontent%2Fsfs%2Fmanuals%2Fpich_man.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DPichia%2520Expression%2520Kit" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Mueller, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darowski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Förster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellmig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paithankar, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pühringer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zocher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. S.</span><span> </span><span class="NLM_article-title">Facilities for macromolecular crystallography at the Helmholtz-Zentrum Berlin</span> <span class="citation_source-journal">J. Synchrotron Radiat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1107/S0909049512006395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1107%2FS0909049512006395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=22514183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFGhu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=442-449&author=U.+Muellerauthor=N.+Darowskiauthor=M.+R.+Fuchsauthor=R.+F%C3%B6rsterauthor=M.+Hellmigauthor=K.+S.+Paithankarauthor=S.+P%C3%BChringerauthor=M.+Steffienauthor=G.+Zocherauthor=M.+S.+Weiss&title=Facilities+for+macromolecular+crystallography+at+the+Helmholtz-Zentrum+Berlin&doi=10.1107%2FS0909049512006395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Facilities for macromolecular crystallography at the Helmholtz-Zentrum Berlin</span></div><div class="casAuthors">Mueller, Uwe; Darowski, Nora; Fuchs, Martin R.; Foerster, Ronald; Hellmig, Michael; Paithankar, Karthik S.; Puehringer, Sandra; Steffien, Michael; Zocher, Georg; Weiss, Manfred S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Synchrotron Radiation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">442-449</span>CODEN:
                <span class="NLM_cas:coden">JSYRES</span>;
        ISSN:<span class="NLM_cas:issn">0909-0495</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Three macromol. crystallog. (MX) beamlines at the Helmholtz-Zentrum Berlin (HZB) are available for the regional, national and international structural biol. user community.  The state-of-the-art synchrotron beamlines for MX BL14.1, BL14.2 and BL14.3 are located within the low-β section of the BESSY II electron storage ring.  All beamlines are fed from a superconducting 7 T wavelength-shifter insertion device.  BL14.1 and BL14.2 are energy tunable in the range 5-16 keV, while BL14.3 is a fixed-energy side station operated at 13.8 keV.  All three beamlines are equipped with CCD detectors.  BL14.1 and BL14.2 are in regular user operation providing about 200 beam days per yr and about 600 user shifts to approx. 50 research groups across Europe.  BL14.3 has initially been used as a test facility and was brought into regular user mode operation during the year 2010.  BL14.1 has recently been upgraded with a microdiffractometer including a mini-κ goniometer and an automated sample changer.  Addnl. user facilities include office space adjacent to the beamlines, a sample prepn. lab., a biol. lab. (safety level 1) and high-end computing resources.  In this article the instrumentation of the beamlines is described, and a summary of the exptl. possibilities of the beamlines and the provided ancillary equipment for the user community is given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEtRGj9KmXzLVg90H21EOLACvtfcHk0lh2etgsAG1syg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFGhu7o%253D&md5=f065b38da0a77d30031a9db5a67eb1cc</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1107%2FS0909049512006395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0909049512006395%26sid%3Dliteratum%253Aachs%26aulast%3DMueller%26aufirst%3DU.%26aulast%3DDarowski%26aufirst%3DN.%26aulast%3DFuchs%26aufirst%3DM.%2BR.%26aulast%3DF%25C3%25B6rster%26aufirst%3DR.%26aulast%3DHellmig%26aufirst%3DM.%26aulast%3DPaithankar%26aufirst%3DK.%2BS.%26aulast%3DP%25C3%25BChringer%26aufirst%3DS.%26aulast%3DSteffien%26aufirst%3DM.%26aulast%3DZocher%26aufirst%3DG.%26aulast%3DWeiss%26aufirst%3DM.%2BS.%26atitle%3DFacilities%2520for%2520macromolecular%2520crystallography%2520at%2520the%2520Helmholtz-Zentrum%2520Berlin%26jtitle%3DJ.%2520Synchrotron%2520Radiat.%26date%3D2012%26volume%3D19%26spage%3D442%26epage%3D449%26doi%3D10.1107%2FS0909049512006395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Krug, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinemann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, U.</span><span> </span><span class="NLM_article-title">XDSAPP: a graphical user interface for the convenient processing of diffraction data using XDS</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">568</span><span class="NLM_x">–</span> <span class="NLM_lpage">572</span><span class="refDoi"> DOI: 10.1107/S0021889812011715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1107%2FS0021889812011715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsFGmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2012&pages=568-572&author=M.+Krugauthor=M.+S.+Weissauthor=U.+Heinemannauthor=U.+Mueller&title=XDSAPP%3A+a+graphical+user+interface+for+the+convenient+processing+of+diffraction+data+using+XDS&doi=10.1107%2FS0021889812011715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">XDSAPP: a graphical user interface for the convenient processing of diffraction data using XDS</span></div><div class="casAuthors">Krug, Michael; Weiss, Manfred S.; Heinemann, Udo; Mueller, Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">568-572</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">XDSAPP is a Tcl/Tk-based graphical user interface for the easy and convenient processing of diffraction data sets using XDS.  It provides easy access to all XDS functionalities, automates the data processing and generates graphical plots of various data set statistics provided by XDS.  By incorporating addnl. software, further information on certain features of the data set, such as radiation decay during data collection or the presence of pseudo-translational symmetry and/or twinning, can be obtained.  Intensity files suitable for CCP4, CNS and SHELX are generated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCqFLQ2J-k07Vg90H21EOLACvtfcHk0lh2etgsAG1syg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsFGmtLo%253D&md5=8f0b78fdea7ed6cc580de9eb561e8b9e</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1107%2FS0021889812011715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889812011715%26sid%3Dliteratum%253Aachs%26aulast%3DKrug%26aufirst%3DM.%26aulast%3DWeiss%26aufirst%3DM.%2BS.%26aulast%3DHeinemann%26aufirst%3DU.%26aulast%3DMueller%26aufirst%3DU.%26atitle%3DXDSAPP%253A%2520a%2520graphical%2520user%2520interface%2520for%2520the%2520convenient%2520processing%2520of%2520diffraction%2520data%2520using%2520XDS%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2012%26volume%3D45%26spage%3D568%26epage%3D572%26doi%3D10.1107%2FS0021889812011715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Mccoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Phaser crystallographic software</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+Mccoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lh2etgsAG1syg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMccoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skubák, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebedev, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholls, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span> </span><span class="NLM_article-title">REFMAC5 for the refinement of macromolecular crystal structures</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span><span class="refDoi"> DOI: 10.1107/S0907444911001314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1107%2FS0907444911001314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=21460454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=355-367&author=G.+N.+Murshudovauthor=P.+Skub%C3%A1kauthor=A.+A.+Lebedevauthor=N.+S.+Pannuauthor=R.+A.+Steinerauthor=R.+A.+Nichollsauthor=M.+D.+Winnauthor=F.+Longauthor=A.+A.+Vagin&title=REFMAC5+for+the+refinement+of+macromolecular+crystal+structures&doi=10.1107%2FS0907444911001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 for the refinement of macromolecular crystal structures</span></div><div class="casAuthors">Murshudov, Garib N.; Skubak, Pavol; Lebedev, Andrey A.; Pannu, Navraj S.; Steiner, Roberto A.; Nicholls, Robert A.; Winn, Martyn D.; Long, Fei; Vagin, Alexei A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">This paper describes various components of the macromol. crystallog. refinement program REFMAC5, which is distributed as part of the CCP4 suite.  REFMAC5 utilizes different likelihood functions depending on the diffraction data employed (amplitudes or intensities), the presence of twinning and the availability of SAD/SIRAS exptl. diffraction data.  To ensure chem. and structural integrity of the refined model, REFMAC5 offers several classes of restraints and choices of model parameterization.  Reliable models at resolns. at least as low as 4 Å can be achieved thanks to low-resoln. refinement tools such as secondary-structure restraints, restraints to known homologous structures, automatic global and local NCS restraints, 'jelly-body' restraints and the use of novel long-range restraints on at. displacement parameters (ADPs) based on the Kullback-Leibler divergence.  REFMAC5 addnl. offers TLS parameterization and, when high-resoln. data are available, fast refinement of anisotropic ADPs.  Refinement in the presence of twinning is performed in a fully automated fashion.  REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for refinement across the entire resoln. spectrum encountered in macromol. crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Jq-i2qIq5rVg90H21EOLACvtfcHk0lh2etgsAG1syg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D&md5=f8f3202d246908500057ad7c71015b7b</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1107%2FS0907444911001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911001314%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DSkub%25C3%25A1k%26aufirst%3DP.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26atitle%3DREFMAC5%2520for%2520the%2520refinement%2520of%2520macromolecular%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D355%26epage%3D367%26doi%3D10.1107%2FS0907444911001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Turk, D.</span><span> </span><span class="NLM_article-title">MAIN software for density averaging, model building, structure refinement and validation</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1342</span><span class="NLM_x">–</span> <span class="NLM_lpage">1357</span><span class="refDoi"> DOI: 10.1107/S0907444913008408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1107%2FS0907444913008408" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1342-1357&author=D.+Turk&title=MAIN+software+for+density+averaging%2C+model+building%2C+structure+refinement+and+validation&doi=10.1107%2FS0907444913008408"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1107%2FS0907444913008408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444913008408%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DD.%26atitle%3DMAIN%2520software%2520for%2520density%2520averaging%252C%2520model%2520building%252C%2520structure%2520refinement%2520and%2520validation%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26spage%3D1342%26epage%3D1357%26doi%3D10.1107%2FS0907444913008408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0li2lWPh10WtCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DMX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DMX','PDB','4DMX'); return false;">PDB: 4DMX</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X6J" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X6J','PDB','4X6J'); return false;">PDB: 4X6J</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X6I" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X6I','PDB','4X6I'); return false;">PDB: 4X6I</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X6H" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X6H','PDB','4X6H'); return false;">PDB: 4X6H</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i42"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00746">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_84484"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b00746">10.1021/acs.jmedchem.5b00746</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Additional details of combinatorial data set and consensus modeling, tables of crystallographic data, schematic representation of virtual synthetic pathways, reversibility test, NMR spectra (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b00746/suppl_file/jm5b00746_si_001.pdf">PDF</a>)</p></li><li><p class="inline">CSV file containing molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b00746/suppl_file/jm5b00746_si_002.csv">CSV</a>)</p></li><li><p class="inline">Additional experimental and combinatorial data and consensus results (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b00746/suppl_file/jm5b00746_si_003.xlsx">XLSX</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00746/suppl_file/jm5b00746_si_001.pdf">jm5b00746_si_001.pdf (4.07 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00746/suppl_file/jm5b00746_si_002.csv">jm5b00746_si_002.csv (0.88 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00746/suppl_file/jm5b00746_si_003.xlsx">jm5b00746_si_003.xlsx (161.63 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB ID codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X6J">4X6J</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X6I">4X6I</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X6H">4X6H</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00746&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-17%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00746%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00746" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67995baac9333ddd","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
